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 FRET is an indispensable tool for the study of membrane proteins, however the 
theory to describe the measured FRET of membrane proteins is not complete, and a robust 
method to measure FRET from small regions of fluorescence of labeled membrane proteins 
in live cells does not exist.  In this work, I extend the theory of FRET for two-dimensional 
distributions of membrane proteins to account for FRET that occurs in the absence of 
specific protein-protein interactions, and occurs solely due to confinement in two 
dimensions.  I then develop a fluorescence imaging methodology that allows for the 
measurement of membrane protein surface densities and FRET efficiencies in small, ~3 
micron-sized patches of membrane in live cells, in a mathematically approximation-free 
manner.  I demonstrate the utility of this improved FRET theory and new methodology by 
measuring the thermodynamic properties of one specific cell membrane receptor that is 
critical for angiogenesis, VEGFR2, in the absence and presence of its activating ligand, 
VEGF.   
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Chapter 1.  Introduction 
 
1-1.  VEGF and VEGFR2 
 Belonging to the second largest family of signal transducing proteins, Receptor 
Tyrosine Kinases (RTKs) epitomize functional regulation through lateral interaction in the 
plasma membrane 1-5. RTK dimerization is necessary for RTK function, as contacts 
between the intracellular kinase domains lead to kinase cross-phosphorylation and 
initiation of downstream signaling cascades that control cell growth, differentiation and 
motility during development and in the adult, and in many pathologies such as  cancers and 
growth disorders1,6. While  RTK dimerization has been long assumed to occur in response  
to ligand binding,  recent work has suggested that RTKs have a propensity to interact and 
even in the absence of bound ligand, thus challenging the canonical view of RTK ligand-
induced dimerization and activation 7,8.  It is thus possible that the intrinsic thermodynamic 
properties of the RTK present a ‘pre-formed’ dimer that is primed for a structural shift 
upon ligand binding.  Yet, the mode of activation of many RTKs has thus far remained 
controversial, and is still a topic of intense investigations and debate.  
  Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is a 151 kDa 
member of the RTK family.  After heavy glycosylation, the final form of VEGFR2 is has 
a molecular weight of nearly 250 kDa9.  VEGFR2 is the main regulator for angiogenesis, 
the formation of new blood vessels from existing vasculature, and vasculogenesis, the de 
novo formation of new blood vessels in tissues 10-14.  VEGFR2 has a typical RTK structure 
consisting of an Extracellular (EC) domain, a single-pass alpha-helical Transmembrane 
(TM) domain, and an intracellular Kinase domain.  VEGFR2’s EC domain is one of the 
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largest of the RTK family, consisting of seven Ig-like domains, known as subunits D1-D7.  
Subunit D1 is a the N-terminal side of the protein, with subunits D2-D3 consisting of the 
binding domain for VEGFR2’s activating ligand.  Subunits D4 and D7 have been identified 
as domains participating in “homotypic contacts,” which are essential for stabilizing the 
active form of the ligand-bound VEGFR2 dimer15-18.   It is currently an open question as 
to whether these homotypic contacts can occur in the absence of ligand, and roles of each 
subunit in the context of the live cell membrane remain unknown.   
 VEGFR2 is a signal transducing protein which is primarily found in the membranes 
of endothelial cells in the vascular system, though a number of difference cell types in 
various tissues also express VEGFR2 in their membranes19-22.  VEGFR2 is activated upon 
paracrine or autocrine stimulation by Vascular Endothelial Growth Factor (VEGF), which 
is predominantly released by cells under hypoxic conditions, though a number of different 
conditions and events can elicit VEGF secretion by cells23,24.  Enhanced and suppressed 
VEGF signaling occurs in a number of pathogenic conditions, making VEGF and VEGFR2 
active targets for both anti- and pro-angiogenic research and drug development.     
 VEGF is found in the body as a disulfide linked homodimer 25.  There are several 
isoforms of VEGF, and the focus of this work will be with the ‘labile’ form of VEGFA, 
VEGF121.  VEGF121 is a 28 kDa soluble disulfide-linked homodimer of two 121 amino 
acid chains, which lacks the binding site required for retention in extracellular matrix.  This 
binding site enables interactions between VEGF and a number of binding partners besides 
VEGFR2 such as heparan-sulfate proteoglycans or Neuropilin 114,26,27.  VEGF121 binds 
specifically to VEGFR2’s EC domain, and it is not retained in the extracellular matrix of 
the cells, like other forms of VEGF11,13,14,24,28.  This property of VEGF121 makes it a great 
3 
 
candidate for the study of VEGF interactions with VEGFR2 EC domains, as non-specific 
ligand-cell interactions are minimized.   
 It was recently shown in the Hristova Lab that full-length VEGFR2 constructs 
dimerize in the absence of VEGF, with low levels of basal kinase domain cross-
phosphorylation 29.  It was also shown that a structural shift occurs upon VEGF binding to 
VEGFR2 under saturating conditions of VEGF, and this structural shift is responsible for 
transmitting the ligand-bound state to the intracellular side of the cell, allowing for full 
cross-phosphorylation and signal transduction  29. 
 Current knowledge of the VEGF affinity for VEGFR2 is limited in that it is not 
known whether or not the affinity of VEGF is enhanced for dimeric VEGFR2 on the cell 
surface, or if the affinity is simply twice that of the affinity of VEGF for monomeric 
VEGFR2 due to the symmetric binding sites in the dimer.  This lack of understanding is 
due to the lack of methodology to study receptor-ligand interactions at the molecular level, 
and in the context of the live-cell membrane.  Previous studies have utilized estimations of 
the surface area of the cell, around 1,000 square-microns, and the number of receptors per 
cell for measurements of the affinity of VEGF for VEGFR2.  Other research groups have 
utilized ITC binding experiments to measure the affinity of soluble, isolated VEGFR2 EC 
domains in an artificially constructed monomeric or dimeric form 15.  However, these 
models do not account for the monomeric and dimeric fractions of VEGFR2, as driven by 
the local effective concentration of receptors on the cell surface through the law of mass 
action.   
 Several mechanisms for VEGF activation of VEGFR2 can be postulated.  One 
possible mechanism for VEGF activation of VEGFR2 is that the VEGF can bind to 
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monomeric VEGFR2, with then undergoes dimerization with a structural shift that is 
transmitted to the Kinase domains through the TM domain, and allows for full cross-
phosphorylation and activation of the receptor.  A second possibility is that VEGF binds to 
a pre-formed dimer of VEGFR2, which exists naturally in a monomer-dimer equilibrium 
in the membrane of the cell, and then after VEGF binds,  a structural shift occurs that is 
then transmitted to the Kinase domains, which are then properly oriented for full cross-
phosphorylation and signal transduction.  Under heavily saturating conditions of VEGF, 
one could even imagine a situation where the monomeric forms of VEGFR2 all have a 
bound VEGF molecule, which would then inhibit dimerization of VEGFR2 through a steric 
clash of a bound VEGF molecule on each monomeric receptor.   Despite the fact that VEGF 
and VEGFR2 are one of the most intensely studied signaling components, the sequence-
specific EC domain interactions of VEGFR2 are still not fully understood, and mode of 
activation of VEGFR2 by VEGF binding remains unclear.  Figure 1-1 below shows the 
current understanding of VEGFR2/VEGF interactions at the beginning of my work, 






        
Figure 1-1.  The model for VEGFR2-VEGF interactions at the start of my work.  
Left: VEGFR2 is a membrane protein belonging to the RTK family of receptors, and 
it is essential for angiogenesis.  From N-terminus to C-terminus, it consists of an 
Extracellular (EC) domain with seven Ig-like subunits D1-D7, a single-pass alpha 
helical Transmembrane) domain, and an intracellular tyrosine kinase domain, as 
shown on the left.  Upon stimulation of VEGFR2 with VEGF, which binds to the D2 
and D3 (yellow) domains of VEGFR2 dimers.  Homotypic D4-D4 and D7-D7 
contacts (blue subdomains, with stars indicating contacts) stabilize the ligand-bound 
dimer, which then undergoes cross-phosphorylation of the kinase domains and 
subsequent signal transduction.    Far right: In this work, I utilize VEGF labeled with 
Alexa Fluor 594(AF594-VEGF), and a truncated form of VEGFR2 having only the 
EC and TM domains, VEGFR2 ECTM.  I utilize VEGFR2 ECTM in which the kinase 
domain is replaced with a fluorescent protein, YFP, to study the interactions of 
VEGFR2 ECTM domains with themselves in the absence of VEGF, and the binding 
affinity of VEGF for monomeric and dimeric forms of VEGFR2 EC domains in the 
context of the live cell membrane.     
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1-2.  Förster’s Theory of Resonance Energy Transfer  
 When the electrons of an optically-active molecule such as a fluorescent protein 
absorb energy, they are energized to higher energy levels.  The probability that a 
fluorophore will emit a photon given an excitation event is known as the quantum yield, 𝑄, 
of that fluorophore.  When another optically active molecule is near a fluorophore existing 
in an excited electronic state, the excited molecule can transfer its energy to the nearby 
molecule in a radiation-less transfer of energy.  This second molecule can then fluoresce, 
and emit a photon.  In this manner, the quantum yield of the donor is reduced by the 
quenched donor fluorescence in the presence of acceptor chromophores.  Similarly, the 
acceptor’s fluorescence is enhanced, or sensitized, and the quantum yield of the acceptor 
is enhanced in the presence of donors30-33.  This radiation-less transfer of energy between 
donor and acceptor chromophores is a quantum mechanical phenomenon that was first 
described mathematically through a consideration of classical electrodynamics and an 
excited-state dipole-dipole coupling by Theodore Förster, in 194634.  Appropriately, this 
form of resonant energy transfer is known as Förster’s Resonance Energy Transfer, or 
FRET 32,35.   
 Förster calculated a 𝑅−6 distance dependence on the rate of FRET between a donor 















In Equation (1-1), 𝜏𝐷 is the fluorescence lifetime of the donor in the absence of FRET.  𝑅 
is the distance from the donor to the acceptor chromophore and 𝑅0 is a numerical quantity 
known as the Förster radius, which is typically ~5 nm.  This strong distance dependence is 
the reason FRET is now often referred to as a “molecular ruler,” as it is capable of probing 
distances on the range of 10-100 nm.   
 The efficiency of resonant energy transfer between a single donor and acceptor 
molecule is known as the intrinsic FRET Efficiency of the donor-acceptor pair and is 
defined as: 





Equation (1-2), the intrinsic FRET efficiency is the ratio of the rate of donor de-excitation 
to the sum of all intrinsic donor de-excitation pathways, including FRET.  These intrinsic 
de-excitation rate pathways include the fundamental radiative emission rate, the rate of 
internal conversion leading to de-excitation without emission of a photon, rates of 
intersystem crossing, collisional quenching, the rate of photo-destruction, etc.   
 Substitution of Equation (1-1) into Equation (1-2) gives the FRET efficiency of a 








 .   
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 Förster’s radius is the distance at which the rate of donor radiation in the absence 
of FRET is equal the rate of resonant energy transfer and is a physical property of the 
donor-acceptor FRET pair ( ?̃? = 0.5  at this distance): 
 
𝑅0 = [






 𝑅0 is a function of the index of refraction, 𝑛, the quantum yield of the donor in the absence 
of FRET, 𝑄𝐷 , a dipole-dipole orientation factor known as kappa-squared, 𝜅
2 , and an 
overlap integral, 𝐽(𝜆).  𝑁𝐴 is Avagadro’s number.  In Equation (1-4), 𝑅0 and 𝜆 are in units 
of centimeters.   
 The overlap integral, 𝐽(?̅?), is an integral over all emission wavelengths, over the 
product of the acceptor’s molar extinction coefficient, 𝜀𝐴(𝜆), in units of cm
-1 mol-1, with 
the normalized fluorescence emission spectrum of the donor, 𝑓𝐷(𝜆), and the wavelength to 
the fourth power: 
 






The dipole-dipole orientation factor known as kappa-squared, 𝜅2 , is a function of the 










Here, ?̂?𝑨 is the unit dipole moment of the acceptor.  ?̂? is the unit vector that points from 
the donor chromophore to the acceptor chromophore, and ?̂?𝑫 is the unit normal vector to 
?̂?, and is parallel to the plane defined by ?̂? and and ?⃑? 𝑫, the donor dipole moment.  If one 
assumes that the acceptor samples all possible configurations during the FRET lifetime, ~ 
10-9 seconds, the defining characteristic of the dynamic isotropic regime for FRET, then 
𝜅2 = 2/3.    
 In this work, I utilize the fluorescent proteins mTurquoise and YFP connected to 
membrane proteins through a flexible GGS5 linker to measure FRET, and to ultimately 
determine membrane protein thermodynamic properties through these FRET 
measurements.  mTurquoise and YFP are fluorescent proteins that were both derived from 
GFP, the original green fluorescent protein isolated from the jellyfish Aequorea 
victoria36,36-39.   Comprised of 238 amino acids, these fluorescent proteins are large 27 kDa 
moieties with a eleven-stranded beta-barrel structure.  The chromophore of the fluorescent 
proteins exists within a kinked alpha helix found in the center of the fluorescent protein’s 
beta barrel.   The quantum yield of mTurqoise, the donor, is 𝑄𝐷 = 0.84, with YFP as the 
FRET acceptor, having a quantum yield, 𝑄𝐴 = 0.61.  I have measured the Förster radius 
of the mTurquoise-YFP FRET pair to be 5.5 nm.   
 The nanosecond FRET lifetime is far too short for any appreciable motion of the 
fluorescent proteins to occur, and thus the FRET experiments in this work occur in the 
static isotropic regime, instead of the dynamic isotropic regime described above.  The use 
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of the GGS5 flexible linkers ensures that the distribution of excited fluorescent proteins in 
the voxel is random.  In the static isotropic regime, all possible donor-acceptor orientations 
are found in the excited ensemble, but their motion is static during the FRET lifetime 40.  
This means that in general, in my experiments, the orientation factor 𝜅2 is not equal to 2/3 
40.  However, it has been shown that even a 100% error in the value of orientation factor 
only leads to a 12% error in the value of the calculated Förster radius, 𝑅0.  In general, the 
error in the orientation factor and the associated error in 𝑅0 are smaller than the error of 
cell-membrane total apparent FRET efficiency measurements performed in these 
experiments 40.  Regardless, I will avoid talking about the distance between the donor and 
the acceptor for a given intrinsic FRET value, but if I do give a distance, I will utilize the 
assumption of 𝜅2 = 2/3.  Thus, if the intrinsic FRET of a donor-acceptor pair increases 
when some condition is changed, the donor-acceptor distance must necessarily decrease, 
and vice versa for a decrease in the intrinsic FRET efficiency where the donor-acceptor 
distance must increase, regardless of the value of the orientation factor.    
 It should be stressed that the value of the Förster radius will only explicitly come 
into use during the interpretation of the measured intrinsic FRET efficiency, if a donor-
acceptor distance is calculated from an intrinsic FRET value.  The theory described above 
only accounts for the FRET between a single donor and an acceptor and in Chapter 2, I 
will extend the theory of FRET to entire ensembles of excited donor and acceptors existing 
in two-dimensions.  As shown in Chapter 4, the actual measurements of the FRET 
efficiencies do not utilize the calculable value for 𝑅0, and only uses only the well-known 




1-3.  Objectives 
 Out of the many interactions that occur between biological macromolecules, the 
interactions between membrane proteins are the least understood due to lack of adequate 
quantitative experimental methodologies 41-46. Yet, these interactions regulate vital cellular 
processes such as signal transduction, nutrient uptake, and motility.  Since roughly one 
third of the open reading frames in the human genome encode for membrane proteins, this 
means that we are very far from truly understanding cells and membrane proteins at a 
meaningful level.  One experimental tool that has provided a wealth of knowledge on 
membrane proteins is fluorescence microscopy, and in particular, measurements of the 
FRET, Förster resonant energy transfer 47-54.  In these experiments, membrane proteins 
linked to fluorescent proteins are used to probe the stoichiometry and association strengths.  
However, since fluorescent protein (FP)-labeled membrane proteins are confined to the 
locally two-dimensional lipid bilayer, the stochastic FRET, or FRET due to close proximity 
of an acceptor to an excited donor, but without any direct protein-protein interaction, 
becomes a substantial component of the measured signal.  Furthermore, it was not even 
known if FRET measurements of the kind being currently performed actually meant 
anything, as the limits of oligomer discernment with two-color FRET is not known.   
The primary, though admittedly not the initial, objective for my thesis research was 
to fully understand the effects of stochastic FRET and the limitations of FRET 
measurements in general.  At the beginning of my time with the Hristova Lab, the effects 
and magnitude of the stochastic FRET were not understood, though it was known that 
stochastic FRET could occur.  The models for the theoretical FRET were written down 
without accounting for stochastic FRET.  Through collaboration with Dr. Raicu in the 
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mathematical extension of the FRET theory to account for inter-oligomeric FRET as well 
as intra-oligomeric FRET, I have developed a mathematical framework that allows one to 
properly account for stochastic FRET in the data analysis of a quantitative FRET 
experiment, where the total concentration of labeled membrane proteins is known, in 
addition to the total apparent FRET efficiency.  I performed simulations of static quenching 
FRET experiments in cell membranes, and I show that the association constant and the 
oligomerization state can be extracted from the total apparent FRET efficiency.  I also have 
surprisingly (or not, depending on whom is asked) found that the FRET signatures of 
oligomerizing membrane proteins are not unique.  In other words, static quenching FRET 
experiments can be used to distinguish monomeric, and dimeric membrane proteins, but 
cannot discern the order of higher order oligomerization because the total apparent FRET 
efficiency of higher order oligomerization is not unique.   This is a controversial finding, 
as many researchers are currently claiming measurements of tetramers or higher-order 
oligomers. 
 In addition to the theoretical issues surrounding analysis of FRET measurements in 
membranes, there are quantitative issues surrounding the measurement of FRET itself, in 
solution and in cell membranes.  Thus, the second objective of my thesis work was to 
develop a robust method for FRET measurement in live cells.  Prior to this work, 
quantitative FRET experiments were performed using models with adjustable parameters 
to account for filter and excitation source bleed through effects.  The intrinsic excitation of 
the donor or acceptor molecules during different scans was/is often approximated to be 
zero, even though this approximation is usually not completely true.   
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 Using a spectral imaging system with two-photon excitation in the IR wavelengths, 
in collaboration with Dr. Stoneman and Dr. Raicu in the derivation of the equations, I have 
developed a quantitative fluorescence imaging methodology, termed Fully Quantified 
Spectral Imaging (FSI), with unique capabilities to probe the stoichiometry and stability of 
protein complexes in biological membranes, in vivo55.  FSI utilizes a fully-solved system 
of equations and yields two-dimensional membrane concentrations and FRET efficiencies 
in native plasma membranes, without the use of filters or correction factors, or constraints 
on the excitation wavelengths utilized. In combination with the FRET theory I developed, 
FSI can be used to characterize the association of membrane proteins: to differentiate 
between monomers, dimers, or oligomers, to produce binding (association) curves, and to 
measure the free energies of association in the membrane.   
 The last objective of my thesis work was to understand the thermodynamic 
properties of VEGFR2 in the absence and presence of VEGF.  Thus, I utilized FSI and the 
newly developed theory for stochastic FRET to directly measure unknown physical-
chemical properties of VEGFR2 in the absence and presence of its activating ligand, VEGF, 
in the cell membrane of living cells.  By studying truncations of the VEGFR2 EC domain, 
I have identified the functional role of the homotypic interactions seen in the ligand-bound 
dimer, in the absence of ligand.  This information on unliganded VEGFR2 interactions is 
new and unique, as there is no phosphorylation signal to monitor in the absence of VEGF 
and this type of direct measurement has not been performed in cells.  Finally, I pushed the 
limits of the technology and methodology and utilize a full thermodynamic cycle and 
fluorescently-labeled VEGF to measure the association constant of VEGF for monomeric 
and dimeric forms of VEGFR2 on the surface of live cells.  This information can be used 
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to predict the active fraction (ligand-bound dimeric fraction) of VEGFR2 at any surface 
density and free-VEGF concentration.   
 The theory and methodology developed here should be applied to study many 
membrane proteins, such as the rest of the RTKs, GPCRs, co-receptors, adhesion 
molecules, etc., and will ultimately aid in the development of diverse molecular therapies 
through proper understanding of protein behavior in the cell membrane that is based on 




Chapter 2. Theory of FRET for Membrane Proteins 
2-1. Introduction 
Many of the label-free techniques that are commonly used to study soluble protein 
interactions cannot be extended to membrane proteins in their native environment.  Instead, 
fluorescence methods, particularly approaches that rely on Fӧrster resonant energy transfer 
(FRET), are often used 48,50,51,56,57. A major advantage of the FRET-based assessment of 
molecular interactions in the membrane is that experiments can be performed in cells or in 
a cell-derived system, without the need for membrane protein extraction and purification58-
62.  
   FRET involves the non-radiative transfer of energy from an optically excited donor 
to an appropriate acceptor molecule 34. In FRET experiments, the membrane proteins of 
interest are tagged with genetically encoded donor and acceptor fluorescent proteins such 
as CFP, GFP, YFP, and mCherry 36,37,63.  The steady-state FRET efficiency in this case can 
be easily measured in a standard fluorescence microscope.  This measured FRET is termed 
the “total apparent FRET efficiency.”   
However, quantitative assessment of the strength of interactions between the tagged 
membrane proteins remains a challenge, partially because of the unknown “proximity 
FRET” or “stochastic FRET” contribution to the total apparent FRET efficiency.  
Stochastic FRET occurs when a donor and an acceptor approach each other by chance 
within distances of about two Fӧrster radii, and does not reflect specific interactions 
between the tagged membrane proteins 64. The magnitude of this effect is significant 
because the fluorophores are confined to diffuse in two dimensions. As we will see, without 
a correction for stochastic FRET, the results of a FRET-based measurement of membrane 
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protein interactions will be incorrect and misleading. Thus, it is critical that the effect is 
understood and reliably predicted even in cases when it is not directly measurable.   I have 
spent considerable time and effort on this problem, ultimately culminating in a full 
theoretical description for the combined effects of the unwanted stochastic FRET and the 
desired FRET due to sequence-specific protein-protein interactions, known as the 
“oligomeric FRET.” 
I will discuss the theoretical models for the FRET due to protein-protein 
interactions, the oligomeric FRET.  I will begin with the case of non-interaction, or 
monomeric membrane proteins.  In this case, all FRET is due to stochastic FRET.  Then, I 
will introduce the Kinetic Theory of Oligomeric FRET for dimerizing and higher-order 
oligomerization of membrane proteins, and demonstrate the method for incorporation of a 
thermodynamic model into the Kinetic Theory of Oligomeric FRET.   I will then derive 
the general Kinetic Theory of FRET.  The Kinetic Theory of FRET describes the total 
apparent FRET efficiency as would be measured in an experiment and accounts for 





2-2. A Numeric Description of the FRET of Monomeric 
Membrane Proteins 
 
When confined to two dimensions, even at relatively low concentrations, donors 
and acceptors can randomly approach each other such that the energy of an excited donor 
can be transferred to an acceptor with significant probability.  This type of random 
stochastic FRET will occur even in the absence of sequence specific interactions.  Unlike 
the FRET of specific protein-protein interactions, there is no analytical solution that 
describes the stochastic FRET as a function of fluorophore surface density (concentration).  
Thus, a numeric model of the stochastic FRET is necessary.   
Wolber and Hudson developed a model for FRET in two dimensions that accounts 
for random encounters of monomeric donors and acceptors, while assuming that the size 
of the donor and acceptor fluorophores is negligible, and the chromophores can come 
infinitely close to each other 64.  This theoretical model has been shown to explain FRET 
data in lipid bilayers when the donor and the acceptor are small organic molecules. 
However, the model is not applicable to large beta-barrel fluorescent proteins used in 
cellular studies because of their rather large finite size (~ 3-4 nm), which limits the distance 
of closest approach between donors and acceptors chromophores.  A model that is useful 
in this case was developed by Snyder and Freire, who used computer simulations to predict 
proximity FRET for monomeric fluorophores with finite size that are confined to a plane 
in two dimensions 65.   
As shown by Wolber and Hudson 64, in a static quenching FRET experiment, the 
relative quantum yield for a donor surrounded by a random configuration, β, of N acceptor 















  (2-1) 
 
In Equation (2-1) above, Ri is the distance from the i’th acceptor molecule to the donor 
and R0 is the Fӧrster Radius, a property of the donor-acceptor FRET pair.  The Fӧrster 
radius is the donor-acceptor distance, R0, at which resonant energy transfer efficiency, E, 
is decreased to 50% 34.  
 








The ensemble average of Equation (2-1) over all configurations of acceptor molecules 
equals the ratio of the donor quantum yield in the presence (QDA) and absence (QD) of the 















The stochastic FRET depends only on the acceptor concentration (because more 
donors do not contribute to additional FRET), and thus it can be predicted based on 
quantum yield calculations for a single donor surrounded by a random configuration of 
acceptors. However, certain cases are more complex (see below), and configurations of 
multiple donors may need to be considered.  As shown by Snyder and Freire 65, if multiple 
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excited donors, ND, are available to transfer their energies to a random configuration of 

























The stochastic FRET transfer efficiency, Eprox, for a given acceptor concentration is then 
given by: 
 
𝐸𝑝𝑟𝑜𝑥 = 1 − 
𝑄𝐷𝐴
𝑄𝐷
⁄  (2-5) 
 
Wolber and Hudson developed analytic equations to calculate proximity FRET as 
a function of acceptor concentration64.  These equations, however, are valid for point 
fluorophores only, and break down when the excluded volumes of donors and acceptor 
molecules becomes relevant, as in the case of fluorescent proteins with diameters of ~ 3 
nm and Fӧrster radius of ~ 5.4 nm.  Snyder and Freire used computer simulations and the 
equations above to determine proximity FRET 65 that is valid for monomers of finite size.  
As discussed below, here I have improved upon their numerical result by simulating over 
a wider range of exclusion radii, and a finer grid of acceptor concentrations. 
 In my simulations, I specifically model the case of integral membrane proteins that 
are labeled with fluorescent proteins at their C-termini, on the intracellular side of the 
membrane. I assume that the attachment of the fluorescent proteins is through an 
intrinsically disordered linker, and thus the fluorophores adopt random orientations.  I 
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assume that 𝜅2 = 2/3 and that R0 is constant between all donor-acceptor pairs in this work.  
The fluorescent proteins are confined to the two-dimensional region in the immediate 
vicinity of the membrane when attached to a membrane protein as described.  Thus, I can 
forego simulations of the complicated membrane environment and focus solely on the 
generation of random 2-D configurations of fluorophores with limited distances of closest 
approach, L.  The simulation is performed in 2-D, and the fluorophores are modeled as 
circles of a fixed exclusion radius, r, with the chromophore at the center of the circle.  In 
the case where donor and acceptor molecules are fluorescent proteins fused to identical 
species of membrane-bound protein, this distance of closest approach, L, is twice the 
exclusion radius, 2r, of a three-dimensional volume sampled freely by the fluorescent 
protein.     
To simulate the stochastic FRET for monomeric membrane proteins, a lone donor 
molecule is placed within the center of a two-dimensional, square simulation region (Figure 
2-1).  For each simulated acceptor concentration, the number of acceptor molecules is 
calculated and acceptors are placed one by one into the simulation region until the desired 
surface density is reached.  For each acceptor molecule to be placed, a random position is 
chosen within the simulation region and evaluated against the condition of no overlap. If 
no overlap occurs between the newly placed acceptor and any other previously placed 
molecule, including the central donor molecule, the position is chosen as acceptable.  If 
not, then a new random position is chosen and the position is evaluated again against the 
condition of no overlap.  This is repeated until all of the acceptor molecules are successfully 
placed without overlap within the simulation region.  Equation (2-1) is then used to 
calculate the quantum yield of the central donor in the presence of the random configuration 
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of acceptors.  After this is done for a large ensemble of such configurations, Equations (2-
3) ((2-4) for simulations of n > 1) is used to calculate the simulated stochastic FRET as a 
function of acceptor concentration.   
The stochastic FRET contribution due to random approach of monomeric 
fluorophores was simulated on a 150 x 150 nm2 2-D plane (see Figure 2-1). Acceptor 
concentrations ranging from 0 to 0.01 acceptors/nm2 were used in the simulations, and the 
simulations were run for exclusion radii ranging from 0 to 4 nm, in 0.02 nm steps.  These 
simulations were performed for N = 40,000 different configurations at each acceptor 
concentration.  The Forster radius for the YFP-mCherry FRET pair of 5.4 nm was utilized 
in the generation of the curves of relative quantum yield. In Figure 2-1, I show a sample 
configuration of monomeric donors and acceptors, when the distance of closest approach 
is 2.8 nm, corresponding to an effective exclusion radius of 1.4 nm. 
The case of stochastic FRET in the case of non-interacting fluorophores with finite 
volume has been considered previously by Snyder and Freire, with the only difference 
being the method of molecular placement 66. They used an elegant Monte Carlo approach 
to generate the various acceptor configurations, from which curves of QDA/QD were 






Figure 2-1.  A random configuration of acceptors (red) surrounding a donor (blue), 
for acceptor concentration of 0.00071 fluorophores/nm2. 40000 such configurations 
are created, and their FRET efficiency is averaged to create a prediction for 




Each curve was fitted to an exponential function of acceptor concentration per R0
2, 
[c], and the dependence of the best-fit parameter was modeled with a third-order 




















𝐶 = [𝑐] ∗ 𝑅0
2 (2-8) 
  
 With the ai determined by fitting A as a function of L/R0, this form of the relative 
quantum yield can be used in any nonlinear least squares fitting algorithm to determine 
the best-fit value of L for a dataset, when R0 is known.   
Thirty years have passed since the publication of these results, during which time 
computer power has increased immensely.  As such, I performed monomer-only 
simulations over a much finer mesh of acceptor concentrations and exclusion radii than 
performed previously.  I have found, in agreement with previous work, that the relative 
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quantum yields, as a function of acceptor concentration, were modeled well as an 
exponential function of the form shown in Equation (2-6). Employing a finer mesh of 
simulated exclusion radii allowed me to confirm that 𝐴(𝐿, 𝑅0)  was indeed a smooth 
function of the exclusion radius. The finer mesh of acceptor concentrations used in the 
simulations, which determines the value of A in a least-squares sense, showed that a fifth-
order polynomial more accurately models the dependence of 𝐴(𝐿, 𝑅0) as a function of the 
fluorophore exclusion radius.   
 Thus, the refined prediction for the relative quantum yield is given here:  
 










𝑎0 = −3.638 𝑎1 =  0.354 𝑎2 = −0.214 










Table 2-1.  The coefficients for use in Equation (2-9), an improved model of Veatch 
and Stryer, to model the FRET of non-interacting, monomeric membrane proteins.  
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2-3. A Theoretical Description of The Intra-Oligomeric FRET 
of Dimerization and Higher-Order Oligomerization 
 
The function of membrane proteins is often modulated by their lateral association 
in the membrane.  Thus, the association state of a membrane protein (monomer, dimer, 
oligomer, etc.) is of primary interest, and static-quenching FRET is often the method of 
choice in the study of the association state.  Two models are currently in use for modeling 
the oligomeric FRET, or FRET arising from specific protein-protein interactions, of static 
quenching FRET experimental data.  The primary model is the Kinetic Theory of 
Oligomeric FRET, derived in 2007, which is applicable to fully quantitative FRET 
experiments where the total surface densities of donor and acceptor labeled membrane 
proteins are known or measured, but the oligomeric state is unknown.  The second is the 
Veatch and Stryer model, derived in 1977, which unfortunately is still often utilized in 
semi-quantitative FRET experiments to determine the oligomeric state of membrane 
proteins67.  In these experiments, the donor to acceptor ratio is known, but the total surface 
density of donor and acceptor labeled fluorophores is unknown.   In this chapter and this 
work, I will focus primarily on the Kinetic Theory of Oligomeric FRET and in a later 
chapter, I show that the model of Veatch and Stryer is not useful.   As given, neither model 
accounts for the effect of stochastic FRET and must be utilized with very low total 
concentrations of membrane proteins to minimize the contamination of the total apparent 
FRET efficiency by stochastic FRET.  Thus, these models describe the intra-oligomeric 




2-3.1 Receptor Dimerization and Oligomerization: the Kinetic Theory 
of Intra-Oligomeric FRET  
 
 The Kinetic Theory of Intra-Oligomeric FRET provides a theoretical description 
of the FRET arising from the protein-protein interactions that will be measured for an 
excited ensemble of oligomeric membrane proteins 68,69.  A complete description of the 
system requires knowledge of the donor-acceptor distances and orientation factors within 
an oligomer. These distances are known in these simulations, but in a real-world 
experimental situation, these distances are unknown.  For this reason, in this work I utilize 
the working assumption that nothing is known about the true oligomerization state of the 
protein before analysis, even though later we will use simulations to predict the FRET by 
constructing virtual oligomers of definite size.  A simplified expression for the Kinetic 
Theory of Oligomeric FRET can be derived, however, if we assume equal donor to 




















In Equation (2-10), n represents the oligomer order.  𝜇𝑜𝑙𝑖𝑔𝑜  represents the 
concentration of oligomers in the ensemble.  It is through 𝜇𝑜𝑙𝑖𝑔𝑜that the Kinetic Theory of 
Oligomeric FRET can be utilized to study the thermodynamic properties of membrane 
proteins by application of the law of mass action, described next. The sum is performed 
over the 𝑘 acceptors in the oligomer.  The sum begins at one because there is no intra-
oligomeric FRET if there are no acceptor molecules in the complex, and ends at n-1 
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because there must be at least one FRET donor present (if there are no donors or acceptors 
in the oligomer, any measured FRET is due to stochastic FRET).   ?̃? is the intrinsic FRET 
efficiency of a donor-acceptor pair in the oligomer, given by Equation (2-2).  (𝑛
𝑘
) is the 
binomial coefficient, 𝑛! 𝑘! (𝑛 − 𝑘)!⁄ , and represents the number of ways of choosing 𝑘 
acceptors from an oligomer of size 𝑛, as shown below in Figure 2-2.  𝑃𝐷 and 𝑃𝐴 are the 
fractions of donors and acceptors in the oligomer.  For large numbers of molecules, these 




with [𝐷] and [𝐴] representing the total donor and acceptor concentrations, and 𝑥𝐷 + 𝑥𝐴 =
1.     
 Equation (2-10) gives the theoretical intra-oligomeric donor-quenched energy 
transfer efficiency for dimers and higher-order oligomers, 𝐸𝑜𝑙𝑖𝑔𝑜, assuming an equal donor 
to acceptor distance for all D-A pairs in the oligomer.  For the case of n = 2, a dimer, and 
n =3 with a trimer arranged as an equilateral triangle, this is always correct as there is only 
one donor to acceptor distance in the oligomer.  For tetramers and above, this is an 
approximation which minimizes the number of adjustable parameters in the theoretical 
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Figure 2-2.  Donors and acceptors (blue and red, respectively) arranged as dimers, 
trimers, and tetramers.  For each value of k (number of acceptors in the oligomer) 
there are 𝑛! 𝑘! (𝑛 − 𝑘)!⁄  ways to distribute the 𝑘 acceptors in an oligomer of size 𝑛.   
For each 𝑛, the last two shown distributions shown on the far right result in zero 
oligomeric FRET.   
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2-3.2 Receptor Dimerization and Oligomerization: The model of Veatch 
and Streyer 
 In some experimental situations, the concentrations of donors and acceptors may 
not be known, but the ratio of donor to acceptor molecules is known or measured.   In this 
case, the model of Veatch and Stryer is often utilized in the analysis of apparent FRET 
efficiencies to determine the oligomeric state of the membrane proteins of interest, as 
shown below: 
 
𝐸𝑎𝑝𝑝 ≈ 𝐸𝑚𝑎𝑥(1 − 𝑥𝐷







In Equation (2-11), 𝐸𝑚𝑎𝑥  is an adjustable parameter corresponding to ?̃?  for dimers 
(equation 2-2), but for higher order oligomers, 𝐸𝑚𝑎𝑥 is interpreted simply as an adjustable 
parameter to aid in the fitting and has no physical meaning.  𝑥𝐷 is the molar fraction of 
donors, which can be written as a function of the acceptor to donor ratio, [A]/[D], and 𝑛 is 
the oligomer order, as defined for Equation (2-10).  Compared to the Kinetic Theory of 
Oligomeric FRET, this model assumes a single donor to acceptor distance in the oligomer, 
and it also assumes a single FRET species in the mixture which contains a single donor, 
corresponding to the 𝑘 =  1 term in the summation of Equation (2-10).     
 The assumptions of the model of Veatch and Stryer are correct for constitutively 
dimeric species, however for non-constitutive dimers and higher order oligomerization, 
this model simplifies the geometry of the oligomer, and it does not take into account the 
combinatorial manner in which a number of donors and acceptors can be found within an 
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oligomer.   In a later chapter, I will show that this model is incapable of properly 
determining the order of oligomerization of membrane proteins.   
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2-4. Building a Thermodynamic Model with the Kinetic 
Theory of Oligomeric FRET 
 
Here I describe the procedure for incorporating a thermodynamic equilibrium into 
the Kinetic Theory of Oligomeric FRET.  The basic idea is to write the concentration of 
oligomers, 𝜇𝑜𝑙𝑖𝑔𝑜 of Equation (2-10), in terms of the total membrane protein (fluorophore) 
concentration and an association constant.   First we begin with the description of 
monomeric membrane proteins, and then we explicitly derive the analytic relation for 
membrane proteins in a monomer-dimer equilibrium.  Finally, we show the general 
procedure of constructing the thermodynamic model using trimers, 𝑛 = 3, as an example.   
 
2-4.1. A special case: Monomeric Receptors 
As a special case of non-interactions, the Kinetic Theory of FRET does not predict 
the total apparent FRET efficiency, in this case occurring solely due to stochastic FRET.  
The apparent FRET efficiency of monomeric membrane proteins tagged with fluorophores 
of non-negligible exclusion radius, i.e. 2D distributions of fluorescent proteins, is described 
by the numeric results of Wolber and Hudson, and verified experimentally with fluorescent 
protein tagged ECTM domains of several RTKs.   The prediction for the relative quantum 
yield of a monomeric donor in the presence of random configurations of acceptors as a 
function of acceptor concentration, R0, and distance of closest approach L, is given by the 
following exponential function:  
𝑄𝐷𝐴
𝑄𝐷
⁄ =   exp(𝐴(𝐿, 𝑅0) ∙ 𝐶) (2-12) 
32 
 






𝑖=0   , 𝐶 = [𝐴] ∙ 𝑅0
2 , the acceptor concentration per R0-squared, 
and the ai given previously in Table 2-1.  In the simulations of FRET described in a later 
chapter, the exclusion radius utilized is 1.4 nm, giving L/R0 = 0.51.    
 
2-4.2  Dimerizing and Oligomerizing Receptors 
Next, the thermodynamic model for membrane protein interactions based on the 
Kinetic Theory of Intra-Oligomeric FRET, Equation (2-10), and the law of mass action is 














𝐷𝑞 = 𝑓𝑑  𝑥𝐴?̃? (2-14) 
  
The fraction of dimers,𝑓𝑑 , can be written as a function of an equilibrium association 
constant, KA, and total receptor concentration, [T], i.e. 𝑓𝐷(𝐾𝐴, [𝑇]).  To do so, we write 













Here, [𝑚] is the concentration of monomeric receptors and [𝑑] is the concentration of 
dimeric receptors.  For the two-state monomer-dimer equilibrium, we define the 
equilibrium association constant, 𝐾𝐴: 
 







First, we solve for the fraction of monomers:   






Since [𝑇] = [𝑚] + 2[𝑑] = [𝑚] + 2𝐾𝐴[𝑚]
2, we use this quadratic equation to solve for [m] 
as a function of the coefficients of the polynomial, 𝐾𝐴 and [T].  There are two real roots to 
this equation, one positive and one negative.  We use the positive root as the physical 
solution.         
                                                         
[𝑚] =  
















By using the relationship 𝑓𝑑 + 𝑓𝑚 = 1, we solve for the fraction of dimers, fD, as a function 
of 𝐾𝐴 and [𝑇]: 
 
𝑓𝑑(𝐾𝐴, [𝑇]) = 1 − 𝑓𝑚 = 1 −




The thermodynamic model of oligomeric FRET for a mixed population of monomers and 




𝐷𝑞 = 𝑓𝐷(𝐾𝐴, [𝑇])𝑥𝐴?̃? 
 
The analytic solutions for the roots become more intractable as n becomes 3 or higher, and 
there is no analytic solution for the roots of a polynomial greater than order five.   Instead 
of writing down the solution for the fraction of oligomers as a function of total receptor 
concentration, I instead utilize a MATLAB root finding function to calculate the roots of 
the binding polynomial.  I take the largest real root as the physical solution to the n’th order 
polynomial which yields [mi] as a function of 𝐾𝐴 and [Ti]. 
 The general procedure for 𝑛 = 3  (trimers) is now described, and the same 
procedure is applied to all dimeric, trimeric, tetrameric, pentameric, and hexameric model 
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construction of 𝐸𝑜𝑙𝑖𝑔𝑜 .  Direct use of Equation (2-20) in Equation (2-14) is not 
recommended, in general.  For the case of a monomer-trimer equilibrium, the theoretical 










2 +  6 ∗ ?̃?𝑃𝐷
2𝑃𝐴 ) (2-21) 
  




2 +  6 ∗ ?̃?𝑃𝐷














Now that we have a theoretical representation for the FRET efficiency, we focus on the 












Here, [𝑡𝑟𝑖] is the concentration of trimeric receptors.  The goal is to express the fraction of 
trimers in terms of the equilibrium association constant and the total receptor concentration.  
For the two-state monomer-trimer equilibrium model, we write: 









Writing the total concentration of macromolecules in terms of KA and [m] and 
rearranging the third order polynomial in [m] gives:           
                          
3𝐾𝐴[𝑚]
3 + [𝑚] − [𝑇] = 0 (2-25) 
 
Next, I use a root-finding algorithm to find the largest positive, real root, [m]( 𝐾𝐴,[T]), and 
write the fraction of trimers as:      










The thermodynamic model of oligomeric FRET for a mixed population of monomers and 








In cases when the oligomeric fraction, determined in the fit, exceeds 95% over the 
very broad range of concentrations used in the simulations or measured during experiments 
(typically 1e-5 rec/nm2-8e-3 rec/nm2), I term the best-fit oligomer to be “a constitutive 




2-5.   A Complete Theoretical Description of the Total Apparent 
FRET Efficiency With the Kinetic Theory  
 
The total donor-quenched apparent FRET efficiency, Eapp, is defined as the ratio of 
the rate of resonant energy transfer, kRET, to the over-all rate of all donor de-excitation 
pathways, including FRET, as shown:  
 
𝐸𝑎𝑝𝑝 ≡  
𝑘𝑅𝐸𝑇
𝑘𝐷 +  𝑘𝑅𝐸𝑇
 (2-28) 
 
where kD denotes the sum of all-de-excitation rates excluding FRET.  When the 
fluorophores are confined to two dimensions, FRET can occur stochastically through 
tagged membrane proteins that are not undergoing dimerization, or oligomerization, in 
addition to the FRET of protein-protein interactions.   This idea is described in Equation 
(2-29) below, by breaking apart 𝑘𝑅𝐸𝑇 into the sum of two components: 𝑘𝑅𝐸𝑇
𝑂𝑙𝑖𝑔𝑜
, the rate of 
donor de-excitation due to FRET of protein-protein interactions and 𝑘𝑅𝐸𝑇
𝑝𝑟𝑜𝑥
, the rate of 
donor de-excitation due to FRET of proximity to neighboring acceptors in other oligomers 




𝑝𝑟𝑜𝑥 +  𝑘𝑅𝐸𝑇
𝑂𝑙𝑖𝑔𝑜
𝑘𝐷 + 𝑘𝑅𝐸𝑇




As mentioned previously, this stochastic FRET contribution is a non-negligible 
component of the total apparent FRET efficiency, and is a function of the concentration, 
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interaction propensity, and oligomerization state of the fluorescent protein-tagged 
membrane proteins.  Until this work, there had been no theoretical model for the total 
apparent FRET efficiency that accounts for all FRET contributions in a bulk, donor-
quenched static quenching FRET experiment.   
In an ideal world, we could set up an experimental situation in which 𝑘𝑅𝐸𝑇
𝑝𝑟𝑜𝑥
 = 0 
and a measurement of 𝐸𝑎𝑝𝑝 would yield 𝐸𝑜𝑙𝑖𝑔𝑜:  
𝐸𝑜𝑙𝑖𝑔𝑜 ≡  
𝑘𝑅𝐸𝑇
𝑜𝑙𝑖𝑔𝑜




Conversely, one could also imagine a situation where only the stochastic FRET was 
measured, 𝐸𝑝𝑟𝑜𝑥:  
𝐸𝑝𝑟𝑜𝑥 ≡  
𝑘𝑅𝐸𝑇
𝑝𝑟𝑜𝑥
𝑘𝐷 +  𝑘𝑅𝐸𝑇
𝑝𝑟𝑜𝑥 (2-31) 
 
 Unfortunately, one cannot experimentally decouple the two contributions from the 
total measured apparent FRET efficiency.  However, by solving for 𝑘𝑅𝐸𝑇
𝑜𝑙𝑖𝑔𝑜
 in Equation (2-
31) and for 𝑘𝐷 in Equation (2-31), and substituting into Equation (2-29), one can write 
down the explicit dependence of 𝐸𝑎𝑝𝑝 on 𝐸𝑜𝑙𝑖𝑔𝑜 and 𝐸𝑝𝑟𝑜𝑥, as shown: 
 
𝐸𝑎𝑝𝑝  =  
 𝐸𝑝𝑟𝑜𝑥 + 𝐸𝑜𝑙𝑖𝑔𝑜 − 2 𝐸𝑝𝑟𝑜𝑥𝐸𝑜𝑙𝑖𝑔𝑜
1 −  𝐸𝑜𝑙𝑖𝑔𝑜𝐸𝑝𝑟𝑜𝑥
 (2-32) 
 
Examination of Equation (2-32) shows that if one knows an appropriate stochastic 
FRET contribution, it can be used along with the measured apparent FRET efficiency to 
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determine the actual FRET due to protein-protein interactions in the membrane.  
Alternatively, Equation (2-32) can be solved for the total stochastic FRET efficiency 
contribution, as a function of the total apparent FRET efficiency and the oligomeric FRET 
efficiency as shown: 
𝐸𝑝𝑟𝑜𝑥 = 
𝐸𝑎𝑝𝑝 − 𝐸𝑜𝑙𝑖𝑔𝑜
1 − 2𝐸𝑜𝑙𝑖𝑔𝑜 + 𝐸𝑎𝑝𝑝𝐸𝑜𝑙𝑖𝑔𝑜
 (2-33) 
 
Examination of Equations (2-32) or (2-33) shows that as 𝐸𝑜𝑙𝑖𝑔𝑜  → 0, 𝐸𝑎𝑝𝑝  →
𝐸𝑝𝑟𝑜𝑥  as expected for monomeric proteins.  Similarly, as 𝐸𝑝𝑟𝑜𝑥  → 0, 𝐸𝑎𝑝𝑝  → 𝐸𝑜𝑙𝑖𝑔𝑜 , 
showing that if the stochastic FRET contribution can be minimized by experimental design, 
the measured apparent FRET is due to protein-protein interactions.   
Sometimes, the two contributions are summed up in the literature, i.e, the total 
apparent FRET efficiency is assumed to be equal to the sum of the oligomeric FRET of 
protein-protein interactions, and the stochastic FRET contribution. Equation (2-32) shows 
that this is not correct in the general case. However, if one of the contributions is very small, 
a Taylor expansion yields: 
 
𝐸𝑎𝑝𝑝 ≈  𝐸𝑜𝑙𝑖𝑔𝑜 +  𝐸𝑝𝑟𝑜𝑥 (2-34) 
 
In the next chapter, I will briefly investigate the validity of this approximation, but in 
general now that the full Kinetic Theory of FRET has been developed and a computer is 
required for analysis, there is no need to utilize this simplification in the analysis of FRET 
data from static quenching FRET measurements of membrane proteins.    
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Chapter 3. Simulations Reveal the (non)Uniqueness of 
the FRET of Interacting Membrane Proteins 
 
3-1. Introduction 
In this section, I describe the theory that I have developed for simulations of static-
quenching FRET experiments.  With this, one can use simulations to predict the total 
apparent FRET efficiency that would be measured for any experimental situation desired 
involving 2-D distributions of fluorophores.  I have performed simulations of FRET 
between membrane proteins labeled with fluorescent proteins by creating discrete two-
dimensional distributions of non-overlapping circles, intended to represent the non-
negligible volume of the fluorescent protein beta barrel structure. This limits the distance 
of closest approach, similarly to that between the chromophores located at the center of the 
beta barrel  in a fluorescent protein.  I then use this methodology to simulate the measured 
FRET for a variety of situations of high interest to membrane protein researchers:  
monomeric, dimeric, trimeric, tetrameric, monomer-dimer equilibrium, and monomer-
tetramer equilibrium.  Analysis of this data with the two primary models, the Kinetic 
Theory of FRET68, and the Veatch and Stryer model67 described in Chapter 2, reveal the 
limitations of both models with respect to determination of association constants, donor-
acceptor distance, and oligomer-order.  These simulations also reveal physical limitations 
of static quenching, two-color FRET experiments to provide different FRET signatures for 




3-2.  Theory of FRET for 2-D Static Distributions of 
Fluorescent Proteins 
 
As described by Wolber and Hudson64, for a 2-D a static quenching FRET 
experiment containing multiple excited donors, the ratio of the quantum yield of the donor 
in the presence of acceptors (and FRET), 
𝑄𝐷𝐴
𝑄𝐷
⁄  , can be estimated through computer 
simulations by generating many different configurations, 𝛽, of donors and acceptors in a 
2-dimensional plane.   This is exactly the physical situation encountered experimentally 
when a large region, several square microns, is excited for microsecond or millisecond 
intervals in a microscope-based FRET experiment.  Many donors are excited and the 
excitation interval lasts for thousands of FRET lifetimes.  Thus, the measured FRET is a 
measurement taking place on a large ensemble of many proteins.  The relative total 
instantaneous quantum yield of a single configuration of fluorophores, 𝑞𝑟,𝑗,𝑡𝑜𝑡
(𝛽)
,  is 
calculated and averaged over the donors, 𝑁𝐷 , per configuration, and over all of the 𝑀 
configurations, as shown below.  After averaging over the M configurations, we have a 






































The total apparent FRET efficiency is then defined as: 
 
𝐸𝑎𝑝𝑝 ≡ 1 −
𝑄𝐷𝐴
𝑄𝐷
⁄  (3-3) 
 
In Equation (3-1), the sum is over N acceptors in the 𝛽′𝑡ℎ configuration.  𝑅0 is the Förster 
radius (5.5 nM for the mTurquoise-YFP FRET pair), and 𝑅𝑖,𝑗  is the distance from the i’th 
acceptor to the j’th donor.  The relative total instantaneous quantum yield of the quenched 
donor, 𝑞𝑟,𝑗,𝑡𝑜𝑡
(𝛽)
, is a sum over all acceptors, including acceptors that are participating in 
oligomeric FRET (intra) and acceptors that experience FRET due to proximity, stochastic 
FRET (inter).   
 In order to determine the FRET due to oligomerization (𝐸𝑂𝑙𝑖𝑔𝑜 as estimated with 
Equation (2-10) without a stochastic FRET contribution, I define the relative oligomeric 
instantaneous quantum yield 𝑞𝑟,𝑗,𝑜𝑙𝑖𝑔𝑜
(𝛽)
  as a sum over only the I = m, n, o, … acceptor 
distances, the intra-oligomeric acceptors to the j’th donor in the β’th configuration, as 















In Equation (3-4), if a donor is monomeric or if an oligomer is comprised solely of donors, 
then 𝑞𝑟,𝑗,𝑜𝑙𝑖𝑔𝑜
(𝛽)
= 1.  In the case of a donor dimerized with an acceptor, it is equal to 1 - ?̃?, 





 over many donors and many configurations leads to the 




















𝐸𝑂𝑙𝑖𝑔𝑜 ≡ 1 −
𝑄𝐷𝐴,𝑂𝑙𝑖𝑔𝑜
𝑄𝐷
⁄  (3-6) 
  
 Similarly to the relative oligomeric instantaneous quantum yield, the relative 
stochastic instantaneous quantum yield of the 𝑗’𝑡ℎ donor is defined as the sum over all 
























 Next, in the spirit of Equation (2-32), we return to Equation (3-1) and we see that 
the relative total instantaneous quantum yield can be written in terms of the relative 








(𝛽)⁄ +  
1
𝑞𝑟,𝑜𝑙𝑖𝑔𝑜

















Substitution of Equation (3-8) into Equation (3-2) shows the complicated configurational 
dependence of the total apparent FRET efficiency on the relative stochastic and oligomeric 
instantaneous quantum yields: 
 
































Now I define the total stochastic FRET efficiency as: 
 
𝐸𝑝𝑟𝑜𝑥 ≡ 1 −
𝑄𝐷𝐴,𝑝𝑟𝑜𝑥
𝑄𝐷




Using Equation (3-10), the oligomeric FRET efficiency (Equation (3-6)) and the 
definition of the apparent FRET efficiency (Equation (3-3)), I can write the total apparent 
FRET efficiency in terms of the ratios of the oligomeric and stochastic quantum yields by 
using Equation (2-32): 
 
𝐸𝑎𝑝𝑝  = 1 −
𝑄𝐷𝐴
𝑄𝐷
⁄ =  
 𝐸𝑝𝑟𝑜𝑥 + 𝐸𝑜𝑙𝑖𝑔𝑜 − 2 𝐸𝑝𝑟𝑜𝑥𝐸𝑜𝑙𝑖𝑔𝑜





⁄ ) + (
𝑄𝐷𝐴,𝑂𝑙𝑖𝑔𝑜
𝑄𝐷










⁄ ) + (
𝑄𝐷𝐴,𝑂𝑙𝑖𝑔𝑜
𝑄𝐷

























⁄ ) + (
𝑄𝐷𝐴,𝑝𝑟𝑜𝑥
𝑄𝐷
⁄ ) − (
𝑄𝐷𝐴,𝑝𝑟𝑜𝑥
𝑄𝐷







Interestingly, Equation (3-11), has the same form as the relative total instantaneous 
quantum yield, 𝑞𝑟,𝑗,𝑡𝑜𝑡
(𝛽)
 in Equation (3-8), despite the summations.  Thus, even though the 
oligomeric and the stochastic FRET are not separable in an actual experiment where the 
total apparent FRET efficiency is measured, with computer simulations we can determine 
each component and understand effects of oligomeric and stochastic FRET on the total 
apparent FRET efficiency.   
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3-3. Computational Methods 
 The fluorescent proteins are modeled as circles in two dimensions with a 1.4nm 
“exclusion radius” as described previously in Chapter 2 for the initial simulations of 
monomeric proteins, which is intended to represent the fluorescent proteins existing in a 
plane which is parallel to the bilayer.   
 To model the FRET arising from two dimensional distributions of donor and 
acceptor fluorescent proteins with non-negligible finite size, I create non-overlapping 
ensembles of circles representing donors or acceptors organized as monomers or oligomers 
of order 𝑛, with random orientations (random 𝜙 in Figure 3-1).  Then I calculate the total 
and oligomeric relative quantum yields per configuration, as described in Equation (3-2), 
and Equation (3-5).  𝑀 =  1,000  trials are performed for each acceptor fraction, 
generating new configurations at each trial and determining the total donor quenching and 
oligomeric quenching and FRET efficiencies as shown in Equations (3-3, and Equation 
(3-6).  The total stochastic quenching contribution is algebraically calculated from  𝐸𝑎𝑝𝑝 
and 𝐸𝑜𝑙𝑖𝑔𝑜 as shown in Equation (2-33).   
 Oligomers are constructed as n-sided regular polygons with circles at the vertices, 
and with a line connecting the circle centers of the oligomer.  The side length, or center-
to-center distance for the circles representing fluorescent proteins is chosen based on a 
distance determined from Förster’s Equation for a given FRET efficiency.  With a dimer 
and a trimer, this distance is exactly ?̃?, the FRET efficiency of a single donor-acceptor pair.   
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For example, a monomer is represented as a simple circle, a dimer as two circles connected 
by a line, a trimer as an equilateral triangle, tetramers as squares, and pentamers as 
pentagons with circles at the corners.  Figure 3-1 shows the geometries of the oligomers 
utilized in the simulations.   
 
Figure 3-1.  The geometries of the monomeric, dimeric, trimeric, and tetrameric 
organizations of fluorescent proteins utilized in the simulations.  Fluorescent 
proteins are modeled as circles, with 𝑑 related to ?̃?, the intrinsic FRET efficiency of 
a donor-acceptor pair, as given in Equation (2-2):  









 Non-overlapping ensembles of circles representing fluorescent proteins are 
generated by first choosing a random position and orientation for all oligomers (including 
monomers).  The computer iterates through the list of oligomers, examining it for overlap 
with any other oligomers.  If overlap occurs, then a new random position is chosen for the 
oligomer of interest until a suitable position is found.  We continue in this manner until all 
monomers and oligomers are placed in a non-overlapping manner.   
 For all the simulations described here, I utilize a pool of 4,000 fluorophores, which 
are randomly placed in a square region that is sized according to the desired fluorophore 
concentration.  I utilized 𝑀 =  1,000 trials per D:A ratio, per simulated total concentration 
value.  After placement, the circles are then randomly assigned to be donor or acceptor 
molecules. In order to avoid edge effects, only donors that are positioned five Förster radii, 
5𝑅0, away from the edges of the region are utilized in the calculations of oligomeric, total, 
and stochastic FRET, as described above.   A Förster radius of 5.5nm, corresponding to 
that of the mTurquoise-YFP FRET pair with an assumed 𝜅2 = 2/3  was used for the 
simulations in this work.  Simulated surface densities in this chapter range from a minimum 
of 1e-5 fluorophores/nm2 (10 per square micron) to a maximum of 8e-3 fluorophores/nm2 





3-4. Analysis of 𝑬𝒂𝒑𝒑: Stochastic FRET Considerations 
 
 The Kinetic Theory of Oligomeric FRET47,48,56,68,70 only accounts for intra-
oligomeric FRET, and does not take into account stochastic FRET, or FRET that occurs 
due to random approach of donors and acceptors in the membrane within distances of ~100 
Å.  I have shown in other work, however, that stochastic FRET can represent a significant 
contribution to the measured FRET efficiency for dimerizing membrane proteins.  I have 
also previously shown that the stochastic FRET contribution decreases when the oligomer 
order increases, and this phenomenon will be seen in the simulated FRET predictions of 
this chapter.  It is thus possible that stochastic FRET becomes negligible for large 
oligomers. To investigate if this is the case, and to determine a possible oligomer size cut-
off, I compare the fitting results with and without a proximity FRET contribution where 
we have utilized a numeric estimation of the stochastic FRET, as shown in Tables 1 and 2.  
 For all 𝑛 > 1 , when we have a monomer-oligomer equilibrium or constitutive 
oligomers, the stochastic FRET contribution, as given by Equation (2-32) or Equation (2-
33), can comprise a major component of the total apparent FRET efficiency, 𝐸𝑎𝑝𝑝 (see 
Table 3-1).  Since there is no analytic form for the stochastic FRET occurring between 
fluorophores with non-negligible size as a function acceptor concentration, I simulated 
proximity FRET for all 𝑛 = 2: 6  over a gridded multidimensional space of the two 
adjustable parameters: ?̃?, and 𝐾𝐴, for acceptor concentrations ranging from zero to 0.008 
acceptors/nm2 (see Computational Methods), with a 1.4nm exclusion radius.  ?̃? values 
range from 0.05 to 0.90, with association constants,  𝐾𝐴 , varying from monomer-only 
(𝐾𝐴 ⟶ 0) through constitutive oligomerization (𝐾𝐴 ⟶ ∞) in steps of 0.5 kcal/mol.  This 
“library” of thousands of stochastic FRET estimations is used to perform a gridded search 
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for the best-fit model to the dataset by building a theoretical model for the apparent FRET 
efficiency that includes the appropriate stochastic FRET contribution, as in Equation (2-
32).   
 The stochastic FRET is a function of all of the parameters of interest in a FRET 
measurement of membrane proteins, ?̃?and 𝐾𝐴, and accordingly, the choice of a stochastic 
FRET model fixes the choice of the parameters in the terms of the fraction of oligomers 
and the intrinsic FRET.   
 It is computationally expensive to estimate the stochastic FRET for every possible 
combination of the intrinsic FRET and dimeric association constant, and furthermore, small 
changes to these parameters have little effect on the magnitude of the stochastic FRET 
contribution.  As such, after the above analysis I then “polish” the best-fit intrinsic FRET 
and dimeric association constant values found during the gridded search by fixing the best-
fit proximity model to that found above in the gridded search, and utilizing a MATLAB 
non-linear least squares fitting algorithm to find the best fit values of the intrinsic FRET, 
?̃?, and the equilibrium association constant, 𝐾𝐴 (See Equation (2-32) and Equation (2-
27)). 
 The best-fit mean-squared errors (MSEs) for all oligomer orders, 𝑛 = 1: 6, are 
compared and the overall lowest MSE value is chosen as the best-fit model to represent a 
given dataset.  I have performed two separate analyses utilizing the Kinetic Theory of 
FRET.  First, for all 𝑛, I fit the total apparent FRET efficiency, as shown in Figures 1C, 
3B, 5B, 7B, 9C, 12C, and Supplementary Figures 1A, 3A, 4A, 6A, 7A, directly with the 
Kinetic Theory of FRET (as in Equation (2-10)) and ignore the stochastic FRET 
contributions.   These results are summarized as a plot of the best-fit MSE as a function of 
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oligomer order, 𝑛, as black circles.  Additionally, for 𝑛 =  2: 6, I utilized a stochastic 
FRET contribution (described above) in Equation (2-32), and examine the minimized 
MSE and best-fit parameters of the model.   The analysis results including the stochastic 
FRET contribution are summarized in the MSE vs. oligomer order plots with a blue circle.  
The MSE is calculated according to: 
         
𝑀𝑆𝐸(𝐾, ?̃?) =  
1
𝑁








 Finally, in order to perform a statistical analysis on the quality of fits, I simulated 
again the total apparent FRET efficiency for monomer only, monomer-dimer equilibrium, 
constitutive dimers, constitutive trimers, monomer-tetramer equilibrium, and the 
constitutive tetramer cases as described above, as shown in Supplementary Figures 5 and 
8. I generated 2,700 data points, with randomly chosen total surface densities of 
fluorophores, and donor to acceptor ratios over the same ranges as given previously.  Next, 
Gaussian-distributed random error was generated for each data point, with 𝜇 = 0 and 𝜎 =
0.08, giving absolute error values typically within 0-24%.  This random error was added 
to the simulated total apparent FRET efficiency to create a simulated dataset with noise 
similar to that found in actual experiments.  For all 𝑛 =  1 𝑡ℎ𝑟𝑜𝑢𝑔ℎ 6, I minimize the 
reduced chi-square value for every 𝑛, as shown below, and choose the model with the 
overall minimum chi-square value as the best-fit model, given the data and its associated 




2 (𝐾, ?̃?) =  
1










 I then subjected the reduced chi-square values for every n’s best-fit value to the chi-
square test for a 1 −  𝛼 = 0.95 confidence limit.  All models with a reduced chi-square 
value less than 1.04 are deemed acceptable within the 95% confidence limit.     This 
information is plotted in the MSE vs. Order figures (use the right axis for 𝜒𝑟𝑒𝑑
2  values), as 
green X’s for analysis with a stochastic FRET contribution, and as black X’s for analysis 
without a stochastic FRET contribution, along with a magenta line repenting the 95% 
cutoff limit.  All models with a reduced chi-square value above the line (> 1.04) are rejected 
as statistically different from the measured data, while all models below the cutoff are 
accepted.   See Supplementary Figures 5 and 8 for the best-fit results to for the simulated 
data sets with noise.        
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3-5. Monomeric Membrane Proteins 
 Figure 3-2 shows the predictions of the monomer-only simulation of 𝐸𝑎𝑝𝑝. To start, 
I created configurations of monomeric receptors (Figure 3-2A) and simulated 𝐸𝑎𝑝𝑝 using 
Equation (3-1) and Equation (3-2).  In this case of no protein-protein interactions, 𝐸𝑎𝑝𝑝 
is equal to 𝐸𝑝𝑟𝑜𝑥, according to Equation (2-32).  The predicted 𝐸𝑎𝑝𝑝 are plotted in Figure 
3-2B as a function of the total concentration, for different the values of 𝑥𝐴.  There is a 
strong dependence on the acceptor fraction, with the highest FRET efficiencies 
corresponding to the highest acceptor fractions. Figure 3-2C shows the dependence of 
𝐸𝑎𝑝𝑝 on the acceptor fraction, for different total concentrations, where the dashed lines 
connect data points with equal total fluorophore concentrations.   
 As seen in Figure 3-2, high stochastic FRET can be recorded even for monomeric 
receptors, especially at high acceptor concentrations. In cases when the association state is 
unknown, researchers may blindly apply the two oligomerization models, the Veatch and 
Stryer model, and the thermodynamic model based on the kinetic theory of FRET, to 
interpret the monomeric FRET data.   The results of such analysis of my monomeric FRET 
predictions with the two models is shown in Figure 3-3.  In Figure 3-3A, the apparent 
FRET efficiencies are plotted as a function of the acceptor to donor ratio of surface 
densities.  This is a typical way to represent the data when using the model of Veatch and 
Stryer. There is a strong dependence on the total concentration of fluorophores, with 
increasing curvature of the apparent FRET efficiency as the surface density increases.  
Thus, I applied the model of Veatch and Stryer67 to three different simulated curves of total 
apparent FRET efficiency vs. acceptor fraction for three different total concentrations of 
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receptors: a very low surface density at [𝑇] = 1e-5 rec/nm2, a moderate surface density at 
[𝑇] = 4e-3 rec/nm2, and a relatively high surface density at [𝑇] = 8e-3 rec/nm2.   
 With the Veatch and Stryer67 model, I optimize for 𝐸𝑚𝑎𝑥 and 𝑛 (Equation 2-11), 
and the best-fit parameters are shown in Table 3-1.  The three fits are shown as red lines 
in Figure 3-3A.   At all surface densities, the model indicates the presence of dimers.  Of 
note, at the low surface density fitting, the adjustable parameter 𝐸𝑚𝑎𝑥 is equal to zero, due 
to a lack of any FRET.  In any case, the model of Veatch and Stryer does not predict 
correctly that the proteins are monomeric because the effect of the stochastic FRET, the 
only contribution to FRET in the monomer case, is not taken into account.  Thus, the use 
of this model will lead to the incorrect conclusion that the measured FRET occurs due to 
the presence of dimers.  If one takes time to review the literature, it will be found that many 
groups are arguing with other groups over the oligomerization status of their membrane 
protein, and here I have shown that they are simply wasting their time trying to use this 
model, as it won’t even tell them if their monomeric proteins are in fact, monomeric.  But, 
I digress, and now we return to the quantitative limitations of bulk FRET measurements in 
membranes.  
 Figure 3-3B shows the results of the analysis of the simulation predictions with the 
thermodynamic model based on the Kinetic Theory of FRET.  In this case, the mean 
squared errors and the reduced chi-square values are plotted as a function of oligomer size .  
In the special case of the monomer-only model, I utilize the model of King et al. and 
optimize for the best fit-distance of closest approach, L, which is twice the exclusion radius 
for the circular models of fluorescent proteins in this work (here, 1.4nm) (Equation 2-6).  
For n = 2-6, I utilize an oligomer model (Equation 2-10 in Equation 2-32) while also 
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taking stochastic FRET into account (MSE shown with a blue open circle) and without 
taking stochastic FRET into account (MSE shown with a black open circle, direct fitting 
of Equation 2-10). We optimize for ?̃? and 𝐾𝐴, and I show the overall best-fit values in 
Table 3-1, after the tetramer simulation section.  
 Next, the simulated total apparent FRET efficiency data with added Gaussian-
distributed random error was fitted and the reduced chi-square value was minimized by 
optimizing for ?̃? and 𝐾𝐴 (𝐿 for 𝑛 = 1) for all 𝑛 = 1 − 6.  The best-fit reduced chi-square 
values are plotted as a function of oligomer order in Figure 3-3B, as black X’s for analysis 
without a stochastic FRET contribution, as above, and green X’s for analysis that includes 
a stochastic FRET contribution, with the optimal  ?̃? and 𝐾𝐴 given in Table 3-1.  
 We see in Figure 3-3B that minimizing the MSE of the total apparent FRET 
efficiency provides a minimum in the MSE when n=1 for analysis that does not consider 
stochastic FRET. The MSE for 𝑛 = 2 − 6, when the stochastic FRET is taken into account, 
is also low and is indistinguishable from that for case of n = 1 (Figure 3-3B, blue circles).  
However, the best-fit parameters for the oligomeric fitting indicate a practical lack of 
interactions with ∆𝐺° > 0.  Further, we see that all of the models for the dataset with added 
random error pass the reduced chi-square test at 95% confidence, indicating that all models 
represent the data equally well.  However, as with the MSE minimization, the best-fit 
parameters for all 𝑛 = 2 − 6 indicate a practical lack of protein-protein interactions.   We 
see that without use of a stochastic FRET contribution, the reduced chi-square analysis 
indicates that the 𝑛 =  3, a trimer model, is the best-fit to the data.  Thus, only the use of 
the stochastic FRET approximation and the thermodynamic model based on the Kinetic 
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Theory of FRET leads to the correct conclusion that the proteins are monomeric and do not 
have measurable interactions.    
 If we do not account for stochastic FRET and only look for interactions (i.e. if we, 
in Figure 3-3B, disregard the analysis for 𝑛 = 1 and we disregard the blue points and green 
X’s) it will appear that the MSE, and reduced chi-square is minimized at 𝑛 = 3. Thus, we 
will reach the incorrect conclusion that we have trimers when in fact we have monomers. 
Failure to account for stochastic FRET will therefore lead to erroneous data interpretation 
with the Kinetic Theory of FRET. 
 While it is easy to make a mistake by not accounting for stochastic FRET (as 
demonstrated above), it is also easy to correctly account for it, and to arrive at a correct 
conclusion. When plotted as a function of the acceptor concentration (Figure 3-3C), we 
see that the total apparent FRET efficiency collapses into a curve that is independent of the 
total concentration, and depends only on the acceptor surface densities, in accordance with 
the accepted theory for monomeric proteins.  As discussed above, we can use the approach 
of King et al (Equation 2-6 and Equation 2-9) to fit a monomer-only model, when 
optimizing for the distance of closest approach between fluorophores.  The fit is excellent, 
and yields   𝑟𝑒𝑥𝑐𝑙𝑢𝑠𝑖𝑜𝑛 = 1.4 ± 0.1 𝑛𝑚. This is exactly the simulated exclusion radius, and 
a value that is generally consistent with the size of a fluorescent protein. 
 The above analysis shows that knowledge of stochastic FRET is critically important 
for the correct interpretation of FRET measurements of monomeric proteins. 
Concentrations of donors and acceptors need to be measured, along with the FRET 
efficiencies. Then, the measured FRET should be plotted as a function of acceptor 
concentration, and the data fitted with Equation (2-9). Even relatively weak sequence-
57 
 
specific interactions will yield values of 𝑟𝑒𝑥𝑐𝑙𝑢𝑠𝑖𝑜𝑛 which are either very small or negative. 
If however, 𝑟𝑒𝑥𝑐𝑙𝑢𝑠𝑖𝑜𝑛 is a reasonable measure of the size of the exclusion radius of the 
protein, then it is highly likely that the FRET measured in the experiment is due to 
stochastic FRET occurring between monomeric proteins.  At the very least, the case of 
























Figure 3-2.  The predictions of the monomer-only simulation.  A.  A sample 
configuration of monomers from the simulation.  Figure is drawn to scale, axes units are 
in nm. B. 𝐸𝑎𝑝𝑝 plotted as a function of acceptor fraction. The dashed lines connect data 
points with constant [𝑇] , as indicated by the numbers on the right side.  C. 𝐸𝑎𝑝𝑝 is 
plotted as a function of the total concentration, [𝑇].  The dashed lines connect data points 








Figure 3-3.  Analysis results for the monomer-only simulations.  A.  The total apparent 
FRET efficiency for the monomer-only simulations as a function of the A:D ratio (black 
circles).  The dashed lines connect data points at constant [T], as indicated on the right.  
In addition, the best fit model of Veatch and Stryer for analysis of Eapp at [T] = 0.008 
rec/nm2 (top), [T] = 0.004 rec/nm2 (middle), and [T] = 0.00001 rec/nm2 (bottom) are 
shown in red.  B.  The best-fit MSE (left axis) versus oligomer order for the analysis of 
Eapp with the thermodynamic model based Kinetic Theory of FRET, without a stochastic 
FRET contribution (black circles).  The blue circles mark the best-fit MSE for fitting 
Eapp with a stochastic FRET contribution as in Equation (2-32).  In both cases, the best-
fit MSE is 𝑛 = 2.  Right axis: The best-fit reduced chi-square versus oligomer order for 
the analysis of Eapp in the presence of random noise with the thermodynamic model 
based Kinetic Theory of FRET, without a stochastic FRET contribution (black X’s).  The 
green X’s mark the best-fit reduced chi-square value for fitting Eapp in the presence of 
random noise with while including a stochastic FRET contribution, as in Equation (2-
32).   The magenta line is the 95% confidence cutoff for the reduced chi-square test- all 
X’s above this line are rejected and all X’s below this line are accepted as equally likely 
models, given the data and its associated error.  Analysis without a stochastic FRET 
contribution does produce acceptable models 𝑛 = 1 and 𝑛 = 3.  Analysis with the 
stochastic FRET consideration shows that all models provide an acceptable fit to the data, 
but the best-fit ∆G° indicates a lack of interactions. C.  The apparent FRET efficiency is 
plotted as a function of the acceptor surface density (black circles), and the best-fit 
monomer-only model (blue line), for an exclusion radius of 1.4nm (see Equation (3-9) 






3-6. Dimeric Membrane Proteins 
 
 Figure 3-4 shows the 𝐸𝑎𝑝𝑝  prediction for dimers, when ?̃? = 0.70 .  The total 
concentrations of fluorophores were varied from 1e-5 fluorophores/nm2, to a maximum 
surface density of 8e-3 fluorophores/nm2, while the acceptor fraction, 𝑥𝐴, was varied from 
0.1 to 0.9.  Figure 3-4A shows one example of a dimer configuration. Figure 3-4B shows 
the predictions of 𝐸𝑎𝑝𝑝 (using equations 8 and 9) and 𝐸𝑂𝑙𝑖𝑔𝑜 (using equations 10 and 11), 
as a function of the total concentration, for acceptor fractions (𝑥𝐴 increasing from 0.1 to 
0.9).  We see that oligomeric FRET, 𝐸𝑂𝑙𝑖𝑔𝑜, is a constant (for a given 𝑥𝐴) across the entire 
concentration range. On the other hand, 𝐸𝑎𝑝𝑝  increases as a function of the total 
concentration, due to stochastic FRET. In Figure 3-4C, we compare the simulated 𝐸𝑎𝑝𝑝 to 
the stochastic FRET contribution, Eprox, calculated with equation (5).  Eprox increases 
monotonically from zero as a function of total concentration to a maximum of ~40% for 
𝑥𝐴 = 0.9, a very significant contribution that cannot be neglected.  Figure 3-6 shows the 
𝐸𝑎𝑝𝑝 prediction for dimers, when ?̃? = 0.30. We see that for this low value of the intrinsic 
FRET efficiency, the stochastic FRET contribution is a much greater component of the 
total apparent FRET efficiency, and at the highest total concentrations and acceptor 
fractions, stochastic FRET comprises a large component of the total apparent FRET 
efficiency.   
 For a dimer, 𝐸𝑂𝑙𝑖𝑔𝑜 (𝐸𝐷𝑖𝑚𝑒𝑟) is linear when viewed as a function of the acceptor 
fraction, 𝑥𝐴 (Equation 2-14).  Often, this linear relationship is used to discern a dimer from 
a higher order oligomer. My simulation predicts this linear behavior, as shown in Figure 
3-4D.  Here, 𝐸𝑂𝑙𝑖𝑔𝑜 is plotted as a function of acceptor fraction with a blue line. This line 
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is plotted for [𝑇] = 1e-5 rec/nm2, where the stochastic FRET contribution is close to zero 
and for [𝑇] = 8e-3 rec/nm2 with maximal stochastic FRET. The two blue lines overlap 
exactly, as stochastic FRET has no effect on the magnitude of the dimer FRET.   
 𝐸𝑎𝑝𝑝 as a function of acceptor fraction is also plotted in Figure 3-4D for low [𝑇] = 
1e-5 rec/nm2 and high [𝑇] = 8e-3 rec/nm2.  We see that the curve for low total surface 
density overlaps exactly the curve of 𝐸𝑂𝑙𝑖𝑔𝑜 vs 𝑥𝐴.  Thus, at low surface densities stochastic 
FRET is minimized and 𝐸𝑂𝑙𝑖𝑔𝑜  = 𝐸𝑎𝑝𝑝 .  𝐸𝑎𝑝𝑝  is also linear with the acceptor fraction 
(overlap of blue and black lines). When [𝑇] = 8e-3 rec/nm2, however, the stochastic FRET 
contribution to the total apparent FRET efficiency is significant, and in this case 𝐸𝑎𝑝𝑝 is 
not a linear function of 𝑥𝐴 (top black curve in Figure 3-4D). This effect is also seen in the 
case of ?̃? = 0.30 , shown in Figure 3-6D. Thus, the stochastic FRET contribution 
introduces curvature in the 𝐸𝑎𝑝𝑝 versus 𝑥𝐴 plot at moderate to high surface densities for 
dimers, and we see that this curvature is not an indication of higher order oligomer 
formation, as is often assumed.    
 Figure 3-5 and Figure 3-7 show the applications of the models of Veatch and 
Stryer, and the thermodynamic model based on the Kinetic Theory of FRET, to the 
simulated dimer predictions for ?̃? = 0.70 and ?̃? = 0.30, respectively. In Figure 3-5A and 
Figure 3-7A, we fitted the constitutive dimer predictions with the model of Veatch and 
Stryer (Equation 2-11) and optimized for 𝐸𝑚𝑎𝑥 and 𝑛. We did this for two different total 
concentrations, [𝑇] = 8e-3 rec/nm2 (high total concentration) and [𝑇] = 1e-5 rec/nm2 (low 
total concentration).  The best-fit Veatch and Stryer (Equation 2-11) fitting results are 
plotted as red curves in Figure 3-5A  and Figure 3-7A and the best fit parameters are 
given in Table 3-1 for ?̃? = 0.70  and Table 3-2 for ?̃? = 0.30 .  When the total 
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concentration is low and the  stochastic FRET contribution is negligible, the fitting 
procedure yields the correct oligomerization order, n=2, and the correct 𝐸𝑚𝑎𝑥 = ?̃?, in both 
cases of ?̃? = 0.7  and ?̃? = 0.3.  
 Fitting 𝐸𝑎𝑝𝑝 at high total concentration, however, yields 𝑛 = 2.5 for Ẽ = 0.7, and 
𝑛 = 2.5 for Ẽ = 0.3.  Thus, the model of Veatch and Streyer, does not predict correctly the 
oligomer size for dimers. Furthermore, the prediction depends on the total concentration, 
and gives the false impression that the oligomer size increases when the total concentration 
increases. This seeming dependence of n on total concentration is an artifact occurring 
because the total concentrations and the stochastic FRET contributions are not taken into 
account in the model of Veatch and Stryer67.    
 Figure 3-5B and Figure 3-7B show the best-fit mean squared error and the best-
fit reduced chi-square as a function of oligomer order, for analysis with and without a 
stochastic FRET contribution.  When the data is analyzed without a stochastic FRET 
contribution, we see that for both the MSE and the reduced chi-square minimizations, the 
best-fits occur for 𝑛 = 2 .  However, none of the models without a stochastic FRET 
contribution are able to pass the reduced chi-square test, indicating poor fits to the data.  
When the proper stochastic FRET contribution is included analysis, the minimum MSE 
and reduced chi-square value for 𝑛 = 2 fitting of 𝐸𝑎𝑝𝑝 becomes very pronounced, (blue 
circles, green X’s in Figure 3-5B ) and the simulated parameters are properly extracted 
through the analysis (Table 3-1).  We also see that the dimer model is the only model that 
passes the reduced chi-square test at a 95% confidence level.   Thus, the total apparent 
FRET efficiency of a dimer is statistically different from the FRET efficiencies of other 
oligomerization orders for, ?̃? = 0.7.  In the case of a low value of intrinsic FRET, ?̃? = 0.3, 
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we see in Figure 3-7B that acceptable best-fit reduced chi-squared values were obtained 
for n=2-5.  Thus, for low values of intrinsic FRET, it will be difficult or impossible to 
determine the oligomerization state of the protein under study.   
 In conclusion, we see that use of the model of Veatch and Stryer can lead to 
misleading results for the case of dimers.  We also see that the donor and acceptor 
concentrations in the FRET experiments need to be known, such that the Kinetic Theory 
formalism can be applied with a stochastic FRET contribution as with Equation (2-32).  
We see that the stochastic FRET contribution must be accounted for when analyzing the 
data of a constitutively dimeric system.  When the stochastic FRET is taken into account, 
however, we are able to correctly identify the presence of constitutive dimers and to recover 


























Figure 3-4.  Predictions of the dimer-only simulation, ?̃? = 0.70.  A.  A sample 
configuration of dimers, as utilized in the simulation, with [𝑇] = 8e-3 fluorophores/nm1.  
Figure is drawn to scale, units of axes are in nm.  Donors: blue circles, Acceptors: red 
circles.  B.  𝐸𝑎𝑝𝑝 (black circles) and 𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) are plotted as a function of 
acceptor fraction, 𝑥𝐴 for [𝑇] = 0.008 rec/nm
2 (upper curve), and [𝑇] = 0.00001 rec/nm2 
(lower curve).  Dashed lines connect data points at constant [𝑇].  The 𝐸𝑂𝑙𝑖𝑔𝑜  curves 
overlap for all [𝑇].  C. 𝐸𝑎𝑝𝑝 (black circles) and Eprox (red circles) as a function of total 
fluorophore surface density.  In both panels, dashed lines connect data points at constant 
acceptor fraction, 𝑥𝐴, as indicated by the numbers on the right.  D.  𝐸𝑎𝑝𝑝 and  𝐸𝑂𝑙𝑖𝑔𝑜 as a 
function of total concentration, [𝑇].  Dashed lines connect data points at constant total 






















Figure 3-5.  Analysis results of the dimer-only simulations, Ẽ = 0.70.  A.  Eapp (black 
circles) versus A:D ratio, and the best-fit Veatch and Streyer model (red lines), for [T] = 
1e-5 rec/nm2 and [T] = 8e-3 rec/nm2 (lower, upper curves respectively).  B. The best-fit 
MSE (left axis) versus oligomer order for the analysis of Eapp with the thermodynamic 
model based Kinetic Theory of FRET, without a stochastic FRET contribution (black 
circles).  The blue circles mark the best-fit MSE for fitting Eapp with a stochastic FRET 
contribution as in Equation (2-32).  In both cases, the best-fit MSE is n = 2.  Right axis: 
The best-fit reduced chi-square versus oligomer order for the analysis of Eapp in the 
presence of random noise with the thermodynamic model based Kinetic Theory of FRET, 
without a stochastic FRET contribution (black X’s).  The green X’s mark the best-fit 
reduced chi-square value for fitting Eapp in the presence of random noise with while 
including a stochastic FRET contribution, as in Equation (2-32).   The magenta line is 
the 95% confidence cutoff for the reduced chi-square test- all X’s above this line are 
rejected and all X’s below this line are accepted as equally likely models, given the data 
and its associated error.  Analysis without a stochastic FRET contribution does not 
produce acceptable models for any order.  Analysis with the stochastic FRET 
consideration shows that the n = 2 model is the only model that passes the reduced chi-





















Figure 3-6.  The predictions of the constitutive dimer simulations, for ?̃? = 0.30.  A.  
𝐸𝑎𝑝𝑝 (black circles) and 𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) versus total concentration.  The dashed 
lines connect data points of constant acceptor fraction, as indicated on the right.  B.  
𝐸𝑎𝑝𝑝 (black circles) and Eprox (red circles) versus total concentration.  C.  𝐸𝑎𝑝𝑝 (black 
circles) and 𝐸𝑂𝑙𝑖𝑔𝑜  (blue circles) versus acceptor fraction, 𝑥𝐴, for [𝑇] = 1e-5 rec/nm
2 
(lower curve) and [𝑇] = 8e-3 rec/nm2 (upper curve).  𝐸𝑂𝑙𝑖𝑔𝑜 overlaps with itself at both 
concentrations for all acceptor fractions.  At low surface density, [𝑇] = 1e-5 rec/nm2, 















Figure 3-7.  Analysis results of the dimer-only simulations, for ?̃? = 0.30.  A.  𝐸𝑎𝑝𝑝 
(black circles) versus A:D ratio, and the best-fit Veatch and Streyer model (red lines), 
for [𝑇] = 1e-5 rec/nm2 and [𝑇] = 8e-3 rec/nm2 (lower, upper curves respectively).  B. 
The best-fit MSE (left axis) versus oligomer order for the analysis of 𝐸𝑎𝑝𝑝 (black 
circles) with the thermodynamic model based Kinetic Theory of FRET, without a 
stochastic FRET contribution.  The blue circles mark the best-fit MSE for fitting 𝐸𝑎𝑝𝑝 
with a stochastic FRET contribution as in Equation (2-32).  In both cases, the best-fit 
MSE is n = 2.  Right axis: The best-fit reduced chi-square versus oligomer order for 
the analysis of 𝐸𝑎𝑝𝑝 (black X’s) with the thermodynamic model based Kinetic Theory 
of FRET, without a stochastic FRET contribution.  The green X’s mark the best-fit 
reduced chi-square value for fitting 𝐸𝑎𝑝𝑝 with while including a stochastic FRET 
contribution, as in Equation (2-32).   The magenta line is the 95% confidence cutoff 
for the reduced chi-square test- all X’s above this line are rejected and all X’s below 
this line are accepted as equally likely models, given the data and its associated error.  
Analysis without a stochastic FRET contribution does not produce acceptable models 
for any order.  Analysis with the stochastic FRET consideration shows a minimum at 
n=2, but n = 2-5, corresponding to dimer through pentamer models, all provide an 





3-7. Trimeric Membrane Proteins 
 
 Figure 3-8 shows the FRET predictions for the constitutive trimer simulations, 
where trimers are arranged circles placed at the vertices of an equilateral triangle with a 
center to center distance on a side corresponding  ?̃? =  0.70.  Figure 3-8A shows a sample 
configuration of trimeric fluorophores utilized in the simulations.  The total concentrations 
of fluorophores were varied from 1e-5 fluorophores/nm2 to a maximum surface density of 
8e-3 fluorophores/nm2, while the acceptor fraction, 𝑥𝐴, was varied from 0.1 to 0.9.   𝐸𝑎𝑝𝑝 
and 𝐸𝑂𝑙𝑖𝑔𝑜 are plotted as a function of total fluorophore concentration in Figure 3-8B as 
black and blue circles.   We find that the total apparent FRET efficiency is much closer in 
value to the oligomeric FRET efficiency for constitutive trimers than with constitutive 
dimers across the range of simulated concentrations.  As in the case of the constitutive 
dimers, the total oligomeric FRET of the trimer-only case is constant as a function of total 
fluorophore concentration for a given acceptor fraction.   Figure 3-8C shows the total 
apparent FRET efficiency along with the stochastic FRET contribution as a function of 
total concentration.    
 Compared to the constitutive dimer simulations, the total stochastic FRET is 
reduced by nearly 10% at the highest surface densities, yet still increases with increasing 
total surface density of fluorophores.   The combination of the increasing stochastic FRET 
contribution along with the constant oligomeric FRET contribution to the total apparent 
FRET efficiency means that 𝐸𝑎𝑝𝑝  also increases as a function of total fluorophore 
concentration.   With a low value of the intrinsic FRET efficiency, ?̃? = 0.30, as shown in 
Figure 3-10A and 3-10B, the effect of the stochastic FRET on the total apparent FRET 
efficiency is more pronounced.  At the highest concentrations the stochastic FRET 
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contribution is only ~10% less than the oligomeric FRET contribution in the total apparent 
FRET efficiency. 
 Figure 3-9 and Figure 3-10 shows the results of the analyses of the trimer-only 
simulations with the models of Veatch and Stryer, and the thermodynamic model based on 
the Kinetic Theory of FRET for ?̃? = 0.70 and ?̃? = 0.30, respectively.  In Figure 3-9A, I 
plot the total apparent FRET efficiency as a function of acceptor to donor ratio, as 
previously with dimers, for two total concentrations: low surface density, [𝑇]  = 1e-5 
rec/nm^2, and high surface density, [𝑇]  = 8e-3 rec/nm^2.  We see that the reduced 
stochastic FRET contribution in the trimer-only case leads to a reduced total concentration 
dependence on the curvature of 𝐸𝑎𝑝𝑝  vs A/D, when compared to the dimer-only 
simulations.  Optimizing for 𝐸𝑚𝑎𝑥 and n in the model of Veatch and Stryer, Equation 2-
11, we find that for low and high surface densities, the results for ?̃? = 0.70 are nearly 
identical: n indicates trimer formation with values of 2.7 and 3.0, but 𝐸𝑚𝑎𝑥 does not reflect 
the true intrinsic FRET of a D:A pair in the trimer with values of 0.80 and 0.81, respectively.   
The best-fit Veatch and Stryer models are shown in Figure 3-9A as red lines, and show 
good agreement with the fitted data.   Of note is the fact that at a low value of the intrinsic 
FRET, ?̃? = 0.30, the model of Veatch and Stryer indicates dimer formation, with 𝑛 = 2 
for low surface density.  Meanwhile, at high surface density, the model indicates trimer 
formation.  This behavior could be incorrectly interpreted as a concentration-dependent 
oligomer order.     
 Figure 3-9B shows the best-fit mean squared error (MSE, left axis, circles) and the 
reduced chi-squared value (left axis, X’s) as a function of oligomer order and the best-fit 
parameters, ∆𝐺° and ?̃?, for the trimer fitting are given in Table 3-1 and Table 3-2.  We see 
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that the stochastic FRET correction has little effect on the overall best-fit MSE for 𝑛 > 2 
(compare blue and black open circles).  The overall minimum MSE is found for the trimeric 
model, and the best-fit 𝑛 = 3  parameters for fitting 𝐸𝑎𝑝𝑝  are very close to the actual 
simulated parameters.  These results indicate that the effect of the stochastic FRET 
contribution for a constitutive trimer with high intrinsic FRET is essentially negligible, 
with regards to determination of the intrinsic FRET efficiency and the oligomeric state 
through analysis.   We also see that for the constitutive trimer reduced chi-square analysis 
with a stochastic FRET contribution, both the trimer and tetramer models are viewed as 
acceptable models, given the data.  This is due to two factors: the approximation of the 
single-donor-to-acceptor distance in the oligomer, which is true for equilateral trimers, but 
becomes worse and worse for 𝑛 > 3, and the fact that the total apparent FRET efficiency 
for higher order oligomer formation, n > 2, is not unique.   For example, even though the 
data is not shown, I can adjust the intrinsic FRET and association constant parameters of a 
pentamer simulation such that the total apparent FRET efficiency matches the trimeric total 
apparent FRET efficiency to within 1%.   
 For the case of a low value of the intrinsic FRET efficiency, ?̃? = 0.30, we see that 
all 𝑛 > 1  provide acceptable reduced chi-squared values when a stochastic FRET 
contribution is modeled in the analysis (Figure 3-10D).  Without a stochastic FRET 
contribution, none of the models produce acceptable best-fit reduced chi-square values at 
95% confidence.  Thus, we find trimer formation will be indiscernible from other 
oligomerization models in bulk two-color, static quenching FRET experiment.  Further, for 
a low value of intrinsic FRET, we find that a stochastic FRET contribution is necessary in 




























Figure 3-8.   The predictions of the trimer-only simulation, ?̃? = 0.70.  A.  A sample 
configuration of randomly labeled trimers, as utilized in the simulations.  Figure is drawn 
to scale, with donors represented by blue circles and acceptors as red circles.  B.  𝐸𝑎𝑝𝑝 
and 𝐸𝑂𝑙𝑖𝑔𝑜 versus total concentration, [𝑇] (black and blue circles, respectively).  C.  𝐸𝑎𝑝𝑝 
and Eprox are plotted as a function of total concentration, [𝑇] (black circles and red circles, 
respectively).  In both panels, the dashed lines connect data points of constant acceptor 































Figure 3-9.  Analysis results for the constitutive-trimer simulation, ?̃? = 0.70.  A. The 
best-fit Veatch and Stryer model plotted (red lines) on top of the measured 𝐸𝑎𝑝𝑝 vs. A:D 
ratio for [𝑇] = 1e-5 fluorophores/nm2 (lower curve, black circles) and for [𝑇] = 8e-3 
fluorophores/nm2 (upper curve, black circles) .  B. The best-fit MSE(left axis, circles) and 
reduced chi-square value (right axis, X’s) versus oligomer order for the analysis of 𝐸𝑎𝑝𝑝 
with the thermodynamic model based on the Kinetic Theory of FRET with a stochastic 
FRET contribution (blue circles, green X’s), and without a stochastic FRET contribution 
(black circles, black X’s).  In both cases, the minimum MSE occurs at 𝑛 = 3.  The line in 
magenta denotes the 95% confidence limit for the reduced chi-square test.   All X’s above 
this line are rejected and all X’s below this line are accepted as equally likely models, 
given the data and its associated error.  In the presence of random noise, 𝑛 = 3 and 𝑛 = 4 
models without a stochastic FRET contribution both pass the reduced chi-square test, and 
similarly, 𝑛 = 3 and 𝑛 = 4 provide acceptable fits to the data when a stochastic FRET 








Figure 3-10.  The predictions of the constitutive-trimer simulations and the results of 
the analyses, for ?̃? = 0.30.  A. 𝐸𝑎𝑝𝑝 (black circles) and 𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) versus 
total concentration.  The dashed lines connect data points of constant acceptor 
fraction, as indicated on the right.  B. 𝐸𝑎𝑝𝑝 (black circles) and Eprox (red circles) versus 
total concentration C. 𝐸𝑎𝑝𝑝 (black circles) versus A:D ratio, and the best-fit Veatch 
and Streyer model (red lines) , for [𝑇] = 1e-5 rec/nm2 and [𝑇] = 8e-3 rec/nm2 (lower, 
upper curves respectively).  D. The best-fit MSE(left axis, circles) and reduced chi-
square value (right axis, X’s) versus oligomer order for the analysis of 𝐸𝑎𝑝𝑝 with the 
thermodynamic model based on the Kinetic Theory of FRET with a stochastic FRET 
contribution (blue circles, green X’s), and without a stochastic FRET contribution 
(black circles, black X’s).  The line in magenta denotes the 95% confidence limit for 
the reduced chi-square test.   In the presence of random noise, all models without a 
stochastic FRET contribution fail the reduced chi square test, and all n > 1 provide 
acceptable fits to the data when a stochastic FRET contribution is included.   Thus, the 
oligomer order is not discernable for this dataset.   
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3-8. Tetrameric Membrane Proteins 
 Figure 3-11 and Figure 3-13 shows the results of the simulations for constitutively 
tetrameric distributions of fluorophores for  ?̃? = 0.70 and ?̃? = 0.30.  Figure 3-11A shows 
a sample configuration of tetrameric fluorophores, represented by circles arranged in a 
square configuration.  The total concentrations of fluorophores utilized ranged from [𝑇] = 
1e-5 fluorophores/nm2 to a maximum surface density of 8e-3 fluorophores/nm2, with the 
acceptor fraction ranging from 0.1-0.9.  Figure 3-11B shows 𝐸𝑎𝑝𝑝 and 𝐸𝑂𝑙𝑖𝑔𝑜 plotted as a 
function of total concentration as black and blue circles, respectively.   We see that 
compared to the constitutive dimer and trimer simulations, the difference between 𝐸𝑎𝑝𝑝 
and 𝐸𝑂𝑙𝑖𝑔𝑜 is further reduced.  We also see that as before, the oligomeric FRET is constant 
for all concentrations, while the total apparent FRET efficiency slowly increases due to 
stochastic FRET.   In Figure 3-11C, we plot 𝐸𝑎𝑝𝑝  and 𝐸𝑝𝑟𝑜𝑥  as a function of total 
fluorophore surface density.   
 A comparison of the stochastic FRET contribution for tetramers with that of trimers 
and dimers shows a drastically reduced stochastic FRET contribution in the constitutive 
tetramer simulations, for both ?̃? = 0.70 and ?̃? = 0.30 simulations.  Additionally, we see 
that the total apparent FRET efficiencies for the constitutive trimer simulations and 
constitutive tetramer simulations are nearly equal (compare Figures 3-8B, C and Figures 
3-11, C).  Furthermore, due to the reduced stochastic FRET contribution, the oligomeric 
FRET and the total apparent FRET efficiency are nearly equal across all concentration 
ranges for  ?̃? = 0.70.   Figure 3-13A, B shows that for low intrinsic FRET, ?̃? = 0.30, 
stochastic FRET becomes a significant component of the total apparent FRET efficiency, 
76 
 
contributing to the steeper increase of the total apparent FRET efficiency with increasing 
surface density of fluorophores.   
 Figure 3-12 and Figure 3-13C, D show the analysis results of the constitutive 
tetramer simulations with the models of Veatch and Stryer, and the thermodynamic model 
based on the Kinetic Theory of FRET for ?̃? = 0.70 and ?̃? = 0.30, respectively.  The 
results of these analyses are summarized in Table 3-1, below (see Table 3-2 for ?̃? = 0.30). 
In Figure 3-12A, I plot the total apparent FRET efficiency as a function of acceptor to 
donor ratio, as previously with dimers and trimers for two total concentrations: low surface 
density, [𝑇] = 1e-5 rec/nm^2, and high surface density, [𝑇] = 8e-3 rec/nm^2.  We see that 
the reduced stochastic FRET contribution in the tetramer-only case leads to a reduced total 
concentration dependence on the curvature of 𝐸𝑎𝑝𝑝 vs A/D, when compared to the dimer- 
and trimer-only simulations.  Optimizing for 𝐸𝑚𝑎𝑥 and n in the model of Veatch and Stryer, 
Equation 2-11, we find that for low and high surface densities, the results for ?̃? = 0.70 
are nearly identical: n indicates trimer formation with values of 2.9 and 3.1, but 𝐸𝑚𝑎𝑥 does 
not reflect the true intrinsic FRET of a D:A pair in the tetramer with a value of 0.81.   The 
best-fit Veatch and Stryer models are shown in Figure 3-12A as red lines.  Of note is the 
fact that at a low value of the intrinsic FRET, ?̃? = 0.30, the model of Veatch and Stryer 
indicates dimer formation with n = 2.4 for low surface density, and gives an indication of 
trimer formation with n = 2.6 at high surface density.  As with trimers, for tetramers, this 
behavior could be incorrectly interpreted as a concentration-dependent oligomer order.     
 Analysis of the total apparent FRET efficiency data with the thermodynamic model 
based on Kinetic Theory of FRET (Equation (3-10)) reveals an apparent minimum at n = 
4 in the MSE versus oligomer-order plot (Figure 3-12B) when the stochastic FRET is 
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ignored.   However, with the stochastic FRET contribution included in the MSE and 
reduced chi-square analysis, we find that the FRET of tetramer formation is 
indistinguishable from the total apparent FRET efficiency of trimer formation.  Both 
models for 𝑛 = 3 and 𝑛 = 4 pass the reduced chi-square test at 95% confidence, as shown 
by the green X’s in Figure 3-12B.  We see that for a low value of intrinsic FRET, ?̃? =
0.30, the MSEs for n > 2 are all nearly equal and the best-fit reduced chi-square values for 
all produce acceptable fits, for analysis with a stochastic FRET contribution (Figure 3-
13D).  This is a consequence of both the single D:A distance approximation in the Kinetic 
Theory of FRET in Equation (3-10) and the low ?̃? value, and further enhanced due to the 
non-uniqueness of the total apparent FRET efficiency for higher-order oligomer formation, 
compare to constitutive trimer results, and also discussed later.  Thus, as with trimers, I 
have found find that tetramer formation will be indistinguishable from that of trimer 
formation in a two-color static quenching FRET experiment.   Since I have shown the 
essential and important distinguishable features in a bulk, static-quenching membrane 
protein FRET experiment, I will not continue this to higher oligomer orders, and as such I 
do not analyze or present simulations of pentameric and higher-order constitutive 


































Figure 3-11.  Predictions of the constitutive tetramer simulation, ?̃? = 0.70.   A.  A 
sample configuration of tetramers, as used in the simulation with a total surface density,  
[𝑇] =  8e-3 fluorophores/nm2.   Figure drawn to scale, axes units in nm.  B.  𝐸𝑎𝑝𝑝 and 
𝐸𝑂𝑙𝑖𝑔𝑜 versus [𝑇] (black and blue circles, respectively).  C.   𝐸𝑎𝑝𝑝  (black circles) and 
Eprox (red circles) as a function of total fluorophore concentration.  In both panels, dashed 
























Figure 3-12.  Analysis results for the constitutive-tetramer simulations, Ẽ = 0.70.  A.  
Eapp plotted as a function of A:D ratio, for [T] = 1e-5 rec/nm
2 (lower line) and for [T] = 
8e-3 rec/nm2 (top line) (black circles) along with the best-fit Veatch and Stryer model 
(red lines).  B. The best-fit MSE(left axis, circles) and reduced chi-square value (right 
axis, X’s) versus oligomer order for the analysis of Eapp with the thermodynamic model 
based on the Kinetic Theory of FRET with a stochastic FRET contribution (blue circles, 
green X’s), and without a stochastic FRET contribution (black circles, black X’s).  
Without a stochastic FRET contribtution, the minimum MSE occurs at 𝑛 = 4, but occurs 
at 𝑛 = 3 when a stochastic FRET model is utilized (see Equation (2-32)).  The line in 
magenta denotes the 95% confidence limit for the reduced chi-square test (X’s, right 
axis).   In the presence of random noise, most models without a stochastic FRET 
contribution fail the reduced chi-square test, except for the 𝑛 = 4 model.  Both 𝑛 = 3 and 
𝑛 = 4 both provide acceptable fits to the data when a stochastic FRET contribution is 
included.   Thus, the oligomer order is not discernable for this dataset, but the presence of 













Figure 3-13.  The predictions of the constitutive-tetramer simulation and the results of 
the analyses, for ?̃? = 0.30.  A.  𝐸𝑎𝑝𝑝 (black circles) and 𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) versus 
total concentration.  The dashed lines connect data points of constant acceptor 
fraction, as indicated on the right.  B. 𝐸𝑎𝑝𝑝 (black circles) and Eprox (red circles) versus 
total concentration.  C.  𝐸𝑎𝑝𝑝 (black circles) versus A:D ratio, and the best-fit Veatch 
and Streyer model, for [𝑇] = 1e-5 rec/nm2, and [𝑇] = 8e-3 rec/nm2 (lower,  upper 
curves, respectively).  D. The best-fit MSE(left axis, circles) and reduced chi-square 
value (right axis, X’s) versus oligomer order for the analysis of 𝐸𝑎𝑝𝑝 with the 
thermodynamic model based on the Kinetic Theory of FRET with a stochastic FRET 
contribution (blue circles, green X’s), and without a stochastic FRET contribution 
(black circles, black X’s).  The line in magenta denotes the 95% confidence limit for 
the reduced chi-square test (X’s, right axis).   In the presence of random noise, all 
models without a stochastic FRET contribution fail the reduced chi-square test, and all 
n>2 provide acceptable fits to the data when a stochastic FRET contribution is 
included.   Thus, the oligomer order is not discernable for this dataset, but the 
presence of dimers is excluded.   
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   Figure 3-14.  Dimer, trimer, and tetramer simulated data (black dots) and best-fit 
model (green dots) of the simulated oligomer order for N = 2700 datapoints at random 
total concentrations, with acceptor fraction ranging from 0.1 – 0.9 in 0.1 steps.  
Gaussian distributed random noise, 𝜇 = 0, 𝜎 = 0.08, was added to each data point 
prior to analysis with the reduced chi-squared test.   A.  Simulated data and best-fit 
dimer model for ?̃? = 0.70 B.  Simulated data and best-fit dimer model for ?̃? = 0.30.  
C.  Simulated data and best-fit trimer model for ?̃? = 0.70.   D.  Simulated data and 
best-fit trimer model for ?̃? = 0.30.  E.  Simulated data and best-fit tetramer model for 
?̃? = 0.70.  F.  Simulated data and best-fit tetramer model for ?̃? = 0.30.   Later, it will 
be useful to compare these simulated FRET experiments to the FRET that I have 












Table 3-1.  Combined results for analysis of the constitutive oligomer simulations for 
dimers (Order = 2), trimers (Order = 3), and tetramers (Order = 4) with the models of 
Veatch and Stryer and the thermodynamic model based on the Kinetic Theory of 
FRET, for ?̃? = 0.70.  The analysis with the model of Veatch and Stryer was 
performed at two different total concentrations: [𝑇]=1e-5 rec/nm2 and [𝑇]=8e-3 
rec/nm2, and the best-fit parameters 𝑛 and 𝐸𝑚𝑎𝑥  are provided in the columns.  The 
thermodynamic model based on the Kinetic theory of FRET was used for fitting of 
simulated FRET data without error for a minimization of the Mean Squared 
Error(MSE).  The black text indicates fitting without utilization of a stochastic FRET 
model and the blue text indicates the best-fit results for analysis that includes a 
stochastic FRET model (see Equation (2-32)).  Additionally, the reduced chi-square 
minimization was performed for analysis with the thermodynamic model based on the 
Kinetic Theory of FRET (N=2,700 data points with added Gaussian-distributed 
random noise).  The rows with black text indicate analysis results without utilizing a 
stochastic FRET model, as with the MSE minimization column, and the green text 
indicates the best-fit reduced chi-squared results for fitting with a stochastic FRET 









Veatch & Stryer 
 





















rexcl = 1.4nm 
𝑛 = 1.9 n = 2.2 𝑛 = 2.4 
 
monomer-only 
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Monomer-only: 








rexcl = 1.4nm 
All n; no 
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𝑛 = 2.0 𝑛 = 2.5 
> 70% 𝐷𝑖𝑚𝑒𝑟𝑖𝑐 
𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 







































































Table 3-2.  Combined results for analysis of the constitutive oligomer simulations for 
dimers (Order = 2), trimers (Order = 3), and tetramers (Order = 4) with the models of 
Veatch and Stryer and the thermodynamic model based on the Kinetic Theory of 
FRET, for ?̃? = 0.30.  The analysis with the model of Veatch and Stryer was 
performed at two different total concentrations: [𝑇]=1e-5 rec/nm2 and [𝑇]=8e-3 
rec/nm2, and the best-fit parameters 𝑛 and 𝐸𝑚𝑎𝑥  are provided in the columns.  The 
thermodynamic model based on the Kinetic theory of FRET was used for fitting of 
simulated FRET data without error for a minimization of the Mean Squared 
Error(MSE).  The black text indicates fitting without utilization of a stochastic FRET 
model and the blue text indicates the best-fit results for analysis that includes a 
stochastic FRET model (see Equation (2-32)).  Additionally, the reduced chi-square 
minimization was performed for analysis with the thermodynamic model based on the 
Kinetic Theory of FRET (N=2,700 data points with added Gaussian-distributed 
random noise).  The rows with black text indicate analysis results without utilizing a 
stochastic FRET model, as with the MSE minimization column, and the green text 
indicates the best-fit reduced chi-squared results for fitting with a stochastic FRET 












Veatch & Stryer 
 



















𝑛 = 2.0 𝑛 = 2.5 
> 40% 𝐷𝑖𝑚𝑒𝑟𝑖𝑐 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 > 10% 𝐷𝑖𝑚𝑒𝑟𝑖𝑐 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 







?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2 = 0.49 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2
= 0.70 ± 0.01 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2 = 0.30 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2




𝑛 = 2.3 𝑛 = 2.7 
> 80% Oligomeric fraction 
> 60% Oligomeric 
fraction 







?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=3 = 0.38 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=3
= 0.36 ± 0.01 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=3 = 0.30 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=3





𝑛 = 2.4 𝑛 = 2.6 











?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=4 = 0.26 
 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=4
= 0.26 ± 0.01 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=4 = 0.24 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=4
= 0.24 ± 0.01 
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3-9. Membrane Proteins in Monomer-Dimer Equilibrium  
 Figure 3-15 and Figure 3-17 show the results of the monomer-dimer equilibrium 
simulations, for Δ𝐺° =  −4.0 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙 and donor-to-acceptor distances corresponding to  
?̃? = 0.70 and ?̃? = 0.30.  In these simulations and Gibbs free energy of dimerization, the 
dimeric fraction ranges from ~ 0% at the lowest simulated fluorophore density of 1e-5 
fluorophores/nm2, to a maximum of ~80% dimeric fraction at the highest surface densities 
of 8e-3 fluorphores/nm2, as shown in Figure 3-15A.  Figure 3-15B shows a sample 
configuration of monomers and dimers as used in the simulations.  Figure 3-15C shows 
the total apparent FRET efficiency and the dimeric FRET efficiency as a function total 
fluorophore concentration.  We see that the oligomeric FRET contribution increases 
proportionally to the dimeric fraction, and that the total apparent FRET efficiency is 
substantially higher than the oligomeric FRET for most of the total concentration range.     
 Figure 3-15D shows 𝐸𝑎𝑝𝑝 and the stochastic FRET, Eprox, plotted as a function of 
total concentration.   We see that the stochastic FRET contribution comprises a major 
component of the total apparent FRET efficiency with a maximum of nearly 50% at T = 
8e-3 rec/nm2 and 𝑥𝐴  = 0.9.  Comparison of the stochastic FRET efficiency and the 
oligomeric FRET contributions in these two panels shows that they approximately of equal 
magnitude at the highest total fluorophore surface densities.  For the monomer-dimer 
simulation with ?̃? = 0.30 , the stochastic FRET contribution is even greater than the 
oligomeric FRET contribution to the total apparent FRET efficiency, as we see in Figure 
3-17A, 3-17B.  In Figure 3-16A, the total apparent FRET efficiency and the oligomeric 
FRET plotted as a function of the acceptor fraction, 𝑥𝐴, for [𝑇] = 1e-5 fluorophores/nm
2 
(lower curve), [𝑇]  = 4e-3 fluorophores/nm2 (middle curve) and [𝑇]  = 8e-3 
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fluorophores/nm2 (upper curve).  𝐸𝑎𝑝𝑝  is plotted as black circles, connected by black 
dashed lines, and 𝐸𝑂𝑙𝑖𝑔𝑜 is plotted as blue circles connected by blue dashed lines.  We see 
that the total concentration, which affects the thermodynamically-driven dimeric fraction, 
has a distinct effect on the curvature and maximal FRET of the apparent FRET efficiency 
versus 𝑥𝐴 curves.   For 𝐸𝑂𝑙𝑖𝑔𝑜, we see in Figure 10A that the lines are straight, but the slope 
of the lines increases with increasing dimeric fraction.   
 Figure 3-16B,C depicts the results of the analysis of the monomer-dimer simulated 
data with the model of Veatch and Stryer (Equation 2.11) and the thermodynamic model 
based on the Kinetic Theory of FRET.  Figure 3-16B shows the results of the Veatch and 
Stryer analysis, plotted as red lines.  In the Veatch and Stryer analysis, we fit 𝐸𝑎𝑝𝑝 vs. 
acceptor to donor ratio for three values of the total concentration: low, moderate, and high 
total receptor concentrations as a function of D:A ratio (red lines)  for ?̃? = 0.70 (see 
Figure 3-17C for  ?̃? = 0.30 results).  When fitting with the Veatch and Stryer model at 
the lowest total simulated fluorophore surface density, the best-fit oligomer order is a dimer, 
n = 2, but 𝐸𝑚𝑎𝑥 = 0.01 occurs because little FRET was measured.  For moderate total 
concentration fitting, we find the best-fit oligomer order is n = 2.3, which properly indicates 
dimer formation with minimal effect by stochastic FRET on the fit results.  However, for 
fitting the low surface density data 𝐸𝑚𝑎𝑥 = 0.56, which is not the proper value for ?̃?.  
When fitting the highest total fluorophore surface densities, 8e-3 fluorophores/nm2, the 
𝐸𝑚𝑎𝑥 = 0.66, which is close to the simulated value, ?̃? = 0.70.  The stochastic FRET 
contribution at this fluorophore surface density is of the same magnitude as the oligomeric 
FRET contribution to the total measured apparent FRET efficiency, and the additional 
curvature gives a best-fit n = 2.5, which would incorrectly be interpreted as a trimer.  These 
89 
 
results are summarized below in Table 3-3 and in Table 3-4 for the ?̃? = 0.30 simulations.  
For this low value of intrinsic FRET, we see a very similar behavior in the Veatch and 
Stryer analysis at low, medium and high surface densities.  Again, initially dimerization is 
indicated at low concentration, but at high concentration, the model indicates trimer 
formation.  In both cases of low and high intrinsic FRET, we see that the best-fit parameters 
give no information about the presence of a concentration-dependent monomer-dimer 
equilibrium.  Furthermore, the seeming dependence of n on the total concentration (due to 
the stochastic FRET contribution and the concentration-dependent association) could be 
interpreted as a concentration dependent change in oligomeric state, with order increasing 
with total concentration, as we have seen previously.       
 Figure 3-16C shows the results of the mean-squared error and the reduced chi-
square analyses of the ?̃? = 0.70  monomer-dimer equilibrium simulations with the 
thermodynamic model based on Kinetic Theory of FRET (Equation (3-10)).  The results 
for the low intrinsic FRET, ?̃? = 0.30, are summarized in Figure 3-17D.   For the ?̃? = 0.70 
simulations, we see that fitting the 𝐸𝑎𝑝𝑝 versus total concentration data without a stochastic 
FRET contribution leads to a minimum mean-squared error at n = 3, with n = 2 and n = 3 
providing similar best-fit MSE values.  The best-fit of a trimer, when directly fitting the 
total apparent FRET efficiency is incorrect, and similar to the results of the Veatch and 
Stryer model for fitting at high [𝑇], where the stochastic FRET contribution is maximal.  If 
one neglects to fit for higher-order oligomer formation and only looks for dimers, then the 
best-fit donor-to-acceptor FRET efficiency in the dimer pair, Ẽ = 0.96, a non-physical 
value (see Table 3-3).  With the appropriate stochastic FRET correction, the minimum 
MSE for fitting the apparent FRET efficiency becomes very pronounced at n = 2 (see 
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Figure 3-16C and Table 3-3, and Figure 3-17D and Table 3-4).  We also see that the n 
= 2 model with a stochastic FRET contribution is the only model that passes the reduced 
chi-squared test at 95% confidence.  Thus, the best-fit model is a dimeric state, with proper 
extraction of ΔG° and Ẽ from the analysis occurring only when stochastic FRET is properly 
taken into consideration.  The best-fit monomer-dimer equilibrium model parameters for 
fitting the total apparent FRET efficiency with and without consideration for the stochastic 
FRET are shown along with the actual, simulated parameters in Table3-3 and Table 3-4.  
For a low value of intrinsic FRET, ?̃? = 0.30,  the reduced chi-square test shows that 
acceptable fits were found for all n>1.  Thus, for a monomer-dimer equilibrium with a low 
value of the intrinsic FRET < 0.5, a monomer-dimer model will be difficult to distinguish 
from other monomer-oligomer states. 
 Finally, I investigated the applicability of a linear approximation to 𝐸𝑎𝑝𝑝 as a sum 
of stochastic and dimeric FRET, Equation (2-34), to properly model the simulation 
predictions for the total apparent FRET efficiency.  I utilized the stochastic FRET 
contribution, as defined in Equation (2-33), in a linear sum with the oligomeric FRET for 
the monomer-dimer simulations described here with ?̃? = 0.30 and ?̃? = 0.70.  Figure 3-
18 shows 𝐸𝑎𝑝𝑝 and the linear approximation as a function of total concentration.  The area 
shaded in green in Figure 3-18 shows the acceptable (<10% error in 𝐸𝑎𝑝𝑝) region for the 
linear approximation.  We see that at low concentrations and low acceptor fractions, the 
linear approximation, Equation (2-34)) models the total apparent FRET relatively well, 
while for high acceptor fractions and moderate surface densities, the linear approximations 
overestimate the total apparent FRET efficiency.   The linear approximation has a wider 
range of applicability for low intrinsic FRET values, as can be seen by comparing the 𝑥𝐴 
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coverage of the shaded regions in Figure 3-18.  As mentioned in the previous chapter, now 
that I have developed the full description of the total apparent FRET efficiency as defined 
in Equation 2-32, and we know that with a library of stochastic FRET estimations we can 


























Figure 3-15.  Predictions of the monomer-dimer simulation, ?̃? = 0.70.  A. The 
dimeric fraction utilized in the monomer-dimer simulation ranges from ~0 % to ~80%. 
B. A sample configuration with a mixture of monomers and dimers at [𝑇] = 8e-3 
fluorophores/nm2 is shown.  Dimers are represented by circles with a connecting line.  
Donors: blue, acceptors: red.  Figure is drawn to scale, axes units are in nm.  C. 𝐸𝑎𝑝𝑝 
(black circles) and Eprox (red circles) are plotted as a function of the total fluorophore 
concentration.  D. 𝐸𝑎𝑝𝑝 and 𝐸𝑂𝑙𝑖𝑔𝑜 (black and blue circles, respectively) vs [𝑇].  The 
dashed lines connect data points at constant acceptor fraction, 𝑥𝐴, as indicated by the 


























Figure 3-16. Analysis results of the monomer-dimer simulations, Ẽ = 0.70.  A.  Eapp  
and EOligo vs. acceptor fraction for [T] = 0.008 rec/nm
2 (top), [T] = 0.004 
rec/nm2(middle), and [T] = 0.00001 rec/nm2 (black circles, blue circles respectively).  
Dashed lines connect data points at constant [T], as indicated.  B.  Eapp versus A:D 
ratio  for [T] = 0.00001 rec/nm2 (low), [T] = 0.004 rec/nm2(middle), and [T] = 0.008  
rec/nm2 (high) as black circles.  Dashed lines connect data points of constant [T, as 
indicated].  The best-fit Veatch and Stryer model is shown in  red. C.  The best-fit 
MSE (left axis) versus oligomer order for the analysis of Eapp with the 
thermodynamic model based Kinetic Theory of FRET, without a stochastic FRET 
contribution (black circles).  The blue circles mark the best-fit MSE for fitting Eapp 
with a stochastic FRET contribution as in Equation (2-32).  Without a stochastic 
FRET model, the best-fit MSE is 𝑛 = 3.  With a stochastic FRET model, the best-fit 
MSE occurs at n=2.  Right axis: The best-fit reduced chi-square versus oligomer order 
for the analysis of Eapp in the presence of random noise with the thermodynamic 
model based Kinetic Theory of FRET, without a stochastic FRET contribution (black 
X’s).  The green X’s mark the best-fit reduced chi-square value for fitting Eapp in the 
presence of random noise with while including a stochastic FRET contribution, as in 
Equation (2-32).   The magenta line is the 95% confidence cutoff for the reduced chi-
square test- all X’s above this line are rejected and all X’s below this line are accepted 
as equally likely models, given the data and its associated error.  Analysis without a 
stochastic FRET contribution does not produce acceptable models for any order.  
Analysis with the stochastic FRET consideration shows that the 𝑛 = 2 model is the 






















Figure 3-17.  The predictions of the monomer-dimer simulations and the results of 
the analyses, for ?̃? = 0.30, ∆𝐺° =  −4 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙  A.  𝐸𝑎𝑝𝑝 (black circles) and 
𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) versus total concentration.  The dashed lines connect data points 
of constant acceptor fraction, as indicated on the right.  B. 𝐸𝑎𝑝𝑝 (black circles) and 
Eprox (red circles) versus total concentration.  C.  𝐸𝑎𝑝𝑝 (black circles) versus A:D 
ratio, and the best-fit Veatch and Streyer model, for [𝑇] = 1e-5 rec/nm2, and [𝑇] = 
8e-3 rec/nm2 (lower,  upper curves, respectively).  D. The best-fit MSE(left axis, 
circles) and reduced chi-square value (right axis, X’s) versus oligomer order for the 
analysis of 𝐸𝑎𝑝𝑝 with the thermodynamic model based on the Kinetic Theory of 
FRET with a stochastic FRET contribution (blue circles, green X’s), and without a 
stochastic FRET contribution (black circles, black X’s).  Without a stochastic FRET 
consideration, the best-fit MSE indicates trmers, but when a stochastic FRET model 
is included in the analysis, the best-fit MSE indicates n = 2.  The magenta line 
denotes the 95% confidence limit for the reduced chi-square test (X’s, right axis).   
In the presence of random noise, all models without a stochastic FRET contribution 
fail the reduced chi-square test, and all n>1 provide acceptable fits to the data when 
a stochastic FRET contribution is included.   The overall reduced chi-square 
minimum is 𝑛 = 2 for the green X’s, however the oligomer order is not discernable 











   
Figure 3-18.  The predictions of the monomer-dimer simulations as a function of total 
concentration for ?̃? = 0.70 (panel A)  and ?̃? = 0.30. (panel B), plotted as black 
circles.  The linear approximation, 𝐸𝑎𝑝𝑝 = 𝐸𝑝𝑟𝑜𝑥 + 𝐸𝑜𝑙𝑖𝑔𝑜,, as a function of total 
concentration is plotted as blue circles.  The dashed lines connect data points of 
constant acceptor fraction, 𝑥𝐴, as indicated on the right.  The green shaded areas 
represent the regions of applicability of the linear approximation, Equation (2-34).   
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3-10.  Membrane Proteins in a Monomer-Tetramer Equilibrium 
 Figure 3-18 and Figure 3-20 show the results for the case of a non-constitutive 
tetramerization of membrane proteins.  We utilized the geometry square tetramers, where 
the fluorophores on a side of the square are separated by a distance corresponding to ?̃? =
0.70, or 4.7 nm, and ?̃? = 0.30 for a side-length of 6.3 nm.   Similarly to the monomer-
dimer simulations, the monomer-tetramer equilibrium constant was set corresponding to a 
∆𝐺° =  −12.0 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙, such that the fraction of tetramers ranges from ~0% at the lowest 
simulated surface density, [𝑇] = 1e-5 fluorophores/nm2, to a maximum of near ~80% at the 
surface density of 8e-3 fluorophores/nm2, the highest simulated concentration, as shown in 
Figure 3-18A.  A sample configuration from the simulations at the maximum simulated 
fluorophore concentration is shown in Figure 3-18B.   
 The predictions of the monomer-tetramer simulation for ?̃? = 0.70 are shown in 
Figures 3-18C, D and Figure 3-20A, B for ?̃? = 0.30.   In Figure 3-18C, we see that the 
total apparent FRET efficiency (black circles) ranges from zero at the lowest simulated 
concentration (with zero tetrameric fraction) to a maximum at the highest simulated 
fluorophore surface densities (~80% tetrameric fraction).  The oligomeric FRET, plotted 
in blue circles, also increases with the total concentration, as the increase drives tetramer 
formation and a higher tetrameric fraction.  In Figure 3-18D, we see 𝐸𝑎𝑝𝑝 plotted as a 
function of total concentration (black circles) alongside the stochastic FRET contribution, 
Eprox (red circles).  Comparing the stochastic FRET in Figure 3-18D to that of the 
constitutive tetramer simulation predictions, shown in Figure 3-11C, we see that the 
presence of monomers greatly increases the stochastic FRET contribution (red circles) to 
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the total apparent FRET efficiency (black circles), similarly to the monomer-dimer 
simulations.   
 In Figure 3-19A, I’ve plotted the total apparent FRET efficiency data as a function 
of acceptor for three total concentrations of fluorophores: low at 1e-5 fluorophores/nm2, 
moderate at 4e-3 fluorophores/nm2, and high at 8e-3 fluorophores/nm2 (see Equation 2-
11).   Examination of Figure 3-19A shows the effect of concentration-dependent 
oligomerization on the curvature of the apparent FRET efficiency vs acceptor ratio is 
drastic:  at low concentration, the total apparent FRET efficiency is ~0 for all A:D ratios, 
while at high concentration, the high surface densities of tetrameric fluorophores leads to 
a higher curvature.   
 Figure 3-19B, C summarizes the results of analysis of the monomer-tetramer 
simulation data with the model of Veatch and Stryer, and the thermodynamic model based 
on the Kinetic Theory of FRET.  The best-fit models for the Veatch and Stryer analysis are 
shown in Figure 3-19B and Figure 3-20C, with the results summarized in Table 3-3 and 
Table 3-4 for ?̃? = 0.70 and ?̃? = 0.30, respectively.  We see that at low concentrations, 
the lack of FRET means there is no useable signal, 𝐸𝑚𝑎𝑥 = 0.0, and at high concentrations 
we fail to identify a proper oligomer order of four, and instead measure trimer formation 
with n = 3.1.  Additionally, as with the monomer-dimer simulation analysis, the Veatch 
and Stryer model gives no indication about the presence of monomers.   
 Figure 3-19C shows the best-fit MSEs for the thermodynamic model (Equation 
(3-10)) as a function of oligomer order, with and without a stochastic FRET contribution 
(left axis, black and blue circles, respectively).  Also shown in Figure 3-19C is the result 
of the reduced chi-squared analysis with and without a stochastic FRET contribution (green, 
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black X’s respectively) as a function of oligomer order (right axis).    We see that the best-
fit MSE values are all essentially equal for n > 2, indicating that the different oligomeric 
models fit the data almost equally well, with or without a stochastic FRET contribution in 
the model.  We also see that the n = 3 and n = 4 models give essential equal reduced chi-
square values, both under the 95% cutoff.  Despite the fact that the oligomer order is not 
well-determined with a monomer-oligomer thermodynamic association, we find that the 
oligomeric fraction is still obtainable, with essentially the proper concentration-dependent 
oligomeric fraction determined whether fitting 𝐸𝑎𝑝𝑝 with or without a stochastic FRET 
contribution, for any n > 2.   The best-fit parameters for the n = 4 analysis are shown in 
Table 3-3 and Table 3-4, for ?̃? = 0.70 and ?̃? = 0.30, respectively.   We see that the best-
fit Gibbs free energy is equal, within error, to the simulated value ∆𝐺° =  −12.0 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙.  
Additionally, the best-fit intrinsic FRET, ?̃? = 0.59 , is lower than modeled, but is an 
expected consequence of the single D-A distance in the simplified Kinetic Theory of FRET.  
This occurs with a square geometry due to the increased distance across the center of the 










Figure 3-18.  The results of the monomer-tetramer simulations, for ?̃? = 0.70.  A.  The 
tetrameric fraction as a function of total receptor surface density.  B.  A sample 
configuration from the simulations at [T] = 0.008 rec/nm2.  Donors: blue cirles, 
Acceptors: red cirles.  C.  𝐸𝑎𝑝𝑝 and 𝐸𝑂𝑙𝑖𝑔𝑜 versus total concentration (black and blue 
circles, respectively).  D.  𝐸𝑎𝑝𝑝 and Eprox versus total concentration (black and red 
circles, respectively).  The dashed lines connect datapoints of constant 𝑥𝐴, as indicated 





  Figure 3-19. Analysis results of the monomer-tetramer simulations, for Ẽ = 0.70.    A.  
Eapp (black circles) and EOligo (blue circles)versus acceptor fraction, xA, for [T] = 
0.008 rec/nm2(top), [T] = 0.004 rec/nm2 (middle), and [T] = 0.00001 rec/nm2 (lower).  
Dashed lines connect data points with constant [T] as indicated.    B. Eapp versus A:D 
ratio plotted as black circles for [T] = 0.008 rec/nm2(top), [T] = 0.004 rec/nm2 
(middle), and [T] = 0.00001 rec/nm2 (lower).  Dashed lines connect data points with 
constant [T].  The red lines represent the best-fit Veatch and Stryer models.  C.  The 
best-fit MSE (left axis) versus oligomer order for the analysis of Eapp with the 
thermodynamic model based Kinetic Theory of FRET, without a stochastic FRET 
contribution (black circles).  The blue circles mark the best-fit MSE for fitting Eapp 
with a stochastic FRET contribution as in Equation (2-32).  Without a stochastic 
FRET model, the best-fit MSE is 𝑛 = 3.  With a stochastic FRET model, the best-fit 
MSE occurs at 𝑛 = 4.  Right axis: The best-fit reduced chi-square versus oligomer 
order for the analysis of Eapp in the presence of random noise with the thermodynamic 
model based Kinetic Theory of FRET, without a stochastic FRET contribution (black 
X’s).  The green X’s mark the best-fit reduced chi-square value for fitting Eapp in the 
presence of random noise with while including a stochastic FRET contribution, as in 
Equation (2.32).   The magenta line is the 95% confidence cutoff for the reduced chi-
square test- all X’s above this line are rejected and all X’s below this line are accepted 
as equally likely models, given the data and its associated error.  Analysis without a 
stochastic FRET contribution does not produce acceptable models for any order.  
Analysis with the stochastic FRET consideration shows that the 𝑛 = 3 and 𝑛 = 4 
models both pass the reduced chi-square test.  Thus, the oligomer order is not 








































Figure 3-20.  The predictions of the monomer-tetramer simulations and the results of 
the analyses, for ?̃? = 0.30, ∆𝐺° =  −12 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙  A.  𝐸𝑎𝑝𝑝 (black circles) and 
𝐸𝑂𝑙𝑖𝑔𝑜 (blue circles) versus total concentration.  The dashed lines connect data points 
of constant acceptor fraction, as indicated on the right.  B. 𝐸𝑎𝑝𝑝 (black circles) and 
Eprox (red circles) versus total concentration.  C.  𝐸𝑎𝑝𝑝 (black circles) versus A:D 
ratio, and the best-fit Veatch and Streyer model, for [𝑇] = 1e-5 rec/nm2, and [𝑇] = 8e-
3 rec/nm2 (lower,  upper curves, respectively).  D. The best-fit MSE(left axis, circles) 
and reduced chi-square value (right axis, X’s) versus oligomer order for the analysis 
of 𝐸𝑎𝑝𝑝 with the thermodynamic model based on the Kinetic Theory of FRET with a 
stochastic FRET contribution (blue circles, green X’s), and without a stochastic FRET 
contribution (black circles, black X’s).  The magenta line denotes the 95% confidence 
limit for the reduced chi-square test (X’s, right axis).   In the presence of random 
noise, n=3 and n=4 models without a stochastic FRET contribution both pass the 
reduced chi-square test, and all n>2 provide acceptable fits to the data when a 
stochastic FRET contribution is included.   Thus, the oligomer order is not discernable 
for this monomer-tetramer equilibrium dataset.    
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=  0.96 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2











































= 0.59 ± 0.01 
Table 3-3.  Combined results for analysis of simulations for monomers-dimer (Order = 
1-2) and monomer-tetramer (Order = 1-4) equilibria with the models of Veatch and 
Stryer and the thermodynamic model based on the Kinetic Theory of FRET, for ?̃? =
0.70.  The analysis with the model of Veatch and Stryer was performed at two different 
total concentrations: [𝑇]=1e-5 rec/nm2 and [𝑇]=8e-3 rec/nm2, and the best-fit parameters 
𝑛 and 𝐸𝑚𝑎𝑥  are provided in the columns.  The thermodynamic model based on the 
Kinetic theory of FRET was used for fitting of simulated FRET data without error for a 
minimization of the Mean Squared Error(MSE).  The black text indicates fitting without 
utilization of a stochastic FRET model and the blue text indicates the best-fit results for 
analysis that includes a stochastic FRET model (see Equation (2-32)).  Additionally, the 
reduced chi-square minimization was performed for analysis with the thermodynamic 
model based on the Kinetic Theory of FRET (N=2,700 data points with added Gaussian-
distributed random noise).  The rows with black text indicate analysis results without 
utilizing a stochastic FRET model, as with the MSE minimization column, and the 
green text indicates the best-fit reduced chi-squared results for fitting with a stochastic 
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= 0.79 ± 0.01 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡 = 0.30 
?̃?𝑏𝑒𝑠𝑡 𝑓𝑖𝑡,𝑛=2










































= 0.21 ± 0.01 
Table 3-4.  Combined results for analysis of simulations for monomers-dimer (Order = 
1-2) and monomer-tetramer (Order = 1-4) equilibria with the models of Veatch and 
Stryer and the thermodynamic model based on the Kinetic Theory of FRET, for ?̃? =
0.30.  The analysis with the model of Veatch and Stryer was performed at two different 
total concentrations: [𝑇]=1e-5 rec/nm2 and [𝑇]=8e-3 rec/nm2, and the best-fit parameters 
𝑛 and 𝐸𝑚𝑎𝑥  are provided in the columns.  The thermodynamic model based on the 
Kinetic theory of FRET was used for fitting of simulated FRET data without error for a 
minimization of the Mean Squared Error(MSE).  The black text indicates fitting without 
utilization of a stochastic FRET model and the blue text indicates the best-fit results for 
analysis that includes a stochastic FRET model (see Equation (2-32)).  Additionally, the 
reduced chi-square minimization was performed for analysis with the thermodynamic 
model based on the Kinetic Theory of FRET (N=2,700 data points with added Gaussian-
distributed random noise).  The rows with black text indicate analysis results without 
utilizing a stochastic FRET model, as with the MSE minimization column, and the green 
text indicates the best-fit reduced chi-squared results for fitting with a stochastic FRET 

















Figure 3-21.  Monomer-only, monomer-dimer, and monomer-tetramer simulated data 
(black dots) and best-fit model (green dots) of the simulated oligomer order for N = 
2700 datapoints at randomly chosen total concentrations, with acceptor fraction 
ranging from 0.1 – 0.9 in 0.1 steps.  Gaussian distributed random noise, 𝜇 = 0, 𝜎 =
0.08, was added to each data point prior to analysis with the reduced chi-squared test.   
A.  Simulated data and best-fit monomeric model.  B.  Simulated data and best-fit 
monomer-dimer model for ?̃? = 0.70.  C.  Simulated data and best-fit monomer-dimer 
model for ?̃? = 0.30.   D.  Simulated data and best-fit monomer-tetramer model for 







3-11. The Non-Unique FRET of Higher-Order Oligomers 
 Figure 3-22 compares the total apparent FRET efficiency, as a function of total 
concentration, for the cases of constitutive trimers (?̃? = 0.74), tetramers (?̃? = 0.70), and 
pentamers (?̃? = 0.74).  We see that the total apparent FRET efficiency for all of these 
oligomers is nearly the same, with a maximum deviation of less than 3%.  Thus, the total 
apparent FRET efficiency for higher-order oligomerization is not unique for 𝑛 > 2, and no 
amount of data points can ever determine the oligomer order for 𝑛 > 2 in a two-color static 
quenching FRET experiment.  For ?̃? < 0.5, even dimerization does not provide a unique 
FRET signature.  Thus, the indeterminacy of the analysis for trimers and tetramers, and for 
all orders with low intrinsic FRET, observed earlier is not only due to the assumption of a 
single donor-acceptor distance in the simplified Kinetic Theory of Oligomeric FRET, but 






   
  
Figure 3-22.  The total apparent FRET efficiency for higher-order oligomerization 
is not unique.  Here I simulated constitutive trimers, tetramers, and pentamers and 
compare the results.  The total apparent FRET efficiency as a function of total 
concentration for trimers, ?̃? = 0.74, plotted as triangles, constitutive tetramers and 




 In this chapter, I simulated the total apparent FRET efficiency for ensembles of 
non-overlapping fluorophores organized as monomers, dimers, trimers, tetramers, a total 
concentration-based monomer-dimer equilibrium, and a total concentration-based 
monomer-tetramer equilibrium over a range of physically realizable membrane protein 
surface densities.  I then subjected the total apparent FRET efficiency, as would be 
measured in a donor-quenched static FRET efficiency measurement, to analysis with the 
two primary models available for use by researchers to analyze FRET data.      
 My goal for this work is to understand the consequences of ignoring the stochastic 
FRET in each case of higher-order oligomer formation (𝑛 > 1) with respect to analysis 
results, and the limitations of each model to correctly describe the intrinsic FRET 
efficiency, oligomeric fraction, and the oligomer order.  I performed simulations of FRET 
in the ideal situation which lacks experimental error and complications from assumptions 
about kappa-squared in the Förster radius.  I also attempted to minimize the complications 
of oligomer geometry by choosing regular polygons, the most ideal geometry for both the 
Kinetic Theory of Oligomeric FRET and the model of Veatch and Stryer.   When the 
oligomeric geometries deviate from the ideal polygon, the assumption of the single D:A 
distance in the oligomer found in both the Veatch and Streyer model and the model of the 
Kinetic Thoery of FRET becomes less and less realistic.   
 The model of Veatch and Stryer is often utilized by researchers performing semi-
quantitative FRET experiments on membrane proteins, in which the total surface density 
of labeled membrane proteins is unknown, but the donor to acceptor ratio is known either 
through experimental design or measurement.  I find that, in general, if one does not know 
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the oligomer order before the experiment, the model of Veatch and Stryer will give the 
researcher confusing and usually incorrect oligomer results.  Of particular surprise was the 
fact that for monomers, the model indicated dimer formation.  In the case of a constitutive 
dimer, the model of Veatch and Stryer will provide a correct result if the concentration is 
kept at a minimum to minimize the stochastic FRET contribution, but fitting of the total 
apparent FRET efficiency at high fluorophore surface densities leads to an indication of 
trimer formation by the model, due to the non-negligible stochastic FRET contribution.  If 
the acceptor concentrations are not known, then it is not possible to make an appropriate 
stochastic FRET correction to the apparent FRET efficiency, or to even know if one is even 
in a regime of surface densities and acceptor fractions in which the stochastic FRET 
contribution is minimal.  Thus, I find that this model has severe limitations for the analysis 
of static quenching FRET experiments to determine dimerization or higher order 
oligomerization and should never be used for data interpretation.  Thus, even though the 
model of Veatch and Stryer is simple, it is not capable of properly modeling FRET.   
 Only recently (in 2007), the Kinetic Theory of Oligomeric FRET was derived 
which accounts for the thermodynamically driven oligomer concentration and the 
oligomeric architecture, along with a combinatorial mixing contribution.  However, one 
needs to know the geometry of the oligomer in order to use the full Kinetic Theory of 
Oligomeric FRET.  This information is not known for most membrane proteins under study.  
Fortunately, a simplified theory, with the assumption of equal donor-to-acceptor distances 
in the oligomer (an assumption that is true for dimers and the trimers utilized in this work) 
is available.   
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 I have found that in general, and despite the assumption of a single D:A distance in 
the oligomer, the simplified Kinetic Theory of Oligomeric FRET can provide the 
researcher with the proper oligomer order, association energetics, and intrinsic FRET 
efficiency when used with a stochastic FRET estimation in the Full Kinetic Theory of 
FRET.  The monomer-only simulation results highlight the importance of checking all 
possible models for their fits to the data.  We see that for dimer formation, the magnitude 
of the stochastic FRET contribution means that it cannot be ignored in the analysis.  Thus, 
with the case of a monomer-dimer equilibrium or a constitutive dimer, a model for the total 
stochastic FRET efficiency is necessary to determine the proper association constant and 
intrinsic FRET efficiency value (D:A distance in the dimer).  Unfortunately, this model is 
only available through the use of computer simulation, but fortunately, it is rather easy to 
estimate with a computer (see Computational Methods).  All scientists today should be 
proficient enough with a computer to recreate these results.  With higher-order oligomer 
formation, 𝑛 > 3, analysis of the total apparent FRET efficiency and with and without a 
stochastic FRET contribution yielded essentially the same results, indicating that the 
stochastic FRET contribution is negligible with respect to analysis for these situations.   
Interestingly, even though the oligomer order was not discernable for higher-order 
oligomer formation, the best-fit oligomeric fraction determined for each oligomer order > 
2 closely matched the simulated tetrameric fraction in the case of the monomer-tetramer 





 This work shows that the total concentration information must be known in order 
to properly determine the oligomer order and fraction in quantitative FRET with the Kinetic 
Theory of FRET.  I have also shown that the total apparent FRET efficiencies of higher-
order oligomer formation is not unique as a function of total concentration.   Thus, bulk 
two-color FRET static quenching experiments provide the most useful information with 
regards to the detailed study of monomer, monomer-dimer, and constitutively dimeric 
membrane proteins, and are intrinsically limited in their ability to distinguish the order of 
higher order oligomerization.  Yet, we note that even though the oligomer order is not 
distinguishable in this case, the ability to distinguish non-constitutive oligomer formation 
from that of the presence of a constitutive oligomeric state remains and can provide a great 
deal of insight into the behavior the oligomerizing system under study.  The above 
limitations must be carefully considered by researchers in the design of FRET experiments 
with fluorescent-protein labeled membrane proteins, especially when higher order 
oligomerization is the subject of study.    
 All of this improvement in theory and analysis was made possible by a simple 
realization:  people have spent forever thinking about the oligomeric FRET by ignoring 
stochastic FRET.  My idea was simply to ignore oligomeric FRET and concentrate on 
stochastic FRET.  It is interesting that understanding the FRET of non-interaction is what 




Chapter 4:  Theory of Fully Quantified Spectral Imaging 
 
4-1. Introduction 
 The function of membrane proteins is often regulated through protein-protein 
interactions in cellular membranes 6,13,71-73.  While methods to study interactions between 
soluble proteins are well established, methodologies to quantify membrane protein 
interactions have been slow to emerge42-44,74-79. Great challenges remain, particularly for 
complex membrane proteins, which cannot be overexpressed in large quantities, and cannot 
be purified and properly reconstituted in model systems. 
 Here I introduce a method that I have developed, Fully Quantified Spectral Imaging 
(FSI), which yields both three-dimensional concentrations of fluorophores in a voxel, two-
dimensional membrane concentrations and FRET efficiencies, and ultimately reports on 
the stoichiometry and stability of protein complexes in live cells.   I derive the equations 
and describe the implementation of the FSI method, created for use with spectral imaging 
systems in which an emission spectrum is measured for every pixel in an image.    I describe 
the results of a set control experiments performed with soluble fluorescent proteins which 
demonstrate successful application of the method.   In later chapters, I will demonstrate the 
implementation and usefulness of the FSI method by using it to study the properties of 
VEGF121 and VEGFR2 in live cells.   
 The FSI methodology requires the use of a spectral imaging system, in which a full 
emission spectrum is captured for every pixel within an image, acquired under 
magnification with any standard microscope.  In the Hristova Lab, we have the OptiMis 
True Line spectral imaging system and a Zeiss inverted wide-field microscope, with a 63x 
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water immersion objective.  This instrument is capable of measuring the full emission 
spectrum of fluorescent molecules for every pixel in a 300 x 440 pixel image in seconds.  
The measurement of the full visible emission spectrum by OptiMis enables a full 
mathematical treatment of emission spectra for the determination of FRET efficiencies.  
Furthermore, we utilize two-photon excitation in the infrared wavelengths, outside of the 
detectable range of OptiMis.  The use of two-photon IR excitation and the spectral imaging 
allows us to measure FRET without the use of any band-pass filters, as are traditionally 
utilized in fluorescence microscopy to separate fluorescence from different flavors of 
fluorophores.   
 The basic operating principle of OptiMis is actually very simple80,81.  The exciting 
laser beam, initially circularly shaped encounters a cylindrical lens (a curved mirror) that 
shapes the beam into a line.  This line is scanned over the sample by computer control.  The 
line of excitation elicits a line of fluorescence is captured by the objective lens and sent 
toward the CCD via a mirror.  The emission fluorescence from the sample passes through 
a transmission grating before hitting the CCD, thus enabling the simultaneous 
measurement of the emission spectra for every pixel in the line.  The concept is illustrated 
below in Figure 4-1.  The spectral properties of the fluorescent proteins mTurquoise and 




Figure 4-1.  A basic schematic diagram of the major components of the OptiMis 
spectral imaging system.  A green laser serves as a pump to elicit pulsed-femtosecond 
IR lasing.  A Gaussian beam is expanded and then shaped into a line at the first mirror, 
and the y-scanning mirror is used to scan the line over the sample.  The line of 
fluorescence emitted from the sample passes through a dichroic mirror and through a 
transmission grating, enabling the CCD to measure fluorescence emission spectra 






























Figure 4-2.  mTurquoise (blue) and YFP (green) spectral properties, with emission 
shown as solid lines and two-photon absorption shown as dashed lines.   The two 
vertical lines (grey) at 840 nm and 960 nm represent the excitation wavelengths λ1 and 
λ2 utilized in the FRET and Acceptor scans, respectively.  The FSI equations can 
account for intrinsic YFP excitation occurring at 840 nm without the use of 
approximations or filters.  Similarly, the FSI equations account for intrinsic excitation 
of the donor and FRET that occurs when performing the Acceptor scan at 960 nm.   
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 The analysis of the emission spectra from the pixels of a co-transfected cell 
expressing both the donor and the acceptor fluorophores, excited in a “FRET scan” at λ1, 
and in an “Acceptor Scan” at λ2, provides all of the information needed to calculate the 
concentrations of donor and acceptor fluorophores and the apparent FRET efficiency, 𝐸𝑎𝑝𝑝.  
The fluorescence emission spectrum from a pixel of the cotransfected cell at both excitation 
wavelengths is assumed to be a linear sum of three contributions: the fluorescence of the 
donor in the presence of the acceptor, 𝐹𝐷𝐴(λ), the fluorescence of the acceptor in the 
presence of the donor, 𝐹𝐴𝐷(λ), and a background contribution: 
         
 
I modeled the pixel-level background contribution in every pixel as a line, as shown below 
(see Figure (4-3).    
 
𝐹(𝜆)𝜆1,𝜆2
𝑝𝑖𝑥𝑒𝑙 =  𝑘𝜆1,𝜆2
𝐷𝐴 ∙ 𝐹𝐷(λ) + 𝑘𝜆1,𝜆2
𝐴𝐷 ∙ 𝐹𝐴(λ) + 𝑎λ + 𝑏 (4-2) 
 
In Equation (4-2), 𝐹𝐷(λ) is the normalized emission spectrum of the donor and 𝐹𝐴(λ) is 
the normalized emission spectrum of the acceptor fluorophore.  Figure 4-4 shows an image 
of a transiently transfected HEK293T cell, expressing VEGFR2-ECTM-GGS5-
mTurquoise and YFP linked membrane proteins.   The total fluorescence from a pixel of 
the cell is a combination of donor and acceptor fluorescence.   
𝐹(𝜆)𝜆1,𝜆2






















Figure 4-3.  A pixel from an OptiMis spectral image of buffer-only with no 
fluorescence, showing that a line, 𝑎𝑥 + 𝑏, is a relatively good model for the 
background contribution.  Traditionally, a single number is subtracted from all 
wavelength values for all pixels, but from an analytical perspective it is preferable to 
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Figure 4-4.  A transiently transfected HEK293T cell expressing VEGFR2-ECTM-
GGS5-mTurquoise/YFP.  A.  An “image” of the cell in a traditional sense is obtained 
from OptiMis by integrating the emission spectrum of every pixel over the measured 
wavelengths.  B.  An emission spectrum from a pixel in the membrane is composed of 
some combination of mTurquoise and YFP fluorescence.   
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 Linear least squares optimization then yields the “best fit” coefficients (i.e, 𝑘𝜆1,𝜆2
𝐷𝐴 , 
𝑘𝜆1,𝜆2
𝐴𝐷 , and background (a and b in Equation (4-2)) that minimizes the chi-square value for 
the fit 82.  The pixel-level integrated intensities of the donor in the presence of the acceptor 








𝐴𝐷 ∙ 𝑤𝐴 (4-4) 
 
Here, 𝑤𝐷 and 𝑤𝐴 are the integrated normalized spectra of the donor and acceptor:  
 
𝑤𝐷,𝐴 = ∫𝐹𝐷,𝐴(λ)𝑑𝜆 (4-5) 
 
The unmixed fluorescence from a pixel’s FRET and Acceptor scans is shown in Figure 4-














Figure 4-5.  The fluorescence emission spectra from a pixel in an image of a 
HEK293T cell expressing VEGFR2 ECTM-GGS5-mTurquoise/YFP.  Left:  The 
donor, mTurquoise, is primarily excited during the FRET scan with excitation at 840 
nm, but due to protein-protein interactions in the membrane and FRET, there is a large 
YFP fluorescence signal.  Right:  During the Acceptor scan at 960 nm, the acceptor is 
primarily excited and there is minimal donor fluorescence, but this approximation is 
not necessary with the FSI method.  
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4-2. Fluorescent Protein Solution Standards  
 The FSI method relies on calibration curves obtained by imaging solution standards 
of the donor and acceptor fluorophores of known concentration.  Given that the total 
fluorescence from a volume of solution containing excited fluorescent molecules is 
proportional to the number of fluorescent molecules present in the solution, we can write 
83: 
 
𝐹𝐹𝑃 ∝ 𝑁𝐹𝑃 
 
𝐹𝐹𝑃,𝐵 = 𝑘𝐹𝑃𝑁𝐹𝑃,𝐵 = 𝑘𝐹𝑃[𝐹𝑃]𝐵𝑑𝑉 (4-6) 
  
Here, 𝐹𝐹𝑃,𝐵, stands for the total integrated fluorescence emission of the fluorophore (in our 
case, a fluorescent protein) in a Bulk solution.  𝑘𝐹𝑃 is a proportionality constant that 
accounts for the dependence of fluorescence on quantum yield, excitation rate and 
wavelength, and other physical parameters.  Equation (4-6) yields an explicit dependence 
of the fluorescence from a bulk solution of fluorophores on the concentration of the 
fluorescent protein and the excitation volume.  
The same relationship of Equation (4-6) can be written when the fluorophore is 
attached to a protein of interest, by fusing the gene encoding the fluorescent protein to the 
gene of interest, with B replaced by S, representing the Sample of interest.   
 




     









Rearranging Equation (4-8) and solving for the concentration of the fluorescent protein in 







Thus, the concentration of the fluorophore in the sample can be calculated from the 
known concentration and fluorescence intensity of the fluorophore in the bulk solution, and 
the experimentally determined fluorescence intensity of the fluorescent protein in the 
sample. 
  By rearranging Equation (4-9) and adding the subscripts 1 and 2 to represent two 
different known concentrations of the fluorescent protein solution standards, we arrive at: 
 
[𝐹𝑃]𝑆 ∙ 𝐹𝐵,1 = 𝐹𝑆 [𝐹𝑃]𝐵,1 ∙ [𝐹𝑃]𝐵,1 (4-10) 
  














In the limit of ∆→ 0, the ratio of the change in bulk fluorescence to the change in bulk 
solution standard concentration is replaced by i, the slope of a line fit to a solution standard 




= 𝑖𝜆 (4-13) 
 
 Equation (4-13) allows the calculation of the concentration of the fluorophore in 
the sample from its fluorescence intensity upon excitation at a specific wavelength.  
Imaging the same sample at the two different excitation wavelengths, λ1 and λ2, and 



















These relations allow the conversion of donor or acceptor fluorescence at one wavelength 
to the fluorescence at the other excitation wavelength through the ratios of the slopes of 
the fluorescence calibration curves. 
As stated earlier, the two excitation wavelengths are chosen based on the 
fluorescence and emission properties of the fluorescent proteins utilized:  𝜆1 is chosen to 
primarily excite the donor; and 𝜆2 is chosen to maximally excite the acceptor.  Several 
concentrations of soluble fluorescent proteins are imaged at both excitation wavelengths, 
and a line is fit to the integrated intensity versus concentration data for every pixel of the 
sample image (see Figure 4-6B).  The four slopes, 𝑖𝐷, 𝜆1 , 𝑖𝐷, 𝜆2 , 𝑖𝐴, 𝜆1 , and 𝑖𝐷, 𝜆2 , are 
calculated for every pixel, for both the donor and acceptor fluorescent protein solution 



































Intensity vs. Concentration Calibration Curves
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A,1












 = 381 M
-1
Figure 4-6.  Top.  Fluorescent proteins are expressed in E. coli, purified, and stored in 
PBS buffer at near milimolar concentration.  Dilutions to make 100%, 75%, and 50% 
solution standards are prepared and imaged.  Bottom.  Images of soluble donor and 
acceptor solution standards are acquired for three known solution concentrations, 
along with images of buffer-only (PBS) controls at two excitation wavelengths, λ1 = 
840 nm and λ2 = 960 nm.  After integration of the fluorescence over the emission 
wavelengths, a line is fit to every pixel’s integrated intensity vs. concentration solution 
standard data, yielding the slopes 𝑖𝐷, 𝜆1, 𝑖𝐷, 𝜆2, 𝑖𝐴, 𝜆1, and 𝑖𝐷, 𝜆2.  The solid and dashed 
lines are the best fit lines to the measured integrated intensity versus concentration 
data with excitation at λ1 and at λ2, respectively.  The best-fit lines for the donor and 
the acceptor are shown in blue and green, respectively.    
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4-3.   Theory of Fully Quantified Spectral Imaging 
 In the FSI method, two scans of a sample are performed: a “FRET scan” at 
excitation wavelength λ1, in which the donor is primarily excited and an “Acceptor scan” 
at excitation wavelength λ2, in which the acceptor is maximally excited.  By using these 
two scans and calibration curves of fluorescence versus known concentration of donor and 
acceptor “solution standards,” one can solve for the full donor fluorescence and the 
acceptor fluorescence in the absence of FRET, as discussed below. 
 The fluorescence of the donor in the presence of the acceptor,  𝐹𝜆𝑛
𝐷𝐴 , and the 
fluorescence of the acceptor in the presence of the donor,   𝐹𝜆𝑛
𝐴𝐷 , at both excitation 










𝐴  (4-17) 
 
In Equations (4-16) and (4-17), 𝐹𝜆𝑛 
𝐷 and 𝐹𝜆𝑛
𝐴   (n=1, 2) are the donor and acceptor 
fluorescence emission spectra after direct excitation at λ1 and λ2, in the absence of FRET.  
𝐹𝑅𝐸𝑇,𝜆𝑛
𝐷  and 𝐹𝑅𝐸𝑇,𝜆𝑛 
𝐴  are the loss and gain of fluorescence by the donor and the acceptor 
fluorophores due to FRET, respectively.   Figure 4-5 shows the components 𝐹𝜆𝑛
𝐷𝐴 and 𝐹𝜆𝑛
𝐴𝐷 





 As derived in 56, a relationship exists between 𝐹𝑅𝐸𝑇,𝜆𝑛
𝐷  and 𝐹𝑅𝐸𝑇,𝜆𝑛
𝐴 .  If one considers 
the number of FRET events from a donor to an acceptor molecule during the excitation 




𝑁𝑅𝐸𝑇 ∙  𝑄𝐷 = 𝐹𝑅𝐸𝑇,𝜆𝑛
𝐷  (4-18) 
 
Similarly, once transferred to the acceptor molecule, a fraction of those excitation events, 
QA, will be detected as photons emitted from the acceptor: 
 
𝑁𝑅𝐸𝑇 ∙  𝑄𝐴 = 𝐹𝑅𝐸𝑇,𝜆𝑛
𝐴  (4-19) 
 
QD and QA in Equations (4-18) and (4-19) are the quantum yields of the donor and acceptor 
fluorophores, respectively.  By solving for 𝑁𝑅𝐸𝑇 and equating Equations (4-18) and (4-
19), (conservation of RET events) we arrive at a general and indispensable relationship 
between 𝐹𝑅𝐸𝑇,𝜆𝑛   















 The “apparent FRET efficiency” of energy transfer, Eapp, is a measure of the 
interaction between the donor and the acceptor.  It can be written in terms of “donor 








𝐷  (4-21) 
 
By solving for 𝐹𝑅𝐸𝑇,𝜆1
𝐷  in Equation (4-16) and substituting into Equation (4-21), we arrive 
at the commonly seen relation for the donor-quenched FRET efficiency: 
 
𝐸𝑎𝑝𝑝




𝐷  (4-22) 
 
Thus, we need an expression for the fluorescence of the donor in the absence of FRET, 𝐹𝜆1
𝐷 , 





4-3.1  Calculation of 𝑭𝝀𝟏
𝑫 , the unquenched donor fluorescence in the 
absence of FRET 
 
 Rearranging Equation (4-16) for 𝐹𝜆1
𝐷  gives Equation (4-23):     




𝐷  (4-23) 
 
Using Equation (4-20), we express 𝐹𝑅𝐸𝑇,𝜆1 
𝐷 in terms of the ratio of quantum yields of the 
donor and acceptor, and 𝐹𝑅𝐸𝑇,𝜆1









By solving Equation (4-17) for 𝐹𝐴𝑅𝐸𝑇,𝜆1, and inserting into Equation (4-24), we arrive at 











The first term, 𝐹𝜆1
𝐷𝐴, is determined by linear least squares “unmixing” of the pixel-level 
emission spectrum.  In the literature, the assumption is often made that 𝐹𝐴𝜆1 ≈ 0 and 𝐸𝑎𝑝𝑝
𝐷𝑞
 
is the estimated based on this assumption.   Here I show, however, that 𝐹𝐴𝜆1  can be 
determined exactly using Equation (4-15) derived in the section, Fluorescent Protein 
Solution Standards.   
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where 𝑖𝐴,𝜆1  and 𝑖𝐴,𝜆2  are concentration calibration constants, namely the slopes of the 
acceptor fluorescence versus concentration calibration curves. 𝐹𝐴𝜆2 is determined using 
information acquired in an “Acceptor scan” of the sample as described next. Thus, 𝐹𝐷𝜆1 
can be calculated exactly using Equation (4-26). 
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4-3.2.  Calculation of 𝑭𝝀𝟐




 By rearranging Equation 4-7 to solve for 𝐹𝜆2
𝐴  and utilizing the fundamental 









Then write 𝐹𝐷𝑅𝐸𝑇,𝜆2 in terms of the ratios of the donor standard slopes at λ1 and λ2 (see 











By using the fundamental relationship (4-20), we solve for 𝐹𝐷𝑅𝐸𝑇,𝜆1 in terms of 𝐹
𝐴
𝑅𝐸𝑇,𝜆1 
and the ratio of the donor and acceptor quantum yields.  Insertion into Equation (4-28) 

























Finally, convert from 𝐹𝐴𝜆1 to 𝐹
𝐴
𝜆2 using the ratios of the calibration slopes as derived in 





















Equation (4-31), along with Equation (4-26), provides an approximation-free calculation 
of 𝐹𝐷𝜆1, and allows for the calculation of 𝐸𝑎𝑝𝑝
𝐷𝑞
 according to Equation (4-22).  In addition, 
Equation (4-31) allows the direct calculation of the pixel-level donor and acceptor 
concentrations (an effective pixel-level concentration for non-freely diffusing 
fluorophores), based on their fluorescence and the calibration slopes i of the intensity 





























































4-3.3.  Verification of the FSI Methodology 
 To validate the capabilities of the FSI method to accurately yield pixel-level 
concentrations and FRET efficiencies, I performed experiments with mixtures of purified 
mTurqoise and YFP soluble fluorescent proteins.  I imaged six different samples, and 
acquired four FRET and acceptor images for each sample.  In three of these samples, the 
concentration was held constant (~10 µM) while the donor (mTurqoise) to acceptor (YFP) 
ratio was varied.  The other three samples contained a fixed donor to acceptor ratio (1:3) 
while the total FP concentration was varied from 2 to 14 M.  Concentrations of 
mTurquoise and YFP in the samples were first measured via UV-Vis spectroscopy using 
the Nanodrop 2000C.  Next, the mixtures were imaged in a FRET scan with excitation at 
840 nm and an Acceptor scan with excitation at 960nm in the two-photon microscope.   
Spectral unmixing and the FSI equations were then used to obtain the FRET efficiencies 
(Figure 4-7A) and the concentrations of mTurqoise and YFP in the sample mixtures 
(Figures 4-7B and 4-7C). 
 The concentrations of the fluorescent proteins determined with the FSI method are 
in complete agreement with the fluorescent protein concentrations measurements obtained 
via UV-Vis absorption measurements.   Furthermore, we measure zero concentration 
dependence on the FRET efficiency, indicating a lack of interactions between the 
fluorescent proteins.  This is expected for three-dimensional solutions of monomeric 
fluorescent proteins.  Changing the excitation wavelength to 800 nm, and thus the amount 
of intrinsic acceptor excitation during the FRET scan (Figure 4-8), had no effect on the 
measured concentrations and FRET efficiencies.  Thus, we see that the FSI equations are 
able to extract the proper fluorophore concentrations over a wide range of total 
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concentrations and donor to acceptor ratios and offers great flexibility in the choice of 






















































































Figure 4-7. Verification of the FSI 
method with 840 nm excitation 
during the FRET scan and 960  nm 
excitation during the Acceptor scan. 
(A) FRET efficiencies measured for 
mixtures of soluble mTurq and YFP, 
as a function of total protein 
concentration. Dashed line: y = 0.  
(B) Comparison of mTurq 
concentrations, measured with FSI 
and Nanodrop. Dashed line: y = x. 
(C) Comparison of YFP 
concentrations, measured with FSI 
and Nanodrop. Dashed line: y = x. 
Red: 3:1 mTurqiouse:YFP; Yellow: 
1:1 mTurqiouse:YFP; Green: 3:1 
mTurqiouse:YFP. Dashed line: y = x. 
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  Figure 4-8. Verification of the FSI 
method with 800 nm excitation during 
the FRET scan and 960  nm excitation 
during the Acceptor scan. (A) FRET 
efficiencies measured for mixtures of 
soluble mTurq and YFP, as a function 
of total protein concentration. Dashed 
line: y = 0.  (B) Comparison of mTurq 
concentrations, measured with FSI 
and Nanodrop. Dashed line: y = x. (C) 
Comparison of YFP concentrations, 
measured with FSI and Nanodrop. 
Dashed line: y = x. Red: 3:1 
mTurquoise:YFP; Yellow: 1:1 
mTurquoise:YFP; Green: 3:1 
mTurquoise:YFP. Dashed line: y = x. 

















































































4-4. Technical Details Important for the Implementation of FSI 
 
  
4-4.1.  Image Acquisition 
 Spectral images with two-photon excitation are acquired with a Mai Tai laser 
(Spectra Physics) and the OptiMis True Line Spectral Imaging system (Aurora Spectral 
Technologies) utilizing a Zeiss Observer wide field microscope with a 63X NA 1.2 water 
immersion objective as described in detail in 80.  Two images of each cell are acquired: a 
“FRET scan” with primary donor excitation at 840 nm and an “Acceptor Scan” with 
primary acceptor excitation at 960nm.  With a 35 ms line scan time of full-field of view 
(300x 440 pixels) , each spectral image requires approximately 15 seconds to acquire at 
full spectral resolution, with approximately 30 seconds required between scans for two 
photon laser emission wavelength tuning from 840 nm to 960 nm.  
The FSI equations described in the theory section are implemented in a MATLAB 
graphical user interface designed by me with a MATLAB’s GUI development tool, GUIDE.  
Linear least squares, or unmixing, is utilized to determine the best-fit 𝑘𝜆1,𝜆2
𝐷𝐴  and 𝑘𝜆1,𝜆2
𝐴𝐷  
values for the donor and acceptor components of the measured spectrum in every pixel (see 
Figure 4-5).  It took me hundreds of hours of my personal time and several thousand lines 





4-4.2.  Noise Analysis  
Straightforward spectral decomposition of every pixel of an image without 
considerations of noise, can lead to decreased accuracy in the calculated values of FDA 
and FAD, from which concentrations and thermodynamic parameters of interest are 
calculated.  Specifically, the best-fit k-values can become negative when unmixing “dim” 
pixels.  In this case, a large positive k-value for the other spectral component can provide 
a fit that basically adds up to a linear background contribution.  This gives erroneous 
calculated pixel-level FRET efficiency and fluorescence information.  Furthermore, 
negative k-values are not physically realizable (there is no such thing as negative 
fluorescence) and they need to be properly corrected.  
With this goal in mind, approximately 500,000 pixels of PBS buffer-only scans at 
840 nm and 960 nm laser excitation were analyzed in order to determine the typical k-
values that occur in a signal comprised only of noise.  The spectra were decomposed as a 
sum of donor and acceptor fluorescence and the kAD and kDA values were analyzed as 
shown in Figure 4-9.    
As a result of this noise-only analysis, I found that the magnitude of the k-values 
from the unmixing of noise-only pixels was generally less than five.  I decided on a 
minimum k value = 10, which is twice the value corresponding to noise.  All pixels in 
which the k-values for both fluorophores are less than 10 are rejected as not having a 
useable signal and excluded from any further analysis.   Regions of cells are allowed to 
be selected (they are rejected by the GUI) if they contain pixels with no measurable 
fluorescence.   
In order to not bias the data in terms of erroneously rejecting pixels with no FRET 
(the FRET scan 𝑘𝜆1𝐴𝐷could be low or zero), or very low donor excitation levels (Acceptor 
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scans at 960 nm can give a 𝑘𝜆2  near zero), the minimum k value and negative k value 
corrections must be carefully applied as shown in Table 4-1, below.  In the case of a 
correction, the negative k value is set to zero and the pixel is unmixed again, but with a 
composite signal lacking the negative fluorescence component.  For example, if the kAD 
value of a pixel in the FRET scan is less than zero, but the kDA value is greater than 10, 
then the pixel will be decomposed as containing only the donor signal, with zero acceptor 
signal.  This prevents the negative k-value from affecting the true value of the remaining 
component in the “best” fit.   The results of applying these conditions to an image are 
shown in Figure 4-10.  We see that these criteria are able to reject most pixels that do not 









Figure 4-9.  Noise analysis.  Control buffer-only scans are unmixed in order to 
determine the typical signal contained within pixels that lack fluorescence.  The 
normalized histograms of k-values were integrated to create cumulative distribution 
functions, which revealed that pixels lacking measurable fluorescence yield k-values < 






Figure 4-10.  Pixel rejection based on noise analysis.  Left: HEK293T cells co-
expressing VEGFR2 EC+TM-mTurq and VEGFR2 EC+TM-YFP.  Right: The spectra 
of every pixel in the image is unmixed and pixels that meet the criteria of Table 1 are 
shown in black, while pixels that failed to meet the unmixing criteria are shown in 
white.  Pixels that do not meet the unmixing requirements are rejected from further 





















FRET Scan   𝑘𝜆1
𝐷𝐴  >  10  𝑘𝜆1
𝐴𝐷  >  10  ACCEPT  
  𝑘𝜆1
𝐷𝐴  >  10  0 < 𝑘𝜆1
𝐴𝐷 < 10   ACCEPT  
  𝑘𝜆1
𝐷𝐴  >  10  𝑘𝜆1
𝐴𝐷 <  0  CORRECTED  
  𝑘𝜆1
𝐷𝐴 <  10  𝑘𝜆1
𝐴𝐷 <  10 REJECT  
Acceptor Scan  𝑘𝜆2
𝐷𝐴  >  10  𝑘𝜆2
𝐴𝐷  >  10 ACCEPT  
  0 < 𝑘𝜆2
𝐷𝐴 < 10 𝑘𝜆2
𝐴𝐷  >  10 ACCEPT  
  𝑘𝜆2
𝐷𝐴 <  0  𝑘𝜆2
𝐴𝐷  >  10 CORRECTED  
  𝑘𝜆2
𝐷𝐴 <  10  𝑘𝜆2
𝐴𝐷 <  10 REJECT  
Table 4-1.  During unmixing, pixels are either accepted, corrected, or rejected based 
on the minimum k-value criteria shown here. 
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4-4.3.  Image Registration  
 
 During the time required to tune the laser for the FRET and Acceptor Scans, a stage 
drift corresponding to one to two pixels is sometimes observed.  To correctly align the 
cells in both images, a subsection of the full field image is selected for analysis and an 
image registration algorithm is applied to align the Acceptor Scan with the FRET scan 
(30).  This ensures that the same regions are selected in both scans.  Images with a 
correction greater than two pixels are excluded from analysis.    
  
4-4.4.  Donor- and Acceptor- Only Expressing Samples  
 
 Donor-only and acceptor-only samples are imaged in order to acquire the donor 
and acceptor emission spectra as a function of emission wavelength.  A large region of a 
singly-transfected cell membrane is selected and the emission spectra for every pixel are 
averaged and smoothed over all emission wavelengths 84.  The donor and acceptor spectra 
are then normalized to their maximum value, so that the values range between 0 and 1, 
providing FD(λ) and FA(λ), which are used for spectral decomposition (unmixing) of pixels 
in the cotransfected samples, as discussed previously. The integrals of these normalized 
spectra over the emission wavelengths are denoted as wD and wA.  The total integrated 
fluorescence is then calculated by multiplication of the best fit coefficients of the 
normalized donor and acceptor spectra with their respective wD and wA  values.  
It is observed that the fluorescence properties of the fluorescent proteins are the 
same in the cytosol and in PBS buffer.  I measure the emission spectra for singly transfected 
cells in each experiment.  The shape of the spectra and the peak emission positions are the 




4-4.5.  Membrane Region Selection  
 
 Cell images are inspected for membrane regions of uniform diffraction limited 
fluorescence.  The fluorescence of the labeled proteins in the stretched membrane appears 
as a diffraction limited line that is approximately 600 nm wide (see Figure 4-11).  One or 
two regions of homogenous fluorescence, ~3 microns in length, are selected from each cell. 
Under 63X magnification of the microscope objective, the 16 µm pixels of the CCD are 
square, with a 254nm side length, as shown in Figure 4-12.  The proper pixels are 
automatically selected in each region by selecting several points along the path length of 
the fluorescence.   Connecting lines are drawn between these points, and the unit normal 
vectors to the vectors pointing from point i to point i + 1 are defined.   A region half-width 
of 1.7 pixels is then used to draw a polygon that outlines the fluorescence of the selected 
region (see Supplementary Figure 5).  With this, a region 3.4 pixels in width is outlined.  
The masking operation used to select pixels chooses the pixels such that their centers fall 
within the polygon of the region selected. Thus, the regions selected are 3 to 4 pixels wide, 
depending on the location and orientation of the line of fluorescence with respect to the 













Figure 4-12.  Selection of membrane regions.  Shown here are three idealized 
representations of the orientation of the diffraction-limited line of membrane 
fluorescence that can be encountered in a cell image (light grey): diagonal to the 
pixels (left), in the center of a line of pixels (center) and between two lines of pixels 
(right).  The line connecting points of fluorescence, chosen by the user, is shown in 
green.  The region selection utilizing a 1.7 pixel region-half width will select regions 
three to four pixels across, depending on the orientation of the membrane with respect 
to the pixels of the CCD.  Only pixels with centers that falls within the polygon 
outlining the fluorescence (blue dashed lines) are selected and used for further 
analysis (yellow).    
Figure 4-11.  Selection of membrane 
regions: experiment. A cell under 
reversible osmotic stress is shown, 
with two ~3 µm regions selected.  A 
1.7 pixel half-width is used to outline 
the path of the membrane.  Pixels 
with centers that fall within the 
outlined membrane region are 
selected and utilized for analysis.   
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4-4.6.  Calculation of Region-level Eapp and Receptor Surface Densities  
 The apparent pixel-level fluorophore (receptor) concentrations calculated during 
the image analysis must be integrated across the diffraction limited segment in order to 
properly determine the 2D surface density from the fluorescence and the calibration curves.  
To do so, FD, FA, and FAD are integrated (summed) over every pixel selected in the region, 
𝐹 𝜆𝑖,𝑅𝑒𝑔
𝐷,𝐴 = ∫𝐹𝑟𝑒𝑔𝑖𝑜𝑛
𝐷 𝑜𝑟 𝐴𝑑𝐴 =  ∑𝐹𝑖,𝑗
𝐷 𝑜𝑟 𝐴.  The apparent FRET efficiency of the region is then 




𝐷⁄  .   
The total integrated fluorescence intensities for the region, 𝐹𝜆1,𝑅𝑒𝑔
𝐷 , and  𝐹 𝜆2,𝑅𝑒𝑔
𝐴 , 
are then divided by the arc length, s, of the selected region to calculate the average 
integrated fluorescence per unit length of membrane (in units of pixel).  We assume a 
perpendicular orientation of the membrane with respect to the focal plane. We also assume 
that the fluorescence originates from an infinitely thin sheet within the width of one pixel, 
or 254nm.  To obtain the fluorescence that would be emitted by a full voxel of 
chromophores, the integrated fluorescence per unit pixel-length is multiplied by the pixel 
width, 254nm.  By dividing the full voxel fluorescence by the average slope, < 𝑖𝜆𝑖
𝐷,𝐴 >, and 
performing the appropriate unit conversion from micromolar concentrations to receptors 
per unit area (in units of rec/nm2), the average receptor surface density for the region is 
calculated, as shown below in Equation (4-34):    
 
[𝐷 𝑜𝑟 𝐴] [
𝑟𝑒𝑐
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4-4.7.  The Need for Reversible Osmotic Stress 
 Measurements of dimer and oligomer stabilities (free energies of oligomerization) 
in membranes require knowledge of the 2D concentration of the proteins in the membrane 
and thus, detailed knowledge of membrane topologies and membrane areas 86. The 
topology of the plasma membrane of cells, however, is very complex because cells possess 
2 to 3 times the membrane needed to sustain their shape 87,88 (Figure 4-13). It has been 
shown, however, that the plasma membrane topology can be controlled in a completely 
reversible and non-lethal manner by subjecting cells to reversible osmotic stress  89.  As a 
result of the osmotic stress, cells disassemble their caveolae (60-80 nm cup-shaped 
invaginations) and “un-wrinkle” their membranes 89. Figures 4-13 and 4-14 compare the 
appearance of HEK293T cells, expressing VEGFR2 EC+TM, before and after the 
application of the reversible osmotic stress.  The treatment results in a simple vesicle-like 
membrane topology90, such that the 2D area of the membrane at the focal plane can be 
calculated precisely.  Here I use such live cells under reversible osmotic stress to 
characterize VEGFR2 EC+TM interactions, in conjunction with the FSI method. 
 Correct two-dimensional concentrations in the membrane, and thus association 
curves and association free energies, cannot be determined if the cells are not subjected to 
reversible osmotic stress.  This is consequence of the complex topology of the membrane 
within a voxel that is nearly a micron thick 87,88.  With the FSI methodology, in order to 
calculate the membrane-protein surface density, the topology of the 2-D surface must be 
known, and in this work, it is assumed that the proteins reside in a locally 2-D environment.  
Figure 4-13 shows an image of a resting HEK293T cell, transiently transfected with 
VEGFR2 ECTM-GGS5-Turq/YFP.  Figure 4-14 shows a hypotonically swollen  HEK cell 
expressing the same fluorescent proteins.  Figure 4-15A, top, shows a membrane patch 
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from an intact cell, with diffraction limited features clearly visible, whereas Figure 4-15A, 
bottom, shows a membrane patch from a swollen cell. The membrane of the intact cell has 
a complex topology which is unknown, while the membrane of the swollen cell is 
perpendicular to the focal plane. The apparent pixel-level concentrations, and the apparent 
FRET efficiencies, calculated with the FSI method under the assumption that the 
membrane is perpendicular to the focal plane, are shown in Figure 4-15B and C.   
 For the intact cell, we see wide variations in fluorophore concentrations, but no 
such variations in FRET efficiencies. According to the thermodynamic formulation of the 
Kinetic Theory formalism, in a dimerizing system, the total fraction of dimers is dependent 
upon the total concentration of receptors, and thus a higher concentration must necessarily 
yield higher pixel-level FRET efficiency.  The lack of correlation therefore demonstrates 
that the results for the intact cell have no physical meaning.  To understand the consequence 
of working with intact cells, about 250 intact cells expressing EC+TM VEGFR2 were 
imaged and 513 regions of membrane were analyzed.  The resultant FRET efficiency 
versus concentration data is shown in Figure 4-16, along with the complementary results 
for swollen cells.  In addition to greatly increased scatter and the presence of negative 
FRET efficiencies, we see that the apparent concentrations appear much higher in intact 
cells despite the fact that the same protein is being expressed, a consequence of the 
membrane folds and wrinkles within the voxel thickness.  Notably, the range of FRET 
efficiencies that are physically realistic are similar in the case of intact and swollen cells, 
suggesting that the interactions between membrane receptors are similar in both systems. 
Thus, swelling does not appear to have a significant effect on labeled membrane protein-
protein interactions, but enables measurements of two-dimensional membrane protein 
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concentrations. On the other hand, the use of intact, resting cells yields erroneous 
concentrations and thus precludes the calculations of association constants for membrane 
proteins. 
  
Figure 4-13.  A resting HEK293T cell, transiently transfected with VEGFR2-ECTM-
GGS5-mTurquoise/YFP.  VEGFR2 is localized to the cell membrane, and complex 




Figure 4-14.  A hypotonically swollen HEK293T cell, transiently transfected with 
VEGFR2-ECTM-GGS5-mTurquoise/YFP.  VEGFR2 is localized to the cell 
membrane, and the diffraction-limited membrane fluorescence is smooth and 











Figure 4-15. The effect of reversible cell swelling on membrane topology and FRET. 
Top: resting cell. Bottom: swollen cell. A. Selected membrane region. B. Map of pixel-
level total concentrations. C. Map of pixel-level FRET efficiencies. In the intact cell, 
there is no correlation between the pixel-level apparent FRET efficiencies and the total 



























Figure 4-16.  Measured FRET efficiencies versus total receptor concentrations, for 
cells under reversible osmotic stress (green) and intact cells (black). The calculated 
two dimensional concentrations for the intact cells are erroneous and thus association 
constants cannot be calculated. The range of measured FRET efficiencies is similar in 
both datasets indicating similar protein-protein interactions in the swollen cell 




4-5.  Conclusions  
 
 In this chapter I have shown the theory and my implementation of the FSI method.  
In the next chapters, I will demonstrate the full utility of the FRET theory and the FSI 
methodology with a study into the heretofore unknown physical-chemical properties of 
VEGFR2 and its activating ligand VEGF, in the context of the living cell membrane.  The 
methodology described up to this point will unlock the true mechanisms of many other 
receptors, ushering in a new paradigm for a thermodynamic understanding of in vivo 
receptor-receptor interactions and activation through direct measurement, instead of 
postulating based on a secondary reporter like phosphorylation in a Western Blot, or based 





Chapter 5.  Application of FRET Theory and FSI:  
VEGFR2 Mutagenesis and EC Domain Truncations 
Reveal Sequence-Specific Interactions in the Absence of 
VEGF 
 
5-1.  Introduction 
 
  The model current model of VEGFR2 activation by VEGF says nothing about how 
the presence of VEGF causes the dimers of VEGFR2 to form.   Since we (or at least I) 
believe that proteins and cells follow the laws of physics, this unphysical model of 
VEGFR2 interactions leaves much to be desired.  Thus, to start, I worked to understand the 
behavior of the receptor in the absence of ligand, even if this state is not “biologically 
exciting.”  Therefore, I began by investigating the properties of a VEGFR2 construct 
composed of the EC and TM domains in the plasma membrane of live cells in the absence 
of VEGF, shown below in cartoon form in Figure 5-1.   
 I then investigated the specificity of the interactions between the EC domains in 
VEGFR2 dimers by first mutating a critical amino acid in the D7 subunit, D731, known to 
stabilize D7-D7 contacts in the isolated D7 crystals.  Next, I created various rational 
truncations of the EC domain by removing sequential Ig-like domains from the VEGFR2 
extracellular domain.  A cartoon schematic of the truncated constructs, with fluorescent 





Figure 5-1.  A cartoon of the VEGFR2 receptor and the construct with the 
intracellular domain replaced with a fluorescent protein used in my experiments.  
VEGFR2 has three primary domains: Extracellular (EC), Transmembrane (TM), and 
the intracellular kinase domain.  The EC domain consists of seven Ig-like subunits 
known as subunits D1 through D7, with D1 at the N-terminus and D7 attached to the 
TM domain.  The subunits D2 and D3, colored in yellow, are the ligand binding 
domains.  D4 and D7, colored in blue, have been shown to be important in stabilizing 
the VEGFR2 ligand-bound dimer, but their role in the absence of ligand is unknown.   
Figure 5-2.  The different forms of VEGFR2 EC-TM with truncated EC domains.  
The D7-TM construct lacks domains D1-D6, and contains only the D7 subunit and 
the TM domain.  The D4:D7-TM construct lacks the D1:D3 distal and VEGF-binding 
domains.  The D5:D7-TM construct lacks  the D1:D4 domains, and the D2:D7-TM 
construct lacks the VEGFR2 D1 domain.     
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 The FSI method, developed in Chapter 4 and used here to study VEGFR2, utilizes 
two excitation wavelengths, pixel-level full spectrum acquisition, and pixel-level 
fluorescence protein calibration curves.  It yields approximation-free measurement of the 
apparent FRET efficiency, as well as the donor- and acceptor- labeled receptor surface 
densities of protein in the plasma membrane. As will be shown, FSI and the full Kinetic 
Theory formalism derived in Chapter 2 allows the measurement of a complete binding 
(association) curve, and yields quantitative information about in vivo VEGFR2 interactions 
in the plasma membrane. The knowledge gained here through the use of the FSI 
methodology is new and challenges the current understanding of VEGFR2 signaling.  Since 
VEGFR2 controls the development of blood vessels in a variety of solid tumors, the new 
knowledge could help guide the development of new VEGFR2 inhibitors as anti-cancer 
therapies.   




5-2.  Experimental Methods 
 
5-2.1  Fluorescent Proteins 
 Soluble monomeric YFP and mTurquoise with an N-terminal 6x His tag were 
expressed and purified to near-milimolar concentrations as described previously.   
Fluorescent protein stocks were buffer exchanged into PBS buffer with a 20kDa MWCO 
concentrator (Pierce #87751) and filtered with a 0.2µm syringe filter.   For each imaging 
session, the stocks were then diluted in buffer to micromolar concentrations to produce 
100%, 75%, and 50% fluorescent protein solution standards.  The mTurquoise and YFP 
solution standard concentrations were measured in a 1 cm path length quartz cuvette using 
NanoDrop 2000C (Thermo Scientific).  Molar absorption coefficients of 83,400 Mol*cm-
1 and 30,000 Mol*cm-1 were used to calculate the concentrations of the solution standards 
from the YFP and mTurquoise absorption maxima of 514 nm and 434 nm, respectively.  
Images of the 100%, 75%, 50% FP solution standards and a PBS buffer-only control were 
acquired at both excitation wavelengths and were used for the calculation of the pixel-level 
slope values, as described in the Chapter 4.   
 
5-2.2  Plasmid Constructs 
 A pBE plasmid encoding for the VEGFR2 signal sequence, extracellular domain, 
transmembrane domain, a 15 amino acid GGS linker, and yellow fluorescent protein (YFP) 
was received from Dr. Kurt Ballmer-Hofer, Paul Scherrer Institute, and was the starting 
product for the mutagenesis required for this work.  The A206K mutation was introduced 
into YFP using QuikChange to render it monomeric.  The pcDNA 3.1+ VEGFR2-EC-TM-
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(GGS)5-mTurqoise construct was created by ligating a double-digested PCR insert of the 
mTurqoise gene between the AgeI and XbaI restriction sites that flank the fluorescent 
protein sequence, thus replacing YFP with mTurqoise.  Ligations were performed with the 
Roche Rapid DNA Ligation Kit (#11635379001), according to the manufacturer’s protocol.   
I am thankful to Sarvenaz Sarabipour for performing these subcloning steps, but I 
personally performed the subcloning for every other construct described here.  VEGFR2 
ECTM-GGS5-FP constructs with a D731A mutation and a D731R mutation were created 
in the same manner as the YFP A206K mutagenesis using the QuikChange II XL Site-
Directed Mutagenesis Kit (Catalog #200251) according to the manufacturer’s protocol.    
 Ligation-dependent cloning utilizing restriction enzymes is difficult and tedious, 
and as such I searched for new, improved methods for cloning truncations of the VEGFR2 
EC domain in to pcDNA.  Ultimately, I decided that Gibson Cloning, developed in 2009, 
was the superior method for subcloning.  Truncated ECTM constructs were designed based 
on the sequence locations of the VEGFR2 EC domain subunits, determined with UniProt.  
D2:D7-TM, D4:D7-TM, D5:D7-TM, D7-TM connected to GGS5-mTurqoise or YFP were 
cloned using the NEBuilder® HiFi DNA Assembly Master Mix (E2621L) cloning kit, 
according to the manufacturer’s protocol.  Briefly, the pcDNA3.1+ was linearized with 
PCR.  Primers for the truncated EC-TM-FP inserts were designed with 18 bp 
complementary overhangs to the pcDNA vector, which was produced via PCR using the 
pcDNA 3.1+ VEGFR2 ECTM-FP plasmid as a template.   Two-piece assembly reactions 
were then performed with a 2:1 insert to vector ratio.  All plasmids were completely 




5-2.3  Cell Culture and Transient Transfection 
 HEK293T cells used for the expression of the VEGFR2-EC-TM-FP plasmid 
constructs were a kind gift from Dr. D. Wirtz, Johns Hopkins University.  The cells were 
cultured in DMEM supplemented with 10% FBS and 20mM glucose, at 37° C in a 5% CO2 
environment.   
Twenty four hours prior to transfection, HEK293T cells were seeded in collagen-
coated, glass bottom 35mm petri dishes (MatTek, P35GCOL-1.5-14-C) at a density of 
2.5e5 cells per dish to achieve 60-70 percent confluency at the time of transfection, 24 
hours later.  Single transfections were performed with a total 3 µg of plasmid DNA and 
cotransfections were performed with a total 4-9 µg of plasmid DNA, using Lipofectamine 
3000 (Invitrogen) according to the manufacturer’s protocol.  A 1:3 donor to acceptor 
plasmid ratio was used in many cotransfection experiments, but for the D7-TM constructs, 
D:A ratios were widely varied in an attempt to discern the oligomer order before I had 
developed the theory that shows the oligomer order is not discernable.  Dang.   
I found that the addition of 10 mM sodium butyrate greatly enhanced expression of 
the pcDNA 3.1+ VEGFR2 EC-TM-(GGS)3 –FP construct  in HEK293T cells 
91,92.  Thus, 
six hours after transfection, 10mM sodium butyrate was added to the cells.  I learned about 
the effects of sodium butyrate on expression with plasmids containing the CMV promoter 
from a biologist at the FASEB conference on cell-membrane biophysics.  Twelve hours 
after transfection, the cells were rinsed twice with phenol-red free, serum free DMEM 
(Sigma, D2902) to remove all traces of phenol red and the cells were serum starved for at 
least 12 hours in the presence of 10 mM sodium butyrate, prior to the application of osmotic 
stress and imaging.   
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5-2.4  Cells Under Reversible Osmotic Stress 
 Hypotonic swelling media was composed of serum-free media, diluted 1:9 with 
diH2O, buffered with 25mM HEPES, and 0.2µm sterile filtered.  Just prior to imaging, the 
starvation media was aspirated from the petri dishes and was gently replaced with 1mL of 
37°C hypotonic swelling media89878685848180807979797978787776757473706867.  The cells in each 
dish were allowed to stabilize for at least 10 minutes before imaging, and swollen cell 




5-3.  VEGFR2 EC-TM  
 
Results for the wild-type VEGFR2 EC+TM measurements are shown in Figure 5-
3.  538 HEK293T cells, co-transfected with VEGFR2 EC+TM-mTurq and VEGFR2 
EC+TM-YFP were imaged with the FSI method, yielding 1024 regions, ~3 µm in length, 
of homogenous membrane fluorescence for analysis.  Figure 5-3A shows the measured 
total apparent FRET efficiency as a function of total VEGFR2 EC-TM expression in blue.  
There is a high variability in total receptor expression levels due to transient transfection 
of the HEK293T cells.  In the FSI methodology, this variability is embraced and utilized 
to ultimately produce binding curves for the receptors.  We see that the apparent FRET 
efficiency increases as a function of the total receptor concentration, suggesting a 
concentration dependent protein-protein association in the membrane.  The mole-fraction 
of VEGFR2 EC+TM-YFP (the acceptor-tagged receptors), for each membrane region, is 
shown in Figure 5-3B (blue bars). The average values agree closely with those expected 
for the 1:3 donor-to-acceptor ratio used in transfection.   
The wild-type VEGFR2 EC+TM data in blue in Figure 5-3A are used to determine 
the type of oligomer in the membrane (dimer, trimer, tetramer, etc) that best describes the 
data. The Kinetic Theory formalism developed in Chapter 2 is used to compute the 
theoretical apparent FRET efficiency as a function of total concentration for different 
oligomeric models (e.g., monomer-only, monomer-dimer, monomer-trimer, monomer-
tetramer, etc.). These models, which include a contribution for stochastic FRET 64,93 were 
fitted to the data.  Theoretical binding curves for a particular oligomeric association model 
depend on two unknown parameters: the monomer-oligomer association constant K and 
the Intrinsic FRET, or the pairwise FRET efficiency. The Intrinsic FRET (the pairwise 
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FRET efficiency) is a structural parameter which depends on the average separation 
between the fluorescent proteins in the oligomer, but not on the association constant, K 86.  
The least squared error is calculated for each oligomeric model, along with the optimal K 
and Intrinsic FRET values. The model which gives the lowest mean squared error (MSE) 
is considered the best overall model to represent the data. 
 For wild-type VEGFR2 EC+TM, the best-fit is achieved for the monomer-dimer 
equilibrium model, which yields the lowest overall MSE (Figure 5-3C). Figure 5A 
compares the measured apparent FRET efficiency and the best-fit theoretical apparent 
FRET efficiency for VEGFR2 EC+TM, with the best-fit theoretical model for the total 
apparent FRET efficiency, shown in red.  We see good agreement with the measured data 
and the theoretical model.  The corresponding dimerization curve is shown in Figure 5-
3D.  With respect to K0 = 1 (rec/nm
2)-1, the apparent Gibbs free energy, -RTln(K/K0), of 
VEGFR2 EC+TM dimerization is -3.5 ± 0.1 kcal/mol.  The Intrinsic FRET for the donor-
acceptor pair in the VEGFR2 EC+TM dimer is 0.85 ± 0.05, corresponding to a donor-to-





Figure 5-3.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 EC-TM construct.   A.  The measured 
total apparent FRET efficiency in the regions (blue) and the best-fit theoretical total 
apparent FRET efficiency (red) as a function of total VEGFR2 EC-TM expression.  
B.  A histogram of measured acceptor fractions.  C.  The best-fit MSE as a function of 
oligomer order.  The best-fit is a monomer-dimer equilibrium at 𝑛 = 2.  D.  The 
measured total apparent FRET efficiency is transformed and binned to plot the 
dimeric fraction and the best-fit dimeric fraction as a function of total VEGFR2 EC-
TM surface density.   









































































































5-4.  VEGFR2 EC-TM D731 Mutants  
 
 The crystal structure of the isolated D7 VEGFR2 EC domains (PDB entry 3KQV) 
shows a very prominent salt bridge between residues D731 and R726, joining two adjacent 
molecules in the dimer 94.  It has been proposed that these contacts form in the ligand-
bound dimer, and the occurrence and nature of sequence-specific EC domain contacts are 
not known. Previously published results show that mutant forms of VEGFR2 in which this 
salt-bridge is broken experience drastically reduced Tyrosine phosphorylation in the 
presence of VEGF.   These results were interpreted to mean the VEGFR2 D731A mutant 
was predominantly monomeric.   
 
5-4.1 VEGFR2 EC-TM D731A  
 To study if this salt bridge plays a role in VEGFR2 EC+TM dimer stabilization in 
the absence of ligand, I introduced a D731A mutation in VEGFR2 EC+TM and measured 
the self-association of this mutant in the plasma membrane with the FSI method. 278 
swollen cells expressing the D731A mutant were imaged, and 523 ~3 m membrane 
regions in these cells were analyzed to yield FRET efficiencies, donor concentrations, and 
acceptor concentrations. The results are shown in Figure 5-4A in green. While I expected 
that the D731A mutation would destabilize the VEGFR2 dimer and thus decrease the FRET 
efficiencies and dimerization propensity, I instead observed a very large increase in FRET 
over all receptor concentrations.   
Next I sought to determine the type of oligomeric interaction in the membrane that 
best describes the mutant data. The MSE for tetramers, pentamers and hexamers are all 
very similar, with no apparent minimum in the MSE as the oligomer order was increased 
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(Figure 5C).  Thus, no single oligomeric model greater than a dimer could be singled out 
as providing the best fit to the data.  Figure 5D shows the best-fit oligomeric fraction as a 
function of total concentration.  We see that the oligomeric fraction of the D731A construct 
is greatly enhanced over the dimeric fraction of VEGFR2 EC-TM.  For example by 
comparing Figure 5-3D and Figure 5-4D, we see that at 1x10-3 receptors/nm2, the 
oligomeric fraction of  the D731A mutant is ~80%, while for VEGFR2 EC-TM, the dimeric 
fraction is ~40%.  The MSEs for all these oligomers, however, were much smaller than the 
dimer MSE. Thus, the data analysis indicates that the D731A mutation induced higher-
order oligomerization greater than dimerization of VEGFR2 EC+TM in the plasma 
membrane.  This FRET signature is likely due to the formation of large aggregates, or due 
to heterogeneous populations of mutant VEGFR2 EC-TM D731A oligomers, undergoing 
non-specific associations.  My simulations in Chapter 3 predict this indeterminacy in 
analysis of the higher-oligomer order.  Here we see that my previous work really does 
describe the FRET that will be measured for any possible situation and that in general, the 
order of higher-order oligomer formation will not be discernable with a bulk, two-color 
static quenching FRET experiment.  Figure 5-10 shows the oligomeric fractions for all of 







Figure 5-4.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 EC-TM D731A mutant construct.   A.  
The measured total apparent FRET efficiency in the regions (green) and the best-fit 
theoretical total apparent FRET efficiency (red) as a function of total VEGFR2 EC-
TM expression.  The total apparent FRET efficiency of the VEGFR2 EC-TM 
construct is shown again in blue for comparison of FRET levels.  B.  A histogram of 
measured acceptor fractions.  C.  The best-fit MSE as a function of oligomer order.  
The best-fit is a monomer-oligomer equilibrium at 𝑛 > 2.  D.  The best-fit oligomeric 
fraction is plotted as a function of total VEGFR2 EC-TM concentration.   









































































































5-4.2 VEGFR2 EC-TM D731R 
 In order to see if the D731A mutation underwent oligomerization due to the effect 
of the presence of the Alanine, I completely reversed the polarity of the aspartic acid side 
chain by replacing it with a positively charged Arginine.  Figure 5-5 shows the results of 
the FSI measurements with the VEGFR2 EC-TM D731R construct.   In all, 118 cells were 
imaged, yielding 145 data points for analysis with the Kinetic Theory formalism.  The 
measured total apparent FRET efficiency is plotted in Figure 5-5A as a function of total 
VEGFR2 EC-TM D731R surface density, in purple.  Figure 5-5B shows the measured 
acceptor mole fractions in the experiment, and again they agree well with that expected for 
the ~1:3 D:A ratio of plasmid used for transient transfection.   
 Figure 5-5C shows the results of the analysis with the Kinetic Theory formalism 
derived in Chapter 2, where the best-fit MSE is plotted as a function of oligomer order.  
As with the D731A EC-TM mutant, the D731R EC-TM mutant undergoes strong 
oligomerization, and there is no minimum in the MSE versus oligomer order plot.  In 
Figure 5-5D, the measured total apparent FRET efficiency data are transformed into the 
measured oligomeric fraction, and binned and plotted as a function of total concentration, 
along with the theoretical oligomeric fraction obtained through the analysis.    This data 
along with the D731A mutant show that sequence specific interactions between unliganded 
VEGFR2 EC domains, at the very least, D7-D7 homotypic interactions involving the salt 
bridge, are required for proper dimerization of the receptor.  Without these sequence-
specific interactions, VEGFR2 has a robust propensity to oligomerize and is never 
monomeric.    Figure 5-10 shows the oligomeric fractions for all of the constructs measured 
here for comparison.   
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Figure 5-5.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 EC-TM D731A mutant construct.   A.  
The measured total apparent FRET efficiency in the regions (purple) and the best-fit 
theoretical total apparent FRET efficiency (red) as a function of total VEGFR2 EC-
TM expression.  B.  A histogram of measured acceptor fractions.  C.  The best-fit 
MSE as a function of oligomer order.  The best-fit is a monomer-oligomer 
equilibrium at 𝑛 > 2.  D.  The best-fit oligomeric fraction is plotted as a function of 
total VEGFR2 EC-TM concentration.   









































































































5-5.  VEGFR2 D7-TM  
 A series of truncations of the VEGFR2 EC domain were created to determine which 
subunits are essential of dimerization of VEGFR2 EC-TM, shown in Section 5-3.  To begin 
with, the entire EC domain was removed except for the juxtamembrane subunit D7.  666 
cells expressing the VEGFR2 D7-TM truncated receptor were imaged yielding 1,170 
regions for analysis with the Kinetic Theory formalism.   Figure 5-6 shows the results of 
the measurements and analysis of the VEGFR2 D7-TM construct.  Figure 5-6A shows the 
measured total apparent FRET efficiency as a function of total concentration in yellow.  
The D:A (mTurquoise/YFP) transfection ratios were widely varied with this construct, as 
shown with the histogrammed acceptor fraction values in Figure 5-6B.  As a result, we see 
a wide range of measured total apparent FRET efficiency values in Figure 5-6A.   
 I analyzed the data shown in Figure 5-6A with the Kinetic Theory formalism 
described in Chapter 2, and the results are shown in Figure 5-6C.  I show the best-fit MSE 
as a function of oligomer order.  There is no minimum in the MSE vs. oligomer order plot, 
and thus we see that the D7-TM constructs oligomerize in the cell membrane.  The best-fit 
total apparent FRET efficiency is plotted in red in Figure 5-6A alongside the measured 
total apparent FRET efficiency.  The best-fit total apparent FRET efficiency is in great 
agreement with the measured data.  In Figure 5-6D, the measured total apparent FRET 
efficiency values are algebraically transformed into the measured oligomeric fraction, 
binned, and plotted alongside the best-fit oligomeric fraction.  Comparing the oligomeric 
fraction of the D7-TM construct with that of the VEGFR2 EC-TM D731A and D731R 
oligomeric fractions shows that this D7-TM construct experiences a much stronger 
thermodynamic propensity for oligomerization.  These experimental results are interpreted 
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as showing that the presence of the D1:D6 subunits serves to reduce the 
dimerization/oligomerization propensity of VEGFR2 EC-TM domains.  Figure 5-10 
shows the oligomeric fractions for all of the constructs measured here for comparison.   
  
Figure 5-6.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 D7-TM truncated EC domain construct.   
A.  The measured total apparent FRET efficiency in the regions (yellow) and the best-
fit theoretical total apparent FRET efficiency (red) as a function of total VEGFR2 EC-
TM expression.  B.  A histogram of measured acceptor fractions.  C.  The best-fit 
MSE as a function of oligomer order.  The best-fit is a monomer-oligomer equilibrium 
at 𝑛 > 2.  D.  The best-fit oligomeric fraction is plotted as a function of total VEGFR2 
EC-TM concentration along with the measured oligomeric fraction of receptors. 
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5-6.  VEGFR2 D5:D7-TM  
 In order to try to determine which subunits of the VEGFR2 extracellular domain 
are required for dimerization of VEGFR EC-TM constructs in the absence of ligand, the 
D5:D7-TM-GGS5-mTurquoise and YFP constructs were cloned.  The D5:D7-TM 
constructs are truncated VEGFR2 EC domains lacking distal domain D1, the ligand-
binding domains D5 and D6, and a domain shown to participate in homotypic interactions 
in the ligand bound VEGFR2 dimer, D4.  Images of 216 cells yielded 347 regions of 
homogenous, diffraction-limited membrane fluorescence for analysis.  Figure 5-7 shows 
the results of these measurements and the analysis of the data.  In Figure 5-7A the total 
apparent FRET efficiency is plotted as a function of measured D5-D7:TM surface density 
in the transiently-transfected cell in purple.  In Figure 5-7B, the measured acceptor-
fractions are histogrammed and agree well with that expected for a ~1:3 D:A ratio of 
plasmids, as utilized for the transient transfections.   
 Figure 5-7C shows the best-fit mean-squared error as a function  of theoretical 
oligomer order.   The MSE versus order plot shows that the D5:D7-TM constructs also 
form oligomers, as the best-fit  MSEs indicate that oligomer formation, 𝑛 > 2, is occurring.  
The best-fit theoretical total apparent FRET efficiency for oligomer formation is plotted in 
red in Figure 5-7A.  The best-fit agrees well with the measured data.  The measured total 
apparent FRET efficiency is algebraically transformed into the measured oligomeric 
fraction, binned, and plotted as a function of total D5:D7-TM surface density, along with 
the best-fit oligomeric fraction in Figure 5-7D.  Comparing the oligomeric fraction as a 
function of total concentration for the D5:D7-TM construct to that of the D7-TM construct 
in Figure 5-6D shows that the presence of D5 and D6 subunits greatly inhibits 
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oligomerization of the VEGFR2 EC-TM construct.  Figure 5-10 shows the oligomeric 
fractions for all of the constructs measured here for comparison.   
 
 
Figure 5-7.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 D5:D7-TM truncated EC domain 
construct.   A.  The measured total apparent FRET efficiency in the regions (purple) 
and the best-fit theoretical total apparent FRET efficiency (red) as a function of total 
VEGFR2 EC-TM expression.  B.  A histogram of measured acceptor fractions.  C.  
The best-fit MSE as a function of oligomer order.  The best-fit is a monomer-
oligomer equilibrium at 𝑛 > 2.  D.  The best-fit oligomeric fraction is plotted as a 
function of total VEGFR2 EC-TM concentration along with the measured oligomeric 
fraction of receptors. 
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5-7.  VEGFR2 D4:D7-TM  
 The D4-D4 and D7-D7 homotypic interactions between VEGFR2 EC domain 
subunits in the ligand-bound dimer have been shown to be essential for proper signaling 
by the receptors.  Thus, I created the D4:D7-TM-GGS5-mTurquoise/YFP truncated 
VEGFR2 construct that lacks the distal domain, D1, and the ligand binding domains D2 
and D3.  366 HEK293T cells co-transfected with the VEGFR2 D4:D7-TM construct were 
imaged, yielding 549 regions of diffraction-limited homogenous membrane fluorescence 
for analysis with the Kinetic Theory formalism.  Figure 5-8 shows the measured data and 
the analysis results.  The measured total apparent FRET efficiency is plotted as a function 
of total VEGFR2 D4:D7-TM surface density in Figure 5-8A, in gray.  In Figure 5-B the 
measured acceptor fractions are histogrammed, and agree well with that expected for a 1:3 
donor-to-acceptor ratio of plasmids utilized in the transient transfection.    
 Figure 5-8C shows the results of the analysis of the measured data with the Kinetic 
Theory formalism, where the best-fit MSE is plotted as a function of theoretical oligomer 
order.  The overall lowest MSE is found for the 𝑛 = 2 model, indicating that dimerization 
is taking place between these truncated VEGFR2 constructs.  The best-fit monomer-dimer 
model for the total apparent FRET efficiency is plotted in red in Figure 5-8A.  The best-
fit parameters for the monomer-dimer equilibrium model are an intrinsic FRET of ?̃? =
0.74 ± 0.03 and a Gibbs free energy of association of ∆𝐺° =  −𝑅𝑇𝑙𝑛 (
𝐾𝐴
𝐾0
⁄ ) =  −3.0 ±




.  Compared to the full-length VEGFR2 EC-TM 
construct, with an intrinsic FRET ?̃? = 0.85 ± 0.03, the intrinsic FRET of the D4:D7-TM 
construct is significantly lower indicating that the fluorescent proteins are further apart, 
and that the C-termini of the TM domains is spaced further apart than the EC-TM 
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construct’s unliganded dimers.   Figure 5-8D shows the measured dimeric fraction and the 
theoretical dimeric fraction.as a function of total concentration.  The Gibbs free energy of 
association of the VEGFR2 EC-TM construct is 0.5 kcal/mol lower than that of the 
truncated D4:D7-TM construct, indicating slightly reduced dimerization of the truncated 
construct compared to that of the VEGFR2 EC-TM domains.  Figure 5-10 shows the 






Figure 5-8.  The results of the FSI measurements and the analysis with the full 
Kinetic Theory formalism for the VEGFR2 D4:D7-TM truncated EC domain 
construct.   A.  The measured total apparent FRET efficiency in the regions (gray) and 
the best-fit theoretical total apparent FRET efficiency (red) as a function of total 
VEGFR2 EC-TM expression.  B.  A histogram of measured acceptor fractions.  C.  
The best-fit MSE as a function of oligomer order.  The best-fit is a monomer-dimer 
equilibrium at 𝑛 = 2.  D.  The best-fit dimeric fraction is plotted as a function of total 




5-8.  VEGFR2 D2:D7-TM  
 Since the D4:D7-TM construct had restored, but weaker dimerization of the 
VEGFR2 EC-TM construct, but with a structural shift in D:A distance and slightly reduced 
dimerization propensity, I reasoned that the presence of the distal domain, D1, or the 
ligand-binding domains, D2:D3,  would be responsible restoring the dimerization of the 
VEGFR2 EC-TM constructs.    Thus, I created the D2:D7-TM-GGS5-mTurquoise/YFP 
truncated VEGFR2 construct that lacks the distal domain, D1 of the VEGFR2 extracellular 
domain.  The cloning was performed and the plasmid constructs were sequence and 
verified to be correct with respect to the UniProt EC-domain sequence positions.  
Unfortunately, when HEK293T cells were transfected with this plasmid, the protein was 
retained the endoplasmic reticulum of the cells, and no cell-membrane fluorescence of 
properly localized proteins was observed.  Thus, it appears that the properties of this 
truncated version of VEGFR2 will remain a mystery forever.  
  
Figure 5-9.  The thermodynamic properties of the VEGFR2 D2:D7-TM construct 




Figure 5-10.  The best-fit dimeric fraction for the VEGFR2 EC-TM and the D4:D7-
TM constructs, and the best-fit oligomeric fraction for the D7-TM, D5:D7-TM, EC-




5-9.  Discussion and Conclusions 
 Here I sought to investigate the specificity of the 2D interactions between VEGFR2 
EC domains in cellular membranes by destabilizing an inter-molecular salt bridge observed 
in crystal structures of isolated D7 dimers, and by creating versions of VEGFR2 with 
various truncations of the VEGFR2 extracellular domain.  The mutagenesis of an aspartic 
acid involved in this interaction, D731, to alanine did not destabilize the VEGFR2 EC+ 
TM dimers, as we expected. Instead, the mutation introduced a very large, surprising 
perturbation in the receptor interactions, leading to receptor oligomerization.  It is curious 
that engineered VEGFR2 TM domain mutations can also alter the oligomerization state of 
the isolated TM domain, inducing trimer formation 95. It can be argued, therefore, that 
similar point mutations that are rationally designed by researchers to interrogate the 
function of VEGFR2, and RTKs in general, may have similar profound effects that 
complicate data interpretation if direct measurements of protein-protein interactions are not 
performed, such as with the FSI methodology and the Kinetic Theory formalism described 
earlier.       
The large perturbation in interactions, observed here when D731 is mutated to Ala 
or Arg, suggests that the Asp731-Arg726 salt bridge between the D7 domains is important 
for VEGFR2 dimerization in the absence of ligand, as it ensures that VEGFR2 forms a 
dimer and not a higher-order oligomer. The mutagenesis therefore reveals that strong D7-
D7 contacts occur in the VEGFR2 EC domain in the absence of ligand.    This is 
fundamentally novel discovery, as D7-D7 interactions are currently believed to occur only 
upon ligand binding 16.   
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As shown in Figure 5-10, The strong oligomerization propensity of the D7-TM 
truncated construct shows that the primary function of the D7 subunit is to provide a robust 
thermodynamic base propensity for receptor-receptor interactions.  We see that the 
D5:D7-TM truncated construct also oligomerizes, yet with drastically reduced 
oligomerization affinity.  The oligomeric fraction is even much less than the dimeric 
fraction of the VEGFR2 EC-TM domains except at the lowest total concentrations of 
VEGFR2.  Thus, it appears that the role of the D5 and D6 domains is to drastically reduce 
the strong propensity for oligomerization provided by the D7-TM construct.   
The VEGFR2 D4:D7-TM construct showed restored dimerization, but with slightly 
weaker dimerization affinity than that of the VEGFR2 EC-TM construct, but with an 
enhanced dimeric fraction when compared to the D5:D7-TM construct. The D4:D7-TM 
constructs also had a larger donor-to-acceptor distance in the dimer, compared to that of 
the EC-TM protein.  Thus, this data is interpreted to show that the same homotypic 
interactions that are required for functional VEGF-bound VEGFR2 dimers, D4-D4 and 
D7-D7 contacts, are also necessary for proper dimerization of the VEGFR2 EC-TM 
domains in the absence of ligand.  Though I do not have direct experimental evidence, the 
lower dimeric binding affinity of the D4:D7-TM construct, compared to that of the 
VEGFR2 EC-TM, indicates that the D1 domain and/or the ligand binding domains D2 and 
D3 may participate in stabilizing the unliganded VEGFR2 dimer.  Figure 5-10, below, 
gives the current model for VEGFR2 interactions in the absence of VEGF.   
We see that essentially every subunit of the extracellular domain plays an important 
role in ensuring that VEGFR2 dimerizes at the “proper” affinity instead of oligomerizing 
with some different binding affinity.  These sequence specific EC-domain interactions (and 
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TM domain contacts as well) are required for the structurally-proper form of the VEGFR2 
dimer, even in the absence of ligand.  I have shown that our previous understanding of the 
behavior of VEGFR2 in the plasma membrane of live cells in the absence of VEGF binding 
was incomplete.  Despite many years of research, our understanding of VEGFR2 activation 
by VEGF, therefore, is likely incomplete as well, and deserves further investigation with 




Figure 5-11.  VEGFR2 dimerizes with sequence-specific interactions in the absence 
of VEGF.   D7-D7 and D4-D4 homotypic contacts provide sequence specific 
interactions that ensure dimerization of VEGFR2, instead of oligomerization, as 
indicated by yellow stars.   Additional interactions between D1, D2, or D3 are 
possibly indicated by the data, but the exact nature remains unknown.   
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Chapter 6.  Advanced Application of FRET Theory and 
FSI: Measurement of VEGF Binding Affinity  
 
6-1.  Introduction 
 
 In this chapter, I utilize 2-photon excitation and the OptiMis spectral imaging 
system, in conjunction with the Fully Quantified Spectral Imaging (FSI) method, to 
measure the affinity of VEGF for monomeric and dimeric VEGFR2 on the surface of live 
cells.   In addition to the ability to measure the three-dimensional concentration of freely 
diffusing fluorescently labeled moieties, FSI provides the unique ability to measure the 
surface density of fluorophore-labeled membrane proteins in 2-3 micron size patches of 
the cell membrane.  I again utilize transiently transfected HEK293T cells expressing 
VEGFR2 ECTM, a truncated form of VEGFR2 that lacks the intracellular kinase domain, 
linked to YFP through a disordered (GGS)5 linker.  I then utilize a form of VEGF121 
known as scVEGF (single chain VEGF) which is labeled with the organic dye Alexa Fluor 
594.  I measured the bound surface densities of VEGF as a function of expressed VEGFR2 
surface density in many cells, each expressing a different total amount of VEGFR2.  I also 
measured the free-ligand concentration directly in the buffer surrounding the cells.  With 
this unique application of the FSI methodology, repeated for many different free-ligand 
concentrations, I am able to globally-fit 12 combined datasets and determine the separate 
values of the affinity of labeled VEGF for monomeric and dimeric forms of VEGFR2 EC 
domains.  With these values in hand, there is full predictive power on the fraction of ligand 
bound dimers of full-length VEGFR2 for any local effective VEGFR2 surface density on 
the membrane of the cell and for any free-VEGF concentration. 
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6-2.  Theory: A Thermodynamic Cycle for VEGF Binding to 
VEGFR2 
 
 Here I describe a thermodynamic cycle that accounts for all for all of the different 
forms of VEGFR2 that can exist in the presence of VEGF: monomeric (M), dimeric (D), 
ligand-bound monomers (LM), and ligand-bound dimers (LD) of VEGFR2 for 
measurement of VEGF binding affinities, as shown in Figure 6-1.  This model assumes 
that one molecule of VEGF can bind per monomer or dimer of VEGFR2.  With this 
thermodynamic cycle, all of the possible pathways for going from an unliganded-monomer 
of VEGFR2 to the active, VEGF-bound dimer of VEGFR2 are accounted for.   We see 
along the top of the cycle, that VEGFR2 can undergo unliganded dimerization, with affinity 
𝐾𝑅 in units of receptors/nm







VEGF can then bind to the pre-formed dimer of VEGFR2 with affinity 𝐾𝐿𝐷 having inverse 







Instead of dimerizing in the absence of ligand, if we move from the top left position in the 
thermodynamic cycle down in a counter-clockwise direction, VEGF ligand in solution can 










By moving right in the cycle, we see that a monomer of VEGFR with a bound VEGF, LM, 
binds to a monomer of VEGFR2 without bound ligand, M, and we again reach the ligand-
bound, active dimeric form of VEGFR2.  This association constant is defined in Equation 







Finally, if we continue counterclockwise down the cycle, we see that after a molecule of 
VEGF binds to both monomers with affinity 𝐾𝐿𝑀, a molecule of VEGF can dissociate from 
a VEGFR2 receptor, providing the third pathway to a ligand-bound, active molecule of 









 In these experiments, I measure the total surface density of YFP-linked VEGFR2 
EC-TM domains, [T] on the membrane of live cells: 
 
[𝑇] = [𝑀] + 2[𝐷] + [𝐿𝑀] + 2[𝐿𝐷] (6-6) 
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 The total bound VEGF surface density is also measured: 
 
[𝐿𝑏𝑜𝑢𝑛𝑑] = [𝐿𝑀] + [𝐿𝐷] (6-7) 
 
Using the association constants defined above, Equation (6-1) – Equation (6-3), we write 
the total concentration of VEGF2, [𝑇], in terms of the free-VEGF concentration, and the 
concentration of monomeric VEGFR2, as shown in Equation (6-8): 
 
[𝑇] =  2𝐾𝑅(1 +  [𝐿]𝑓𝑟𝑒𝑒𝐾𝐿𝐷)[𝑀]
2 + (1 + [𝐿]𝑓𝑟𝑒𝑒𝐾𝐿𝑀)[𝑀] (6-8) 
 
 Next we write down the bound surface density of VEGF (Equation (6-7)) in terms 
of the monomeric VEGFR2 surface density, the free-VEGF concentration, and the 
association constants defined in Equations (6-1) through (6-3): 
 
[𝐿]𝑏𝑜𝑢𝑛𝑑 = [𝐿]𝑓𝑟𝑒𝑒[𝑀](𝐾𝐿𝑀 + [𝑀]𝐾𝐿𝐷𝐾𝑅) (6-9) 
 
By subtracting [T] from both sides of Equation 8, we then use the root of the second order 
polynomial to write the monomeric VEGFR2 surface density, [M], in terms of, 𝐾𝑅, [𝐿𝑓𝑟𝑒𝑒], 
[𝑇], the known and measured parameters, and our main parameters of interest: 𝐾𝐿𝑀 and 
𝐾𝐿𝐷.  Substitution of [𝑀] into Equation (6-9), provides a theoretical model for the bound 
surface density of VEGF as a function of the known parameters 𝐾𝑅, [𝐿𝑓𝑟𝑒𝑒], and [𝑇], and 
two unknown, adjustable parameters 𝐾𝐿𝑀 and 𝐾𝐿𝐷 .  Due to linkage in the thermodynamic 
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cycle, this model completely accounts for all of the different pathways for ligand binding 
to VEGFR2 EC domains, as depicted in Figure 6-1.   
 From the buffer fluorescence, I directly measure the three-dimensional equilibrium 
concentration of ligand in the dish surrounding the cells, [𝐿𝑓𝑟𝑒𝑒].  Previous work has shown 
that the intrinsic binding affinity of VEGFR2 ECTM domains is equal to 𝐾𝑅 =
[𝐷]
[𝑀]2
 = 370 (𝑟𝑒𝑐 𝑛𝑚2⁄ )
−1.   Thus, only two parameters remain undetermined in Equation 
(6-8) and Equation (6-9):   𝐾𝐿𝑀 and 𝐾𝐿𝐷.   By measuring many cells with varying VEGFR2 
surface densities and associated levels of bound VEGF, and repeating these measurements 
for many different levels of free-VEGF concentrations, global fitting can then be utilized 
on all of the combined datasets to determine the separate VEGF affinities for monomeric 
and dimeric forms of VEGFR2, 𝐾𝐿𝑀  and 𝐾𝐿𝐷 , with a non-linear least squares analysis 





Figure 6-1.  A thermodynamic cycle describing all of the ligand-free and ligand-bound 
forms of monomeric and dimeric VEGFR2, along with definitions of the association 
constants.   As we move from top left to the right, we start with monomeric VEGFR2 (M).  
It can undergo unliganded dimerization (D) on the top path, with affinity K
R
, whereby a 
free molecule of VEGF can then bind to the preformed VEGFR2 dimer (LD), which would 
represent the active form for the full-length receptors.  On the other two paths to a liganded 
dimer of VEGFR2, if we move down from the M + M state, VEGF can bind to a monomer 
of VEGFR2 (LM).   A liganded monomer can then bind to a monomeric receptor, or under 
saturating conditions, a molecule of VEGF will need to dissociate from a VEGFR2 
monomer for dimerization to the active form of VEGFR2 with on molecule of VEGF 
bound.   [L] has units of micromolar, while [M] and [D] have units of receptors/nm
2
.   
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6-3.  Methods 
 
 
6-3.1.  Plasmid Constructs 
 A pBE plasmid encoding for the VEGFR2 signal sequence, extracellular domain, 
transmembrane domain, a 15 amino acid GGS linker, and yellow fluorescent protein (YFP) 
was received from Dr. Kurt Ballmer-Hofer, Paul Scherrer Institute, and was the starting 
product for the mutagenesis required for this work.  The A206K mutation was introduced 
into YFP using QuikChange to render it monomeric.  The pcDNA 3.1+ VEGFR2-EC-TM-
(GGS)5-YFP construct was created by ligating a double-digested PCR insert of the ECTM-
FP gene at restriction sites that flank the chimeric protein sequence, thus inserting the gene 
into the MCS of pcDNA 3.1+.  Ligations were performed with the Roche Rapid DNA 
Ligation Kit (#11635379001), according to the manufacturer’s protocol.   
 
6-3.2.  Alexa-Fluor 594 conjugated VEGF 
 In this work, I utilize scVEGF (single chain VEGF) conjugated to the organic dye 
Alexa Fluor 594, purchased commercially from Sibtech Inc (#SBT309) at >90% purity.  
The scVEGF conjugate utilized is a ~28 kDa moiety and consists of two fragments of 
human VEGF121(AA 3-112)  cloned head to tail and fused to an N-terminal Cys-Tag 
(SibTech #SBT301).  The AF594-scVEGF (AF594-VEGF) conjugate is singly labeled in 
a site-specific manner at the C4 residue of the Cys-Tag, and retains 95-100% of VEGF 
activity.   scVEGF was originally developed so that only one side of the cysteine-linked 
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homodimer can be labeled at a time.  I utilize it here to measure the binding affinity of 
VEGF to VEGFR2 EC domains.  
6-3.3.  Cell Culture and Transient Transfection 
 HEK293T cells are utilized with transient transfection in these experiments.  The 
HEK293T cells used for the expression of the VEGFR2-EC-TM-YFP plasmid construct 
were a kind gift from Dr. D. Wirtz, Johns Hopkins University.  The cells were cultured in 
DMEM supplemented with 10% FBS and 20mM glucose, at 37° C in a 5% CO2 
environment.   
Twenty-four hours prior to transfection, HEK293T cells were seeded in collagen-
coated, glass bottom 35mm petri dishes (MatTek, P35GCOL-1.5-14-C) at a density of 
2.2e5 cells per dish to achieve ~65 percent confluency at the time of transfection, 24 hours 
later.  Transfections were performed with a total 3 µg of plasmid DNA, using 
Lipofectamine 3000 (Invitrogen) transfection reagent, according to the manufacturer’s 
protocol.   
I found that the addition of 10 mM sodium butyrate greatly enhanced expression of 
the pcDNA 3.1+ VEGFR2 EC-TM-(GGS)3 –YFP construct  in HEK293T cells (37, 38).  
Thus, six hours after transfection, 10mM sodium butyrate was added to the cells.  Twelve 
hours after transfection, the cells were rinsed twice with phenol red-free, serum-free 
DMEM (Sigma, D2902) to remove all traces of phenol red.  The cells were serum starved 
for at least 12 hours in the presence of 10 mM sodium butyrate, prior to the application of 
osmotic stress and imaging.  At the time of serum starvation, the dishes were blocked with 
0.1% BSA to prevent non-specific binding of VEGF.   A 0.1% BSA concentration is 
maintained throughout the rest of the experiment.  
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6-3.4.  Reversible Osmotic Swelling and Addition of VEGF to Cells 
 Hypotonic swelling media was composed of serum-free media, diluted 1:9 with 
diH2O, buffered with 25mM HEPES, supplemented with 0.1% BSA, and 0.2µm sterile 
filtered.  AF594-scVEGF was re-suspended in PBS buffer at a concentration of 1mg/mL, 
and stored in aliquots of ~2.5 𝜇g/aliquot at -20 C.  These aliquots were then used at 1:1, 
1:5, 1:10, 1:15, 1:20, 1:25, and 1:50 dilutions and mixed with swelling media.  Just prior 
to imaging, the starvation media was aspirated from the petri dishes and was gently 
replaced with 1mL of 37°C hypotonic swelling media (39) containing AF594-labeled 
VEGF.  The cells in each dish were allowed to stabilize for at least 15 minutes before 
imaging, and swollen cell images were acquired at room temperature for up to 2.5 hours 
per dish post swelling.   
 
6-3.5.  Image Acquisition 
 Spectral images in which we acquire the full fluorescence emission spectrum in 
every pixel of the image (see Figure 6-3 for YFP and AF594-VEGF emission spectra 
obtained from cell membranes) are utilized in the FSI methodology. Two-photon 
fluorescence excitation is produced with a Mai Tai laser (Spectra Physics) and the OptiMis 
True Line Spectral Imaging system (Aurora Spectral Technologies), and provides 
excitation outside of the detectable range of the spectral imaging system.  Images are 
acquired utilizing a Zeiss Observer wide field microscope, with a 63X NA 1.2 water 
immersion objective as described in detail in (30).  Essentially, two different FSI 
experiments are performed per dish.  Two images of each cell are acquired: a “FRET scan” 
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to excite YFP with primary donor excitation at 960 nm and an “Acceptor Scan” to excite 
AF594-scVEGF with primary acceptor excitation at 800 nm or 840 nm.  Additionally, 
images of buffer fluorescence, in a region of the dish where no cells were located, were 
acquired for determination of the free-VEGF concentrations, as shown in Figure 5.  
Different OptiMis image acquisition settings were used during these scans to either 
minimize (for cells) or maximize the buffer fluorescence signal (for free-ligand 
measurement).  The settings for imaging of cell membrane fluorescence and buffer 





Table 6-1.  The settings used for cell membrane fluorescence and buffer fluorescence 
measurements.   
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35 ms 1 nm 960 nm 840 nm 35 ms 2 nm 800 nm 
38.5 
nM 
35 ms 1 nm 960 nm 840 nm 35 ms 2 nm 800 nm 
6.81 
nM 
35 ms 2 nm 960 nm 840 nm 
140 
ms 
2 nm 800 nm 
5.88 
nM 
35 ms 2 nm 960 nm 840 nm 
140 
ms 
2 nm 800 nm 
2.00 
nM  
35 ms 2 nm 960 nm 840 nm 
140 
ms 
2 nm 800 nm 
3.00 
nM 
35 ms 1 nm 960 nm 800 nm 
200 
ms 
2 nm 800 nm 
1.09 
nM 
35 ms 1 nm 960 nm 800 nm 
200 
ms 
2 nm 800 nm 
1.54 
nM 
35 ms 1 nm 960 nm 800 nm 
200 
ms 
2 nm 800 nm 
1.23 
nM 
35 ms 1 nm 960 nm 800 nm 
300 
ms 
2 nm 800 nm 
0.98 
nM 
35 ms 1 nm 960 nm 800 nm 
300 
ms 
2 nm 800 nm 
0.45 
nM 
35 ms 1 nm 960 nm 800 nm 
300 
ms 
2 nm 800 nm 
0.21 
nM 
35 ms 1 nm 960 nm 800 nm 
300 
ms 
2 nm 800 nm 
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6-3.6.  VEGFR2, VEGF Surface Density and Free-VEGF Measurements 
 The Fully Quantified Spectral Imaging (FSI) method is utilized in this work to 
measure the bound AF594-VEGF surface densities, the expressed VEGFR2 ECTM-GGS5-
YFP surface density, and the three-dimensional concentration of free VEGF in the buffer 
surrounding the cells in the dish.  Figure 6-2 shows a cartoon of the imaging scheme 
utilized for these experiments:  
 
 Due to their spectral properties, YFP is regarded as the FRET donor, and AF594-
scVEGF is considered the FRET acceptor (see Figure 6-3 below).  I measured the surface 
density of expressed VEGFR2 ECTM-YFP and the bound AF594-VEGF surface density 
in 2-3 micron size patches of membrane on hypo-osmotically swollen, adherent HEK293T 
cells.   It has been previously shown that swelling the cells is required for proper extraction 
of the surface densities of labeled membrane proteins, and that the swelling does not 
perturb the protein-protein interactions in the swollen cell.  1-2 regions per swollen cell are 
Figure 6-2.  The scheme for the equilibrium binding experiments described in this 
chapter.  Many swollen cells exhibiting homogenous diffraction-limited membrane 
fluorescence are imaged in a 35mm petri dish providing surface densities of expressed 
VEGFR2 ECTM-YFP and bound AF594-VEGF.  A volume of buffer without cells is 
also imaged with settings optimized for measuring weak buffer fluorescence, 
providing a free-VEGF measurement in the buffer surrounding the cells.   
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measured, and 25-50 cells per dish are acquired.  I also measure the free-VEGF 
concentration in the same dish by measuring buffer fluorescence in a region of the dish 
without adherent cells present. 
  
Figure 6-3.  The spectral properties of the fluorophores utilized in this chapter.  A.  
The emission spectra and absorption spectra (solid and dashed lines, repectively) are 
given for YFP in yellow and Alexa Fluor 594 in red.   The grey dashed lines show the 
wavelengths utilized in the FRET scans to excite the YFP donor at 960nm and to 
excite the acceptor, AF594, at 800nm or 840nm B.  The integrated intensity of the 
solution standards, YFP in yellow, and Alexa-Fluor 594 in red as a function of total 
concentration.  A line is fit to the data for excitation during the FRET scan at 960nm 
(solid line) and for excitation during the Acceptor scan, shown here at 840 nm, for 
both fluorophores.   YFP is primarily excited at 960nm, while Alexa Fluor 594 is 
primarily excited at 840nm.  The fully-solved system of equations of the FSI method 
is able to account for intrinsic excitation of both fluorophores at both excitation 
wavelengths in an approximation-free manner by using the slopes of these lines of 




Here, I only review the primary equations and ideas fundamental to performing the 







 In these equations, 𝐸𝑎𝑝𝑝 is the measured total apparent FRET efficiency, 𝐹
𝐷
𝑅𝐸𝑇, 𝜆1 
is the theoretical fluorescence of the donor that is transferred to an acceptor instead of being 
emitted, for excitation in the FRET scan at 𝜆1.  𝐹
𝐷,𝐴
𝜆1,2 is total fluorescence of the donor 
or acceptor in the absence of FRET for excitation at 𝜆1 or 𝜆2 .  𝐹
𝐷𝐴
𝜆1 is the measured 
fluorescence of the donor in the presence of acceptors, and 𝐹𝐴𝐷𝜆2  is the measured 
fluorescence of the acceptor, enhanced due to FRET.  𝑖𝐷, 𝜆1 and 𝑖𝐴, 𝜆2 are the slopes of the 
solution standard intensity versus micromolar concentration curves determined by imaging 
solution standards of known concentration, described in the YFP and Alexa-Fluor 594 
Solution Standards section below.   
Equation (6-12) is directly applied to buffer fluorescence images and the measured 
pixel-level concentrations are histogrammed.  A Gaussian curve is fit to the data to 
determine the values of the mean, 𝜇, and the standard deviation, 𝜎, the value and error in 









































𝐹𝐴𝜆2))  (6-11) 
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 For the surface density measurement, the apparent pixel-level fluorophore (receptor 
and bound ligand) concentrations calculated during the image analysis must be integrated 
across the diffraction limited segment in order to properly determine the 2D surface density 
from the fluorescence and the calibration curves.  To do so, FD, FA, and FAD are integrated 
(summed) over every pixel selected in the region, 𝐹 𝜆𝑖,𝑅𝑒𝑔
𝐷,𝐴 = ∫𝐹𝑟𝑒𝑔𝑖𝑜𝑛
𝐷 𝑜𝑟 𝐴𝑑𝐴 =  ∑𝐹𝑖,𝑗
𝐷 𝑜𝑟 𝐴.  





𝐷⁄  .   
 The total integrated fluorescence intensities for the region, 𝐹𝜆1,𝑅𝑒𝑔
𝐷 , and  𝐹 𝜆2,𝑅𝑒𝑔
𝐴 , 
are then divided by the arc length, s, of the selected region to calculate the average 
integrated fluorescence per unit length of membrane (in units of pixel).  By swelling the 
cells with osmotic stress, we are able to simplify the complex topology of the membrane 
and assume a perpendicular orientation of the membrane with respect to the focal plane. 
We also assume that the fluorescence originates from an infinitely thin sheet within the 
width of one pixel, or 254nm.  To obtain the fluorescence that would be emitted by a full 
voxel of chromophores, the integrated fluorescence per unit pixel-length is multiplied by 
the pixel width, 254nm.  By dividing the full voxel fluorescence by the average slope, <
𝑖𝜆𝑖
𝐷,𝐴 >, and performing the appropriate unit conversion from micromolar concentrations to 
receptors per unit area (in units of rec/nm2), the average receptor surface density for the 
region is calculated, as shown below: 
 






























6-3.7.  YFP and Alexa-Fluor 594 Solution Standards 
 Soluble monomeric YFP with an N-terminal 6x His-tag was expressed and purified 
to near-milimolar concentrations as described (27).  Fluorescent protein stocks were buffer 
exchanged into PBS buffer with a 20kDa MWCO concentrator (Pierce #87751) and filtered 
with a 0.2µm syringe filter.   Unconjugated Alexa Fluor 594 (A37572) was purchased in 
lyophilized form from ThermoFisher Scientific and suspended in PBS buffer.  For each 
imaging session, the stocks were then diluted in buffer to micromolar concentrations to 
produce 100%, 75%, and 50% fluorescent protein and AF594 solution standards.  The 
solution standard concentrations were measured in a 1 cm path length quartz cuvette using 
NanoDrop 2000C (Thermo Scientific).  Molar absorption coefficients of 83,400 Mol*cm-
1 and 73,000 Mol*cm-1 were used to calculate the concentrations of the solution standards 
from the YFP and AF594 absorption maxima of 514 nm and 590 nm, respectively.  Images 
of the 100%, 75%, 50% solution standards and a PBS buffer-only control were acquired at 
both excitation wavelengths (800nm or 840nm for AF594, and 960nm for YFP) and were 
used for the calculation of the pixel-level slope values as used with the FSI method 
described briefly in this work, but previously described in excruciating detail.   
 Figure 6-3A shows the shows the normalized YFP and AF594-VEGF fluorescence 
obtained from the membranes of live cells.  I see no apparent change in the fluorescence 
emission properties in the AF594-VEGF or YFP fluorophores on the surface of the cells 
when compared to that of the solution standards, and the respective emission maxima of 
618 nm and 527 nm remain unchanged.  This is not surprising given the AF594 resides in 
buffer that is mostly water, and the fluorescent proteins exist in the cytosol, just on the 
intracellular side of the membrane.  Figure 6-3B shows the measured fluorescence versus 
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concentration curves of the solution standards for a single pixel.  The slopes of these lines 






6-4.  Results  
 Here, I used the FSI methodology to study the binding properties of AF594-VEGF 
with the EC domains of monomeric and dimeric VEGFR2.  FSI allows one to measure the 
surface densities of fluorescently labeled membrane proteins, as well as FRET between the 
labeled moieties.  Additionally, FSI allows measurement of three-dimensional 
concentrations of fluorophores in the buffer.  These three features are utilized in 
conjunction to study VEGF affinities for VEGFR2.   
 As shown in Figure 6-4A, I utilized a truncated form of VEGFR2 where the kinase 
domain is replaced by a fluorescent protein, YFP, attached to the TM domain by a GGS5 
flexible linker (VEGFR2 ECTM-YFP)  and a form of VEGF121, scVEGF, linked to the 
organic dye Alexa-Fluor 594.  Figures 6-4B,C depict three transiently transfected 
HEK293T cells, swollen with hypo-osmotic stress, and expressing different amounts of 
VEGFR2 ECTM-YFP while in the presence of AF594-VEGF in the buffer.  Figure 6-4B 
shows the cells under excitation at 960nm, which primarily excites VEGFR2-ECTM-YFP.  
We can see large stretches of homogenous membrane fluorescence and that the protein is 
primarily localized to the cell membrane, but the fluorescence of intracellular proteins 
being trafficked to the membrane is also visible.  In Figure 6-4C, we see the same cells 
under excitation at 800 nm, which primarily excites AF594-VEGF.  AF594-VEGF is 
highly concentrated on the surface of the cells, but no VEGF-fluorescence originates from 
the intracellular space, as the VEGFR2 ECTM domains do not contain the kinase domains, 
and thus activated receptors are not taken into the cell through endocytosis.   In cells with 
no VEGFR2 ECTM-YFP fluorescence, I find no measurable AG594-VEGF fluorescence, 




Figure 6-4.  A.  A cartoon showing 
VEGF bound to a dimer of VEGFR2.  
The YFP is attached via a GGS5 
flexible linker to the ECTM domain of 
VEGFR2.  VEGF, with an attached 
AF594 fluorophore, diffuses freely in 
the buffer and binds to subunits D2 
and D3 of the VEGFR2 extracellular 
domain (colored in yellow).  At 960 
nm excitation, we elicit primarily YFP 
fluorescence.  At 800nm or 840nm 
excitation, we elicit fluorescence 
primarily from AF594- VEGF.  B.  
Three HEK293T cells transiently 
transfected with VEGFR2-ECTM-
YFP and swollen with hypo-osmotic 
stress, in the presence of AF594-
VEGF.  The cells exhibit large 
stretches of homogenous membrane 
fluorescence when YFP is excited at 
960nm.  We see VEGFR2-ECTM-
YFP being trafficked to the membrane 
in the intracellular space.  C.  The 
same cells as B., but under excitation 
at 800nm, which excites Alexa Fluor 
594-VEGF.  As with VEGFR2 
ECTM-YFP, large stretches of 
homogenous membrane fluorescence 
are visible from bound AF594-VEGF, 
but we see no intracellular AF594 
fluorescence.  No ligand is taken up 
into the cell for the duration of the 
experiments.  Scale bar is 30 𝜇𝑚.  








 I measured VEGFR2 ECTM-YFP and bound AF594-VEGF surface densities in 12 
independent experiments from a total of 387 cells.  These images provided a total of 661 
data points at twelve different free-VEGF concentrations.  Figure 6-5 shows the measured 
total apparent FRET efficiency between the intracellular YFP of VEGFR2 ECTM and the 
AF594-VEGF, bound to the distal region of the VEGFR2 EC domain.  We see zero 
concentration dependence on the total apparent FRET efficiency, and the FRET is zero for 
all concentrations of VEGFR2.  This data indicates that the YFP (FRET donor) and the 
AF594 (FRET acceptor) are greater than 10 nm apart when VEGF is bound to VEGFR2’s 
EC domain.  This lack of measured FRET is expected given that the cell membrane is ~5nm 
thick on its own, and YFP is a large beta barrel of considerable extent around the YFP 
chromophore, which is connected to VEGFR2 TM domains via a 15 amino acid GGS 









Figure 6-5.  The measured total apparent FRET efficiency between VEGFR2-ECTM-
YFP and bound AF594-VEGF is plotted as a function of total VEGFR2 surface 
density.  The FRET is zero at all concentrations, indicating that the fluorophore of 
AF594-VEGF bound to the VEGFR2 EC domain is greater than 10nm from the 
intracellular YFP, linked to the VEGFR2 TM domain by a 15 amino acid GGS linker.     
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 Figure 6-6 shows the bound AF594-VEGF surface density plotted as a function of 
the expressed VEGFR2 ECTM-YFP surface density for three values of free-VEGF 
concentrations: 42.3 nM, 1.54 nM, and 0.21 nM (green, orange, and blue circles, 
respectively).   We a distinct dependence on the three-dimensional free-VEGF 
concentration on the bound VEGF vs expressed VEGFR2 surface densities.  Since the 
number of data points at each free-VEGF concentration is not enough to determine KLM 
and KLD , I combined the data from the twelve datasets obtained at different free-VEGF 
concentrations and globally fit the data with Equations (6-8) and (6- 9) to find the best-fit 
values of the two adjustable parameters:  the binding affinity of AF594-VEGF for 
monomeric VEGFR2 EC domains, KLM, and the binding affinity of AF594-VEGF from 
dimeric VEGFR2 EC domains: KLD.  These are the best-fit values of KLM and KLD  that 
globally minimize the error of the model, and as such the accuracy and precision of the fit 
is improved.  
 The best fit results are: 𝐾𝑙𝑚 =  9.6𝑒7 ± 1.8𝑒7 𝑀
−1  and 𝐾𝑙𝑑 = 4.3𝑒9 ±
0.6𝑒9 𝑀−1  (95% confidence), indicating a ~40-fold enhancement of VEGF binding 
affinity dimeric VEGFR2 over the affinity of AF594-VEGF for monomeric VEGFR2 EC 
domains.  Plotted in red solid lines in Figure 6-6 are the predicted values of the bound 
VEGF as a function of expressed VEGFR2 ECTM surface density.  The dashed red lines 
indicate the confidence limits on the fit, obtained through propagation of errors on KLM and 
KLD in Equations (6- 8) and (6-9), with the 95% confidence limits on KLM and KLD.   We 
see good agreement between the measured data and the best-fit predicted bound-VEGF 
surface densities as a function of free-VEGF and expressed VEGFR2 surface densities.  
Figure 6-7 shows the measured bound-VEGF surface density as a function of the expressed 
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VEGFR2 ECTM surface density for each of the twelve individual datasets, as well as the 
best-fit theoretical bound VEGF surface density for that free-VEGF concentration.  Figure 
6-8 shows the results of the free-AF594-VEGF buffer measurements.   
  
Figure 6-6.  The bound AF594-VEGF surface density is plotted as a function of 
expressed VEGFR2 ECTM-YFP surface density for several values of free-VEGF in 
the buffer:  42.3 nM, 1.54 nM, and 0.21 nM (green, orange, and blue circles, 
respectively).  We see that the bound VEGF is not only a function of VEGFR2 surface 
density, but also the three-dimensional free-VEGF concentration.   Plotted in red is the 
best-fit  result of the global fitting for the theoretical bound AF594-VEGF as a 
function of VEGFR2 surface density at each of the three free-VEGF values.  The 
dashed lines indicate 95% confidence intervals on the fit.  We see good agreement 






Figure 6-7.   The measured AF594-VEGF surface density plotted as a function of the 
expressed VEGFR2 surface density (filled circles) for each of the 12 independent 
experiments performed at different values of the three-dimensional free-VEGF 
concentration.  The data were combined and globally fit with the thermodynamic cycle 
described in the text, and the best-fit theoretical VEGF surface density for each 
experiment at a given free-VEGF value is plotted as a function of total VEGFR2 




Figure 6-8.  The free-VEGF measurement results for each of 12 experiments.  The 
pixel-level buffer concentrations were obtained by imaging a region of buffer where 
no cells were located.  A large region was chosen in each image, and the pixel-level 
AF594-VEGF concentrations were binned and histogrammed for each of the twelve 
experiments.  Each histogram was fit to a Gaussian distribution, and thebest-fit values 
for mu and sigma are utilized as the free-VEGF value and its associated error, 
respectively.   
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6-5.  Discussion and Conclusions 
 In this chapter, I utilized a thermodynamic cycle and global fitting of many 
combined datasets to measure the separate binding affinity of VEGF for monomeric and 
dimeric forms of VEGFR2 EC domains, in the context of the living cell membrane.  
Surprisingly, we find that the affinity of VEGF for dimeric VEGFR2 EC domains is 
substantially greater than the affinity of VEGF for monomeric VEGFR2 EC domains.  The 
dimerization affinity of the full length VEGFR2 molecule known from previous 




 = 2.97𝑒4 (𝑟𝑒𝑐 𝑛𝑚2⁄ )
−1 .   
Here I utilized the truncated form of VEGFR2 lacking the kinase domain, VEGFR2 
ECTM-YFP, which dimerizes with a greatly reduced Gibbs free energy of ∆𝐺°𝐹𝐿 =
 −3.5 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙 with 𝐾𝑅 =
[𝐷]
[𝑀]2
 = 370 (𝑟𝑒𝑐 𝑛𝑚2⁄ )
−1.   
 Figure 6-9 shows the dimeric fraction as a function of total VEGFR2 surface 
density for the full-length and the truncated ECTM VEGFR2 forms, in the absence of 
VEGF.  We see that the dimeric fraction of the full-length VEGFR2 is significantly 
enhanced over that of the VEGFR2 ECTM construct.  In these experiments, I overexpress 
membrane proteins to the range of 1e-5 to 4e-3 rec/nm2, and in this range, full-length 
VEGFR is essentially a constitutive dimer in the absence of ligand.   In addition to avoiding 
the complexities of receptor activation, endocytosis, and receptor trafficking that are 
involved when working with the full-length VEGFR2 construct and VEGF, by using the 
truncated ECTM construct I also expose a large population of monomeric VEGFR2 for 
AF594-VEGF binding, enabling a measurement of the VEGF affinity for monomeric 
VEGFR2 EC domains.  Thus, the use of a form of VEGFR2 (ECTM) with significant 
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fractions of monomeric and dimeric EC domains in the absence of VEGF was required to 
measure the separate affinities of VEGF for VEGFR2 monomeric and dimeric EC 





Figure 6-9.  The dimeric fraction of full-length VEGFR2, which dimerizes with a 
Gibbs free energy of -6.1 kcal/mol is plotted as a function of total VEGFR2 surface 
density in black.  The dimeric fraction of VEGFR2 ECTM domains, which dimerize 
with a Gibbs free energy of -3.5 kcal/mol, is also plotted as a function of total 
VEGFR2 surface density.  The dimeric fraction of full-length VEGFR2 is 
significantly greater than the dimeric fraction of VEGFR2 ECTM membrane proteins 
for all concentrations of VEGFR2, due to the presence of the intracellular domain.   
VEGFR2𝐹𝐿 ∆𝐺° = −6.1 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙 
VEGFR2𝐸𝐶𝑇𝑀  ∆𝐺° = −3.5 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙 
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 However, now that we know the binding affinities of VEGF for the monomeric and 
dimeric forms of VEGFR2 EC domains, we can utilize Equations (6-8) and (6-9) with the 




 = 2.97𝑒4 (𝑟𝑒𝑐 𝑛𝑚2⁄ )
−1 to 
predict the saturation of VEGFR2 binding sites at any surface density of full-length 
VEGFR2 and any free-VEGF concentration.  Figure 6-10A shows the fraction of occupied 
binding sites, ?̅? =  
[𝐿𝑀]+[𝐿𝐷]
[𝑀]+[𝐷]+[𝐿𝑀]+[𝐿𝐷]
 as a function of total VEGFR2 surface density (left 
axis) and the free-VEGF concentration (bottom axis).    
 We can write ?̅? as a sum of the saturations of monomeric and dimeric VEGFR2 
binding sites:  
 
?̅? = ?̅? + ?̅? =
[𝐿𝑀]
[𝑀] + [𝐷] + [𝐿𝑀] + [𝐿𝐷]
+ 
[𝐿𝐷]
[𝑀] + [𝐷] + [𝐿𝑀] + [𝐿𝐷]
 (6-14) 
  
 In Figures 6-10B, 6-10C I have plotted ?̅? and ?̅? as a function of total VEGFR2 
surface density and free-VEGF concentration.  We see that dimeric VEGFR2 binding sites 
saturate at the lowest free-VEGF concentrations, 1e-9 M through 1e-7 M , while at higher 
VEGF concentrations, VEGF binding to dimers is reduced and binding of VEGF to 
monomeric VEGFR2 EC domains dominates.  At surface densities of VEGFR2 > 1e-4 
rec/nm^2, where unliganded VEGFR is > 70% dimeric, this condition of suppressed 





Figure 6-10.  The predicted 
fractions of occupied VEGF 
binding sites for full-length 
VEGFR2 as a function of 
VEGFR2 surface density and 
free-VEGF concentration.  A.  
The fractional saturation of all 
monomeric and dimeric 
VEGFR2 binding sites.  B.  The 
fractional saturation of 
monomeric VEGFR2 binding 
sites.  C.   The fractional 
saturation of dimeric VEGFR2 






 Figure 6-11 A-D shows the theoretical fractions of monomeric VEGFR2, [M], 
VEGF-bound monomeric VEGFR2, [LM], dimeric VEGFR2 [D], and VEGF-bound 
dimeric VEGFR2, [LD], as functions of total VEGFR2 surface density and the free-VEGF 
concentration.  In Figure 6-11A, we see that the VEGFR2 full-length construct essentially 
never exists in the unliganded monomeric form.  In Figure 6-11B, we see that free-VEGF 
concentrations greater than micromolar are required to force full-length VEGFR2 into the 
monomeric state.  Figure 6-11C shows that unliganded dimers dominate at all 
concentrations of free-VEGF less than 100 pM.  Finally, Figure 6-11D shows the active 
fraction of VEGFR2 as a function of free-VEGF and VEGFR2 surface density: at 
exceptionally high free-VEGF concentrations, the active fraction of VEGFR2 can be 
suppressed to near zero.   
 From these predictions, one can say much about how the cell must utilize the 
VEGFR2 receptor with its activating ligand, VEGF.  We see that VEGF binds with higher 
affinity to dimers of VEGFR2 than to monomers of VEGFR2.  With physiological surface 
densities of VEGFR2 ranging from 10-100 receptors/micron, or 1e-5- 1e-4 rec/nm2, and 
due to the law of mass action, and the ∆𝐺°𝐹𝐿 = −6.1 𝑘𝑐𝑎𝑙/𝑚𝑜𝑙 dimerization affinity, at 
these concentrations VEGFR2 will be 70-50 % monomeric and 30-50% dimeric.  If there 
are only 10 receptors in a square micron, then there are only 1-2 preformed dimers of 
VEGFR2.  Thus, it can be predicted from this data that the cells must be clustering the 
receptors in order to enhance the local effective concentration of VEGFR2 to ~10e-3 
rec/nm2, in effect pre-staging the VEGFR2 into unliganded dimers so that small amounts 
of VEGF can bind with high affinity specifically to VEGFR2 dimers.    
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 Given that VEGFR2 can interact with a number of different membrane proteins, 
and that VEGF also binds to a number of different membrane proteins, this finding makes 
a lot of sense.  The purpose of these co-receptors is probably to attract VEGFR2 molecules, 
and pre-stage dimers for efficient signal transduction.  Binding of VEGF to a preformed 
dimer of VEGFR2 immediately and rapidly activates the receptor for signal transduction.  
Thus, even though full-length VEGFR2 has the ability to exist in its monomeric form, the 
pre-formed dimeric form of VEGFR2 is the “signaling-ready” complex, and relatively 
small amounts of VEGF can be released to specifically activate dimeric VEGFR2.   An 
important question remains unanswered in that we still do not know exactly how many 
dimers of VEGFR2 must be activated for a cellular response to occur.  Ultimately, this 
number of minimum required active VEGFR2 molecules per cell will decide the amount 
of VEGF required for signal transduction, and will determine the best course of treatment 
in order to control VEGFR2 signaling, especially in pathological cases like enhanced 











Figure 6-11.  The predicted fractions of the various forms of VEGFR2 as a function 
of VEGFR2 surface density and free-VEGF concentration.  A.  The fraction of 
monomeric VEGFR2 without bound VEGF.  B.  The fraction of dimeric VEGFR2 
without a bound VEGF.  C.  The fraction of monomeric VEGFR2 with VEGF bound.  
D.  The fraction of dimeric VEGFR2 with bound VEGF.  This Is the active form of 





Chapter 7.  Conclusion 
 
 In this body of work, I have taken quantitative FRET analysis to its edge and shown 
the limits of static quenching two-color FRET measurements utilizing fluorescent proteins 
linked to membrane proteins diffusing freely within a lipid bilayer.  With a numerically 
estimated stochastic FRET contribution included in the model to the total apparent FRET 
efficiency, one is able to measure the thermodynamic properties of membrane proteins 
existing as monomers, dimers, or higher-order oligomers.   Even though the oligomer order 
is not distinguishable in such an experiment involving oligomers greater than dimers, the 
oligomeric fraction is still accessible and can be compared to other proteins or conditions.    
 I also extended the limits of FRET measurements in cell membranes.  The Fully 
Quantified Spectral Imaging method gives the researcher the unique ability to measure 
membrane protein surface densities in live cells, in addition to a FRET efficiency.  
Furthermore the FSI method allows for the measurement of the three-dimensional 
concentration of fluorophores freely diffusing in buffer.  Here, I utilized all of these features 
of the FSI method to measure the previously unknown nature of the extracellular domain 
contacts of VEGFR2, in the absence of its activating ligand, VEGF.  I then utilized the FSI 
methodology in an exceedingly tedious and difficult set of experiments that permitted a 
measurement the binding affinity of VEGF, labeled with a fluorescent dye, for the separate 
monomeric and dimeric VEGFR2 EC domains.  VEGFR2 is a signal transducing 
membrane protein critical for angiogenesis, and thus a true understanding of this protein in 
the context of the live-cell membrane is critical to treating a variety of medical problems 
stemming from enhanced or suppressed angiogenic signaling.   
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 I have shown that the theory and methodology developed during this thesis will 
revolutionize our understanding of membrane proteins by permitting their relatively 
unperturbed study in the context of the live-cell membrane.  Many membrane proteins can 
be more completely understood by applying similar methodologies.  This is especially true 
for the case of co-receptors, or scaffolding proteins with no direct function, like 
phosphorylation, to monitor as an observable in experiments.  Thus, performing a direct 
measurement of protein-protein interactions is needed to truly understand the roles of these 
membrane proteins, which are primarily understood through secondary effects on binding 
partners.  The theory and methodology that I have developed in this thesis is one set of 
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